JPH0467957B2 - - Google Patents
Info
- Publication number
- JPH0467957B2 JPH0467957B2 JP61068857A JP6885786A JPH0467957B2 JP H0467957 B2 JPH0467957 B2 JP H0467957B2 JP 61068857 A JP61068857 A JP 61068857A JP 6885786 A JP6885786 A JP 6885786A JP H0467957 B2 JPH0467957 B2 JP H0467957B2
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- primers
- primer
- dna
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 claims description 136
- 150000007523 nucleic acids Chemical group 0.000 claims description 134
- 239000013615 primer Substances 0.000 claims description 133
- 108020004707 nucleic acids Proteins 0.000 claims description 86
- 102000039446 nucleic acids Human genes 0.000 claims description 86
- 108020004414 DNA Proteins 0.000 claims description 79
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 43
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 42
- 230000003321 amplification Effects 0.000 claims description 42
- 230000000295 complement effect Effects 0.000 claims description 37
- 238000003786 synthesis reaction Methods 0.000 claims description 31
- 230000015572 biosynthetic process Effects 0.000 claims description 27
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 24
- 102000004594 DNA Polymerase I Human genes 0.000 claims description 21
- 108010017826 DNA Polymerase I Proteins 0.000 claims description 21
- 108091034117 Oligonucleotide Proteins 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 15
- 125000003729 nucleotide group Chemical group 0.000 claims description 15
- 239000003155 DNA primer Substances 0.000 claims description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 12
- 238000006116 polymerization reaction Methods 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 10
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 8
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 108060004795 Methyltransferase Proteins 0.000 claims description 6
- 102000053602 DNA Human genes 0.000 claims description 5
- 239000001226 triphosphate Substances 0.000 claims description 5
- 235000011178 triphosphate Nutrition 0.000 claims description 5
- 239000002777 nucleoside Substances 0.000 claims description 4
- -1 nucleoside triphosphates Chemical class 0.000 claims description 4
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 2
- 239000000411 inducer Substances 0.000 claims 2
- 102100034343 Integrase Human genes 0.000 claims 1
- 108020004682 Single-Stranded DNA Proteins 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 79
- 239000000047 product Substances 0.000 description 49
- 239000012634 fragment Substances 0.000 description 45
- 239000000523 sample Substances 0.000 description 34
- 239000003153 chemical reaction reagent Substances 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 24
- 208000007056 sickle cell anemia Diseases 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 239000000499 gel Substances 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 16
- 108700028369 Alleles Proteins 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 230000029087 digestion Effects 0.000 description 11
- 108091008146 restriction endonucleases Proteins 0.000 description 11
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 10
- 229960005542 ethidium bromide Drugs 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 10
- 229920002401 polyacrylamide Polymers 0.000 description 10
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 238000007792 addition Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 8
- 230000002194 synthesizing effect Effects 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 238000010369 molecular cloning Methods 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 230000002285 radioactive effect Effects 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 208000035473 Communicable disease Diseases 0.000 description 5
- 239000007984 Tris EDTA buffer Substances 0.000 description 5
- 239000011543 agarose gel Substances 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 5
- 239000003298 DNA probe Substances 0.000 description 4
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 4
- 239000011654 magnesium acetate Substances 0.000 description 4
- 235000011285 magnesium acetate Nutrition 0.000 description 4
- 229940069446 magnesium acetate Drugs 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000013638 trimer Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 239000005549 deoxyribonucleoside Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 108060003196 globin Proteins 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- 150000004713 phosphodiesters Chemical class 0.000 description 3
- 239000002987 primer (paints) Substances 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KDELTXNPUXUBMU-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid boric acid Chemical compound OB(O)O.OB(O)O.OB(O)O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KDELTXNPUXUBMU-UHFFFAOYSA-N 0.000 description 2
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010087504 Beta-Globulins Proteins 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108091005903 Hemoglobin subunit delta Proteins 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 2
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 102000001218 Rec A Recombinases Human genes 0.000 description 2
- 108010055016 Rec A Recombinases Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 201000006288 alpha thalassemia Diseases 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000005980 beta thalassemia Diseases 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000006642 detritylation reaction Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101100243024 Arabidopsis thaliana PCO1 gene Proteins 0.000 description 1
- 101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000272185 Falco Species 0.000 description 1
- 108010044495 Fetal Hemoglobin Proteins 0.000 description 1
- 102100039894 Hemoglobin subunit delta Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 1
- 101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000005289 controlled pore glass Substances 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ããã®ååšããæ žé
žé
åãå¢å¹
ããã
ãã®æ¹æ³ã«é¢ããããã詳现ã«ã¯æ¬çºæã¯ãäžã
ãããDNAåã¯RNAé åããåæã«ååšããé
ã«æ¯èŒããŠãã倧éã®ä»»æã®ç¹å®ã®æ žé žé åãç
æããããæ¹æ³ã«é¢ããã該DNAåã¯RNAã¯å
éåã¯äºééã§ãã€ãŠããããæ¯èŒççŽç²ãªçš®ã§
ãã€ãŠãæ žé žã®æ··åç©ã®äžæåã§ãã€ãŠãããã
æ¬çºæã®æ¹æ³ã§ã¯ãææã®æ žé žé åã®å¢å¹ ãéæ
ããããã«åå¿ãç¹°ãè¿ãè¡ãããã«ããã ãåŸæ¥ã®æè¡ã ç¹ã«èšºæäžã®çšéã®ããã«ã¯ãæšçæ žé žé åã¯
åé¡ã®DNAåã¯RNAã®ã»ãã®å ããªéšåã§ãã
ããšããããéåäœäœæšèåã¯æ«ç«¯æšèãªãªãŽã
ã¯ã¬ãªãããããŒãã䜿çšããã®ã§ã¯ãã®ååšã
æ€åºããããšã¯å°é£ã§ããããããŒãæ€åºã·ã¹ã
ã ã®æ床ãåäžãããããã«å€ãã®åŽåãè²»ãã
ããŠããããçŸåšå©çšã§ããæ¹æ³ãçšããŠå®¹æã«
æ€åºã§ããã«å åãªéãåŸãããã«ãæšçé åã
å¢å¹ ãããããªç 究ã¯æ®ã©è¡ãããŠããªãã æ žé žãåãããããããã¯æ¢åã®é åããåæ
ããæ¹æ³ãããã€ãã®æç®ã«èšèŒãããŠãããã
ããã®æ¹æ³ã¯ãå®å šã«ç¹å®ãããé åã®äžããã
ãæ žé žã倧éã«çç£ããããšãå¯èœã«ãããã®ã§
ããã æ žé žãåãããåæããïŒã€ã®æ¢ç¥æ¹æ³ã¯ãã
ã¯ã¬ãªã·ãèªå°äœããã®æ žé žã®ææ©åæãå«ãã
ã®ã§ããããã®åæã¯æº¶æ¶²äžåã¯åºäœæ äœäžã§è¡
ããããææ©åæã®ïŒã€ã®ã¿ã€ãã¯ãªã³é žããªãš
ã¹ãã«æ³ã§ãããããã¯éºäŒåæçåã¯çãéºäŒ
åã調補ããããã«å©çšãããããªã³é žããªãšã¹
ãã«æ³ã§ã¯ããªãªãŽãã¯ã¬ãªããã調補ããã次
ã«ããã¯çµåãããŠããé·éã®æ žé žã圢æããã
ãã®æ¹æ³ã¯ãS.A.ããŒã©ã³ã¯ãã«ãããMeth.
Enzymol.68å·»90é ïŒ1979幎ïŒåã³ç±³åœç¹èš±ç¬¬
435627å·ã«é瀺ãããŠããã該ç¹èš±ã¯ããœããã¹
ã¿ãã³éºäŒåã®åæãšã¯ããŒãã³ã°ãé瀺ããŠã
ãã ææ©åæã®ç¬¬ïŒã®ã¿ã€ãã¯ãªã³é žãžãšã¹ãã«æ³
ã§ãããããã¯ãã©ã³ã¹ãã¢ãŒRNAéºäŒåã®èª¿
補ã«å©çšãããŠããããã®æ¹æ³ã¯E.L.ãã©ãŠã³ã
ã«ããMeth.Enzymol.68å·»109é ïŒ1979幎ïŒã«é
瀺ãããŠããããªã³é žããªãšã¹ãã«æ³ãšåããã
ã«ããªã³é žãžãšã¹ãã«æ³ããªãªãŽãã¯ã¬ãªããã®
åæãå«ã¿ãããããå®è³ªçã«çµåãããŠææã®
æ žé žã圢æãããã äžèšããåãããã®åææ³ã¯æ žé žã®é·éãåæ
ããããã«å©çšãããããæ žé žã倧éåæããã
ãã®å®çšçæ¹æ³ã§ã¯ãªããäž¡æ³ãšãåŽåãšæéã
æ¶è²»ãé«äŸ¡ãªè£ 眮ãšè©Šè¬ãå¿ èŠãšããã€å šäœåç
ãäœããå šäœåçãäœãã®ã¯ããªãªãŽãã¯ã¬ãªã
ãã®åæãšããããçµåããåå¿ãéå¹ççã§ã
ãããšã«èµ·å ãããé·éã®æ žé žãåæããéãã
ãã¯çéã®æ žé žã倧éã«åæããå Žåã§ãããã
å€ãã®ãªãªãŽãã¯ã¬ãªãããåæãå€ãã®çµåå
å¿ãè¡ãããšãèŠæ±ããããåŸã€ãŠãããã®æ¹æ³
ã¯ä»»æã§ææã®æ žé žã倧éã«åæããã«ã¯å®çšç
ã§ã¯ãªãã åãã«ååšããå°éã®æ žé žãã倧éã®æ žé žãç
ç£ããæ¹æ³ãååšããããããã®æ¹æ³ã¯å¥œé©ãªå®¿
䞻系å ã§ã®æ žé žã®ã¯ããŒãã³ã°ãå«ã¿ãããã§ã¯
ææã®æ žé žã¯å®¿äž»ã®åœ¢è³ªå€æã«äœ¿çšããã奜é©ãª
ãã¯ã¿ãŒäžã«æ¿å ¥ãããã宿䞻ãå¹é€ããããšã
ã¯ã¿ãŒãè€è£œãããææã®æ žé žã®ã³ããŒãçç£ã
ãããæ žé žæçã®ãµãã¯ããŒãã³ã°ã«ã€ããŠã¯ã
T.ããã¢ãã¹ãã«ãããã³ãŒã«ãã»ã¹ããªã³
ã°ã»ã©ãã©ããªãŒã®Molecular Cloning390â401
é ïŒ1982幎ïŒã«ç°¡åã«èšè¿°ãããŠããããã®æè¡
ã«ã€ããŠã¯ç±³åœç¹èš±ç¬¬4416988å·åã³4403036å·ã«
ãèšè¿°ãããŠããã ç±³åœç¹èš±ç¬¬4293652å·ã«èšèŒãããŠããæ žé žã®
第ïŒã®åææ³ã¯ãäžè¿°ã®ææ©åæãšååã¯ããŒã
ã³ã°æ³ãåããããã®ã§ããã該æ³ã§ã¯ãææã®
æ žé žé åãäœãäžããã®ã«å¿ èŠãªå¥œé©ãªæ°ã®ãªãª
ãŽãã¯ã¬ãªãããåãã«åæãã次ã«ãããã次
ã®æ¿å ¥ã®åã«å¢æ®ã«ããå¢å¹ ããããã¯ã¿ãŒã«æ¿
å ¥ããã ãçºæã解決ããããšããåé¡ç¹ã æ¬çºæã¯ããã®ååã¯ããŒãã³ã°æ³ã«å¹Ÿããã®
é¡äŒŒæ§ãæããŠããããããæ¬çºæã¯ãããªãç
ç©ã®ç¹æ®ããå«ãŸããåŸã€ãŠç¹æ®ã«äŒŽã€ãŠèµ·ãã
åŸãå±éºãäžéœåãåé¿ããããšãã§ãããæ¬çº
æã¯ææã®æ žé žãšé¢é£ããªãæ žé žã®åæãå¿ èŠãš
ãããåŸã€ãŠæ¬çºæã«ããã°è€éãªçç©åŠçæ··å
ç©ããã³ã¹ãããããŠçæç©ã粟補ããããšãå
é¿ã§ããã æ¬çºæã¯ãã©ã€ããŒãšéåè©Šè¬ãçšããŠïŒçš®ã®
æ žé žåã¯è€æ°ã®æ žé žã®æ··åç©äžã«ååšããïŒåã¯
ïŒä»¥äžã®ç¹å®ã®æ žé žé åãå¢å¹ ããæ¹æ³ã«é¢ã
ãããã©ã€ããŒã¯å¢å¹ ãããã¹ãé åã®æ«ç«¯ãå®
ãããããŠïŒã€ã®ãã©ã€ããŒã®äŒžé·çæç©ã¯ãä»
ã®ãã©ã€ããŒãšãã€ããªãã€ãºãããšãã«ææã®
ç¹å®ã®æ žé žé åã®çæã®ããã®é³åãšãªããåã
ã®éãèµ·ããããããŠãã®ããã»ã¹ã¯æå®éã®é
åãçæãããŸã§å¿ èŠãªã ãç¹°ãè¿ããããæšç
é åãã倧éã®æ žé žãæ¯èŒççæéã§çç£ããã
ãã«ã¯ãæ¬æ¹æ³ã¯äžèšã®åŸæ¥æ³ããå¹ççã§ãã
ãšæåŸ ããããæ¬æ¹æ³ã¯æ žé žæ··åç©ã«å ãããå«
ãŸããŠããªãæ žé žçš®ãå¢å¹ ãã該皮ãå¹ççã«æ€
åºããããã«ç¹ã«æçšã§ããã ãåé¡ç¹ã解決ããããã®æ段ã ããã«è©³ããã¯ããã®çºæã¯ãæ žé žåã¯æ žé žæ··
åç©äžã«ååšããå°ãªããšãïŒçš®ã®ç¹å®ã®æ žé žé
åãå¢å¹ ããæ¹æ³ãæäŸãããã®å Žåãåæ žé žã¯
åãé·ãåã¯ç°ãé·ãã®ïŒã€ã®å¥åã®çžè£çãªé
ããæãããããŠåèšã®æ¹æ³ã¯ã (a) åèšéããïŒä»¥äžã®ãªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã«ããåŠçããŠãå¢å¹ ãããã¹ãæ žé žé
åã«ã€ããŠè©²æ žé žé åã®éã«çžè£çãªãã©ã€ã
ãŒã®äŒžé·çæç©ãåæããããã§ãåèšãã©ã€
ããŒã¯ãç¹å®ã®æ žé žé åã®éãšå®è³ªçã«çžè£ç
ã§ãããäžã€å¢å¹ ãããã¹ãæ žé žé åã®äž¡ç«¯ã
èŠå®ããåãã©ã€ããŒããåæããã䌞é·çæ
ç©ããã®çžè£äœããåé¢ãããå Žåã«æŽãªãå
æã®ããã®é³åãšããŠæ©èœããããšãã§ããã
ãã«éžæããïŒ (b) åèšãã©ã€ããŒäŒžé·çæç©ãããããåæã
ããé³åããåé¢ããŠåéååãçæãããïŒ
ãã㊠(c) 段é(b)ããçããåéååã段é(a)ã®ãã©ã€
ããŒã«ããåŠçããŠã段é(b)ã«ãããŠçæãã
ååéååãé³åãšããŠçšããŠãã©ã€ããŒäŒžé·
çæç©ãåæããïŒ ããšãå«ãã§æãã ãããã®æ®µéã¯é次çã«åã¯åæã«è¡ãããšã
ã§ãããããã«ã段é(b)åã³(c)ã¯é åã®ææã®ã¬
ãã«ã®å¢å¹ ãåŸããããŸã§å埩ããããšãã§ã
ãã ãã®çºæã¯ãå®å šã«ç¹å®ãããé åã®æ¢åã®æ ž
é žãå€éã«è£œé ããããã®ã¿ãªãããååšããã
ãšã¯ç¥ãããŠããããããå®å šã«ã¯ç¹å®ãããŠã
ãªãæ žé žé åã補é ããããã«ãæçšã§ãããã
ããã®å Žåã«ããå¢å¹ ãããã¹ãé åã®æåã®ã³
ããŒã¯å ¥æå¯èœã§ãªããã°ãªããªããäœãããã¯
çŽç²ã§ããå¿ èŠã¯ãªããåã¯å¥åã®ïŒdiscreteïŒ
ååã§ããå¿ èŠã¯ãªãã ãå ·äœçãªèª¬æã ãã©ã€ããŒããããŒããæ€åºãã¹ããªãªãŽããŒ
æçããªãªãŽããŒå¯Ÿç §äœãåã³æšèãããŠããªã
ããããã³ã°ãªãªãŽããŒã«é¢ããŠäœ¿çšãããããª
ãªãŽãã¯ã¬ãªããããšããçšèªã¯ãïŒåã¯ãã以
äžã®å¥œãŸããã¯ïŒããå€ãã®ããªãã·ãªããã¯ã¬
ãªããåã¯ãªããã¯ã¬ãªããããæãååãšããŠ
å®çŸ©ãããããã®æ£ç¢ºãªå€§ããã¯å€ãã®å åã«äŸ
åãããã®å°åã¯ãªãªãŽãã¯ã¬ãªããã®ç©¶æ¥µçãª
æ©èœãšçšéã«äŸåããã ããã§äœ¿çšãããããã©ã€ããŒããšããçšèª
ã¯ã粟補ãããå¶éæ¶åç©ãšããŠèªç¶ã«ååšãã
ããã¯åæçã«èª¿è£œããããªãªãŽãã¯ã¬ãªããã
æå³ãããã®ãã©ã€ããŒã¯ãäŸãã°å¥œé©ãªæž©åºŠå
ã³PHã§ãã¯ã¬ãªãããšDNAããªã¡ã©ãŒãŒã®ãã
ãªéåè©Šè¬ãååšãããããªæ žé žéã«çžè£çãªã
ã©ã€ããŒã®äŒžé·çæç©ã®åæãèªçºãããæ¡ä»¶äž
ã«çœ®ããããšãã«åæéå§ç¹ãšããŠæ©èœããããš
ãã§ããã該ãã©ã€ããŒã¯å¢å¹ å¹çãæ倧ã«ãã
ããåéã§ããããšã奜ãŸãããããã®ä»£ããã«
äºééã§ãã€ãŠããããäºééã§ãããšããã©ã€
ããŒã¯äŒžé·çæç©ã調補ããããã«äœ¿çšãããå
ã«ãŸããã®éãåé¢ããããã«åŠçãããããã©
ã€ããŒã¯ãªãªãŽããªãã·ãªããã¯ã¬ãªããã§ãã
ããšã奜ãŸããããã©ã€ããŒã¯ãéåè©Šè¬ã®ååš
äžã§äŒžé·çæç©ã®åæãéå§ããããã«ååãªé·
ãã§ãªããã°ãªããªãããã©ã€ããŒã®æ£ç¢ºãªé·ã
ã¯ã枩床ããã©ã€ããŒæºãå«ãå€ãã®å åã«äŸå
ãããäŸãã°ãç®çãšããé åã®è€éãã«äŸåã
ãŠãªãªãŽãã¯ã¬ãªãããã©ã€ããŒã¯å žåçã«ã¯15
ããïŒåã¯ããããå€ãã®ãã¯ã¬ãªãããå«ã
ããããå°ãªããã¯ã¬ãªãããå«ããã®ã§ãã€ãŠ
ããããçããã©ã€ããŒååã¯ãé³åãšãšãã«å
åå®å®ãªãã€ããªãè€åäœã圢æããããã«ãã
ãäœã枩床ãèŠæ±ããã ãã©ã€ããŒã¯å¢å¹ ãããã¹ãåç¹å®ã®é åã®ç°
ãªãéãšãå®è³ªçãã«çžè£çã§ããããã«éžæã
ããããã®ããšã¯ãã©ã€ããŒã¯ããããã®éãšã
ã€ããªãã€ãºããã«ååã«çžè£çã§ãªããã°ãªã
ãªãããšãæå³ãããåŸã€ãŠãã©ã€ããŒã®é åã¯
é³åã®é åãæ£ç¢ºã«åæ ããå¿ èŠã¯ãªããäŸãã°
çžè£çã§ãªããã¯ã¬ãªããæçãããã©ã€ããŒã®
é åã®æ®éšãéã«çžè£çã§ããããã«ãã©ã€ããŒ
ã®ïŒâ²æ«ç«¯ã«çµåãããŠãããã代ããã«ããã©
ã€ããŒã®é åãå¢å¹ ãããã¹ãéã®é åãšååãª
çžè£æ§ãæããŠããŠããããšãã€ããªãã€ãºãã
ããã«ãã€ãŠä»æ¹ã®ãã©ã€ããŒã®äŒžé·çæç©åæ
é³åã圢æãããªãã°ãçžè£çã§ãªãå¡©åºåã¯ã
ãé·ãé åããã©ã€ããŒå ã«æ£åšããŠããŠãã
ãã æ¬çºæã§äœ¿çšãããå¶éãšã³ããã¯ã¬ã¢ãŒãŒã
åã³ãå¶éé µçŽ ããšããçšèªã¯ãäºééDNAã
ç¹å®ã®æ žé žé ååã¯ãã®è¿åã§åæãããããªçŽ°
èæ§é µçŽ ãæå³ããã æ¬çºæã§äœ¿çšããããDNAã®å€åœ¢çŸè±¡ããšã
ãçšèªã¯ãDNAäžã®ã®ç¹å®éšäœã«ïŒåã¯ããã
ãå€ãã®ç°ãªã€ããã¯ã¬ãªããé åãååšã§ãã
ç¶æ ãæå³ããã ãå¶éæçé·ãã®å€åœ¢çŸè±¡ïŒRALPïŒããšãã
çšèªã¯ãç¹å®ã®å¶éãšã³ããã¯ã¬ã¢ãŒãŒã«ããæ¶
åã«ãã圢æãããå¶éæçã®é·ãã«åäœéã®çž
éãããããšãæå³ããã æ¬çºæã¯ãæ žé žäžã«ååšãããšæãããïŒåã¯
ãã以äžã®ææã®ç¹å®ã®æ žé žé åãå¢å¹ ããæ¹æ³
ã«é¢ãããæ¬æ³ã«ããã°å€§éã®ç¹å®ã®é åã調補
ã§ããã®ã§ãæ¬çºæã¯DNAåã¯ã¡ãã»ã³ãžã€ãŒ
RNAã®ã¯ããŒãã³ã°å¹çãæ¹è¯ãããã€æšçé
åãå¢å¹ ããŠãã®æ€åºã容æã«ããããã«äœ¿çšã
ãããšãã§ããããã®çºæã¯ãŸããäžå®å šãªååŠ
åæããçããæ žé žã®æ··åç©ããææã®é åãå€
éã«åŸãããã«ãæçšã§ããã äžè¬ã«ãæ¬çºæã®æ¹æ³ã¯ãçšããããåå¿ã¹ã
ããã®æ°ã«é¢é£ããŠææ°çãªåéã§å°ãªããšãïŒ
ã€ã®ç¹å®ã®æ žé žé åãçç£ããé£éåå¿ãå«ã¿ã
該é åã¯(a)å¿ èŠãšãããæ«ç«¯ãããããšãã€ããª
ãã€ãºãããªãªãŽãã¯ã¬ãªãããåæã§ããã«å
åãªçšåºŠã«è©³çŽ°ã«ç¥ãããŠããã(b)é£éåå¿ãé
å§ããããã«å°éã®é åãå ¥æå¯èœã§ããããšã
æ¡ä»¶ãšãªããé£éåå¿ã§åŸãããçæç©ã¯ã䜿çš
ããç¹å®ã®ãã©ã€ããŒã®æ«ç«¯ã«å¯Ÿå¿ããæ«ç«¯ãæ
ãããããªåå¥çãªæ žé žã®ããŠãã¬ãã¯ã¹ã§ã
ãã 粟補ãããç¶æ ã§ã粟補ãããŠããªãç¶æ ã§ã
ããä»»æã®æ žé žæºããææã®ç¹å®ã®æ žé žé åãå«
ããšæãããã®ã§ããã°ãåºçºæ žé žãšããŠäœ¿çšã§
ãããåŸã€ãŠæ¬æ³ã§ã¯ãäŸãã°åéã§ãã€ãŠãäº
ééã§ãã€ãŠãããDNAåã¯RNAäŸãã°ã¡ãã»
ã³ãžã€ãŒRNAã䜿çšããããšãã§ãããæŽã«ã
ãããïŒã€ã®éãå«ãDNAâRNAã®ãã€ããªã
ã䜿çšããŠãããããããã®æ žé žã®æ··åç©ã䜿çš
ããŠããããåå è¡ããå¢å¹ åå¿ã«ãããŠåãã
åã¯ç°ãªã€ããã©ã€ããŒãçšããŠçç£ãããæ žé ž
ã䜿çšããŠããããå¢å¹ ãã¹ãç¹å®ã®æ žé žé åã¯
倧ããªååã®äžéšã§ãã€ãŠããããç¹å®ã®é åã
æ žé žå šäœãæ§æããããã«ã¯ããããåå¥çãªå
åãšããŠååšããŠããŠããããå¢å¹ ãã¹ãé åã¯
åãããçŽç²ãªç¶æ ã§ååšããå¿ èŠã¯ãªãã該é
åã¯ãè€éãªæ··åç©ã®å°éšåãäŸãã°å šãã
DNAäžã®Î²âã°ããã³éºäŒåãåã¯ç¹å®ã®çç©
çè©Šæã®æ¥µãå ãã®éšåã®ã¿ãæ§æããç¹å®ã®åŸ®
çç©ã«èµ·å ããæ žé žé åã®éšåã§ãã€ãŠãããã
åºçºç©è³ªãšããŠã®æ žé žã¯ãåããåã¯ç°ãªã€ãïŒ
以äžã®ææã®ç¹å®ã®æ žé žé åãå«ãã§ããŠãã
ããåŸã€ãŠæ¬çºæã®æ¹æ³ã¯ãïŒã€ã®ç¹å®ã®æ žé žé
åã倧éã«çç£ããã ãã§ãªããåããåã¯ç°ãª
ã€ãæ žé žååäžã«äœçœ®ããïŒä»¥äžã®ç°ãªã€ãç¹å®
ã®æ žé žé åã®åæå¢å¹ ã«ãæçšã§ããã æ žé žã¯ãäŸãã°pBR322ã®ãããªãã©ã¹ããã
ã¯ããŒã³åãããDNAåã¯RNAãåã¯çŽ°èãé µ
æ¯ãããŒã«ã¹åã³æ€ç©ãåç©ãªã©ã®é«çŽçç©çã®
èªç¶ã«ããDNAåã¯RNAçã®ä»»ææºããåŸãã
ãšãã§ãããDNAåã¯RNAã¯ãäŸãã°ããã¢ã
ã¹ãã«ããMolecular Cloningã®280ãã281é
ïŒ1982幎ïŒã«èšèŒãããŠãããããªçš®ã ã®æè¡ã«
ãããè¡ã絚æ¯åã¯çŸè现èçã®ã®çµèç©è³ªãã
æœåºããããšãã§ããã æ¬çºææ¹æ³ã«ãããä»»æã®ç¹å®ã®æ žé žé åãç
ç£ããããšãã§ãããé åã®äž¡æ«ç«¯ã®ååãªæ°ã®
å¡©åºãåå詳现ã«åãã€ãŠãããããã«ããææ
ã®é åã®ç°ãã¹ã©ã€ãã«å¯Ÿãããã€è©²é åã«æ²¿ã€
ã次ã®ãããªçžå¯Ÿäœçœ®ã«ãã€ããªãã€ãºããïŒã€
ã®ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒã調補ããããš
ãã§ããã°ãããããªãã¡ãïŒã€ã®ãã©ã€ããŒã
ãåæ䌞é·ããçæç©ããé³åïŒçžè£äœïŒããå
é¢ããããšãã«ãéå®ãããé·ãã®æ žé žã«ä»ã®ã
ã©ã€ããŒã䌞é·ãããããã®é³åãšããŠã®åœ¹å²ã
æãã°ãããé åã®äž¡æ«ç«¯ã®å¡©åºã«é¢ããç¥èã
å¢å ããã»ã©ç®çãšããæ žé žé åã®ããã®ãã©ã€
ããŒã®ç¹ç°æ§ã倧ãããªããåŸã€ãŠæ¬æ³ã®æå¹æ§
ã倧ãããªãã以åŸäœ¿çšãããã©ã€ããŒãšããçš
èªã¯ãç¹ã«å¢å¹ ãã¹ãæçã®æ«ç«¯é åã«é¢ããæ
å ±ã«ããããã®æå³ããããå Žåã«ã¯ãïŒãã倧
ããæ°ã®ãã©ã€ããŒãæå³ãããã®ãšç解ããã
ã¹ãã§ãããäŸãã°ãæ žé žé åãèçœè³ªé åã®æ
å ±ããæšæž¬ã§ããå ŽåãéºäŒåã³ãŒãã®çž®éã«èµ·
å ããå šãŠã®å¯èœãªã³ãã³å€åã瀺ãé åãå«ã
ãã©ã€ããŒãéããŠåéçšãšããŠäœ¿çšããããã®
ãããªéåã®ãã¡ã®ïŒã€ã®ãã©ã€ããŒã¯ãå¢å¹ ã
ã¹ãææé åã®æ«ç«¯ãšäžèŽããã ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒã¯ä»»æã®å¥œé©ãª
æ¹æ³ãäŸãã°äžèšãããªã³é žããªãšã¹ãã«æ³åã³
ãªã³é žãžãšã¹ãã«æ³åã¯ãããã®ãªãŒãã¡ãŒã·ãš
ã³åãããæ¹æ³ã䜿çšããŠèª¿è£œããããšãã§ã
ãããã®ãããªãªãŒãã¡ãŒã·ãšã³åãããæ¹æ³ã®
ãã¡ïŒã€ã«ããã°ãããŠãŒã±ãŒãžãã«ãã
Tetrahedron Letters22å·»1859â1862é ã«èšèŒã
ããŠããéãããžãšãã«ããªã¹ããªãã¢ããã€ã
ãåºçºç©è³ªãšããŠäœ¿çšããŠåæããããšãã§ã
ãã修食ãããåºäœæ äœäžã§ã®ãªãªãŽãã¯ã¬ãªã
ãåæã®ïŒã€ã®æ¹æ³ãç±³åœç¹èš±ç¬¬4458066å·ã«èš
èŒãããŠãããçç©æºïŒäŸãã°å¶éãšã³ããã¯ã¬
ã¢ãŒãŒæ¶åç©ïŒããåé¢ãããã©ã€ããŒã䜿çšã
ãããšãå¯èœã§ããã ç¹å®ã®æ žé žé åã¯ã該é åãé³åãšããŠå«ãæ ž
é žã䜿çšããŠçç£ããããæ žé žãïŒã€ã®éãå«ã
ã§ãããšãã¯ãå¥ã®ã¹ããããšããŠã§ããã©ã€ã
ãŒã®äŒžé·çæç©ã®åæãšåæã§ãããããè©²æ žé ž
ã¯é³åãšããŠäœ¿çšãããåã«éãåé¢ããå¿ èŠã
ããããã®éåé¢ã¯ãç©ççãååŠçåã³é µçŽ ç
æ¹æ³ãå«ãä»»æã®å¥œé©ãªå€æ§æ³ã«ããè¡ãããšã
ã§ãããæ žé žã®éãåé¢ããïŒã€ã®ç©ççæ¹æ³
ã¯ãå®å šã«ïŒ99ïŒ ä»¥äžïŒå€æ§ããããŸã§æ žé žãå
ç±ããããšãå«ããå žåçãªå ç±å€æ§ã¯80ãã
150âã§ïŒãã10åéå ç±ããããšãå«ããéã®
åé¢ã¯ãããªã«ãŒãŒãåã¯ããªã«ãŒãŒæŽ»æ§ãæã
ãªãATPã®ååšäžã§DNAãå€æ§ããããã®ãšã
ãŠç¥ãããé µçŽ RecAãšããŠç¥ãããé µçŽ é¡ãã
ã®ïŒé µçŽ ã«ããèªçºãããããšãã§ãããããªã«
ãŒãŒã§æ žé žã®éãåé¢ããã®ã«å¥œé©ãªåå¿æ¡ä»¶ã¯
ã¯ãŒã³ ãããã³ ããŒãªã³ã°ã«ãã
CSHQuantitative Biologyã®43ãã63é ïŒ1978
幎ïŒã«èšèŒãããRecAã䜿çšããæè¡ã¯ãC.ã©
ãã€ã³ã°ã«ããAnn.Rev.Geneticsã®16å·»405ãã
437é ã«èšèŒãããŠããã å¢å¹ ãã¹ãé åãå«ãåœåã®æ žé žãåéã§ãã
ãšããã®çžè£äœãããã«ïŒã€åã¯ã€ã®ãªãªãŽãã¯
ã¬ãªãããã©ã€ããŒãå ããŠåæããã奜é©ãªå
äžãã©ã€ããŒãå ãããããšããã©ã€ããŒãéå
è©Šè¬åã³åŸè¿°ããïŒã€ã®ãã¯ã¬ãªããã®ååšäžã§
ãã©ã€ããŒäŒžé·çæç©ãåæããããçæç©ã¯éš
åçã«åéæ žé žãšçžè£çã§ãæ žé žéãšãã€ããªã
ã€ãºããŠé·ãã®ç°ãªãããŠãã¬ãã¯ã¹ã圢æãã
ããã¯äžèšããéãåéã«åé¢ãããçžè£çãªïŒ
ã€ã®åé¢ãããéãšãªãã代ããã«ïŒã€ã®å¥œé©ãª
ãã©ã€ããŒãåéã«å ããŠåå¿ãè¡ãããšãã§ã
ãã åœåã®æ žé žãå¢å¹ ãã¹ãé åãæ§æãããªã
ã°ããã©ã€ããŒã®äŒžé·çæç©ã¯åœåã®æ žé žã®éãš
å®å šã«çžè£çãšãªãããã€ããªãã€ãºããŠåãé·
ãã®éããæãããŠãã¬ãã¯ã¹ã圢æããããã¯
åé¢ãããŠåéã®ååãšãªãã æ žé žã®çžè£çãªéãåé¢ãããšãåœåã®æ žé žã
äºééã§ãã€ãŠãåéã§ãã€ãŠãããã®éã¯ä»ã®
æ žé žéã®åæçšé³åãšããŠå®¹æã«äœ¿çšããããšã
ã§ããããã®åæã¯ä»»æã®å¥œé©ãªæ¹æ³ãçšããŠè¡
ãããšãã§ãããéåžžããã¯å¥œãŸããã¯PHãïŒã
ãïŒãæã奜ãŸããã¯ïŒã§ããç·©è¡æ°Žæº¶æ¶²äžã§èµ·
ããã奜ãŸããã¯éå°ã®ã¢ã«æ¯ïŒã¯ããŒã³åãã
ãæ žé žã«ã€ããŠã¯ãéåžžãã©ã€ããŒå¯Ÿé³åã
1000ïŒïŒããããŠã²ãã ã®æ žé žã«ã€ããŠã¯éåžžã
ã©ã€ããŒå¯Ÿé³åã106ïŒïŒïŒã®ïŒã€ã®ãªãªãŽãã¯
ã¬ãªãããã©ã€ããŒãåé¢ãããé³åéãå«ãç·©
è¡æ°Žæº¶æ¶²äžã«å ããããããæ¬æ³ã蚺æççšéã«
䜿çšããå Žåã«ã¯çžè£çãªéã®éã¯æ¢ç¥ã§ã¯ãªã
ããšãç解ãã¹ãã§ãããåŸã€ãŠçžè£çãªéã®é
ã«é¢é£ãããã©ã€ããŒã®éã確信ããã€ãŠæ±ºå®ã
ãããšã¯ã§ããªãããããå®éã«ã¯ãå¢å¹ ãã¹ã
é åãè€éãªé·éã®æ žé žéã®æ··åç©äžã«å«ãŸãã
å Žåã«ã¯ãå ãããããã©ã€ããŒã®éã¯çžè£çãª
éïŒé³åïŒã®éãããéåžžã¢ã«éå°ãšãããæ¬æ³
ã®å¹çãæ¹è¯ããããã«ã¯ã倧ããªéå°ã¢ã«æ¯ãš
ããããšã奜ãŸããã ããªãã·ãªããã¯ã¬ãªã·ãäžãªã³é žã§ããããª
ãã·ATPãããªãã·CTPãããªãã·GTPåã³
TTPã®ååãªéãåææ··åç©ã«å ããçæãã
溶液ãçŽ90â10âã§çŽïŒãã10åã奜ãŸããã¯ïŒ
ããïŒåéå ç±ããããã®å ç±æéã®åŸã溶液ã®
枩床ããã©ã€ããŒã®ãã€ããªãã€ãŒãŒã·ãšã³ã«å¥œ
é©ãªå®€æž©ãŸã§äžããããã®å·åŽããæ··åç©ã«ãã©
ã€ããŒäŒžé·åå¿ãèªå°ãåã¯è§Šåªããããã®é©åœ
ãªè¬å€ïŒèªå°è©Šè¬åã¯éåè©Šè¬ãšç§°ããïŒãå
ããåŸæ¥ç¥ãããŠããæ¡ä»¶äžã§åå¿ãè¡ãããã
ãã®ã®åæåå¿ã¯ã宀枩ãããããè¶ãããšéå
è©Šè¬ãå¹ççã«æ©èœããªã枩床ãŸã§ã®éã§è¡ãã
ãããšãã§ãããåŸã€ãŠäŸãã°DNAããªã¡ã©ãŒ
ãŒãéåè©Šè¬ãšããŠäœ¿çšãããšãã¯ã枩床ãéåžž
40â以äžã«äžæãããªããæã奜ãŸããã¯åå¿ã¯
宀枩ã«ãããŠèµ·ããã éåè©Šè¬ïŒèªå°è©Šè¬ïŒã¯ããã©ã€ããŒã®äŒžé·ç
æç©ã®åæãéæã§ãããã®ãªãã°ãé µçŽ ãå«ã
ã©ã®ãããªååç©ã§ãç³»ã§ãããããã®ç®çã®ã
ãã®å¥œé©ãªé µçŽ ã¯ãäŸãã°E.ã³ãŒãªãŒDNAããª
ã¡ã©ãŒãŒïŒ©ãE.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®
ã¯ã¬ããŒæçãT4DNAããªã¡ã©ãŒãŒãä»ã®å ¥æ
ã§ããDNAããªã¡ã©ãŒãŒãé転åé µçŽ åã³èç±
æ§é µçŽ ãå«ãä»ã®é µçŽ ãå«ã¿ããããã¯å¥œé©ãªæ
æ§ã§ã®ãã¯ã¬ãªããã®çµåãä¿é²ããåæ žé žéãš
çžè£çã§ãããã©ã€ããŒã®äŒžé·çæç©ã圢æã
ããäžè¬ã«åæã¯åãã©ã€ããŒã®ïŒâ²æ«ç«¯ããå§
ãŸããåæãçµäºãããŸã§é³åéã«æ²¿ã€ãŠ5â²æ«ç«¯
æ¹æ³ã«åãã€ãŠé²è¡ããç°ãªã€ãé·ãã®ååãç
æããããããäžè¿°ã®æ¹æ³ãšåãæ¹æ³ãçšããŠ
5â²æ«ç«¯ã§åæãå§ããä»ã®æ¹æ³ã«åãã€ãŠåå¿ã
é²è¡ãããè©Šè¬ãããã æ°ãã«åæãããéãšãããšçžè£æ§ãæããæ ž
é žéã¯ãæ¬æ³ã®ãã®åŸã®ã¹ãããã«ãããŠäœ¿çšã
ããäºééååã圢æããã次ã®ã¹ãããã§ã¯ã
äºééååã®éã¯äžè¿°ã®ä»»æã®æé ãçšããŠåé¢
ãããåéååãæäŸããã æ°ããªæ žé žã該åéååäžã§åæããããè¿œå
ã®èªå°è©Šè¬ããã¯ã¬ãªããåã³ãã©ã€ããŒããäž
èšã«èŠå®ããæ¡ä»¶äžã§åå¿ãé²è¡ãããããã«å¿
èŠãªãã°å ããŠãããããªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã®äžæ«ç«¯ããå床åæãå§ãŸãããããŠé³
åã®åéã«æ²¿ã€ãŠé²è¡ããŠä»ã®æ žé žãçæããã
ãã®ã¹ãããã®åŸã«ããã䌞é·çæç©ã®ååã¯ïŒ
ã€ã®ãã©ã€ããŒãçµåããç¹å®ã®æ žé žé åããæ
ã€ãŠããã éåé¢ãšäŒžé·çæç©åæã®ã¹ãããã¯ãç¹å®ã®
æ žé žé åãæå®éçç£ãããŸã§å¿ èŠãªã ãã®åæ°
ç¹°ãè¿ãããšãã§ãããåŸã«ãã詳现ã«èšèŒãã
ããã«ãç¹å®ã®æ žé žé åã¯ææ°çã«èç©ãããæ
åã®æ žé žåã¯æ žé žã®æ··åç©ããïŒä»¥äžã®ç¹å®ã®æ ž
é žé åãçç£ããããšãæãŸããå Žåã¯ã奜é©ãª
æ°ã®ç°ãªã€ããªãªãŽãã¯ã¬ãªãããã©ã€ããŒã䜿
çšãããäŸãã°ïŒã€ã®ç°ãªã€ãç¹å®ã®æ žé žé åã
çæããå Žåã«ã¯ãïŒã€ã®ãã©ã€ããŒã䜿çšã
ãããã©ã€ããŒã®ãã¡ã®ïŒã€ã¯ç¹å®ã®æ žé žé åã®
ãã¡ã®ïŒã€ã«é¢ãããã®ã§ãä»ã®ïŒã€ã®ãã©ã€ã
ãŒã¯ç¬¬ïŒã®ç¹å®ã®æ žé žé åã«é¢ãããã®ã§ããã
ããã«ãããïŒã€ã®ç°ãªã€ãç¹å®ã®é åãæ¬æ³ã
çšããŠææ°çã«çç£ããåŸããæ¬çºæã¯ãåã¹ã
ããåŸã«æ°ããè©Šè¬ãå ãã段éçæ¹æ³ãåã¯å š
ãŠã®è©Šè¬ãåæã®ã¹ãããã§å ããåæçæ¹æ³ã
åã¯ããäžããããæ°ã®ã¹ãããã®åŸã«æ°ããè©Š
è¬ãå ããäžéšæ®µéçã§äžéšåæçã§ããæ¹æ³ã®
ãããã«ãã€ãŠãè¡ãããšãã§ãããç±åŠçã®ã
ãã«éåè©Šè¬ãäžæŽ»æ§åããéåé¢æ¹æ³ãæ¡çšã
ãå Žåã«ã¯ãç±ã«å¯ŸããŠäžå®å®ã§ããé µçŽ ã®å Žå
ãããã§ããããã«ãåéåé¢ã¹ãããåŸã«éå
è©Šè¬ãè£å ããããšãå¿ èŠã§ãããããªã«ãŒãŒã®
ãããªé µçŽ çæ段ãå«ãå€æ°ã®ç²Ÿè£œãããæåã
éåé¢ã¹ãããã§äœ¿çšããå Žåã¯ãåæçæ¹æ³ã
䜿çšããããšãã§ãããåæçæ¹æ³ã§ã¯ãåå¿æ··
åç©ã¯ãææã®é åãå«ãæ žé žéã®ä»ã«ãéåé¢
é µçŽ ïŒäŸãã°ããªã«ãŒãŒïŒãrATPã®ãããªéå
é¢é µçŽ ãžã®é©åãªãšãã«ã®ãŒäŸçµŠæºãïŒã€ã®ãã¯
ã¬ãªãããã¢ã«éå°ã®ãªãªãŽãã¯ã¬ãªãããã©ã€
ããŒåã³E.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®ã¯ã¬
ããŒæçã®ãããªèªå°è©Šè¬ãå«ãããšãã§ããã
åæçæ¹æ³ã§å€æ§ã®ããã«ç±ã䜿çšãããšãã¯ã
èªå°è©Šè¬ã«äŸåããã奜ãŸãã65â90âã®é«æž©ã§
æ©èœããç±å®å®æ§ããªã¡ã©ãŒãŒçã®ç±å®å®æ§èªå°
è©Šè¬ã䜿çšãããã®æž©åºŠã§æ žé žã¯å¹³è¡ç¶æ ã«ãã
åéãšäºééããæã€ãŠãããé·ãã®çãæ žé žã«
ã¯ãçŽ50âçšåºŠã®äœæž©ãæ¡çšããããã©ã®çšåºŠã®
é«æž©ã䜿çšã§ãããã¯ããã®æž©åºŠã§é µçŽ ã倱掻ã
ãããããã¯ãã©ã€ããŒã®ãã€ããªãã€ãŒãŒã·ãš
ã³ãäžååãªçšåºŠããèµ·ãããªããã©ããã«äŸå
ããããã®ãããªç±å®å®æ§é µçŽ ã¯ãäŸãã°A.S.ã«
ã¬ãã€ã³ãã«ããBiokhimiya45å·»644â651é
ïŒ1980幎ïŒã«èšèŒãããŠãããæ¬æ³ã®åã¹ããã
ã¯ãå šãŠã®è©Šè¬ãå§ãããååšããã«ããããã
ããç¶ããŠèµ·ãããå¿ èŠãªãã°è¿œå ã®è©Šè¬ãå ã
ãŠããããé©åãªé·ãã®æéãçµéããŠææéã®
ç¹å®ã®æ žé žé åãçæããåŸãä»»æã®å ¬ç¥æ¹æ³ã§
é µçŽ ã倱掻ããããåå¿æåãåé¢ãããããŠå
å¿ãåæ¢ãããã æ¬çºææ¹æ³ã¯é£ç¶çã«è¡ã€ãŠãããããªãŒãã¡
ãŒã·ãšã³åãããæ¹æ³ã®äžæ æ§ãšããŠãåå¿ãã
å€æ§åºåãè©Šè¬æ·»å åºååã³åå¿åºåãéã€ãŠãµ
ã€ã¯ã«ããããããªæ¹æ³ããããä»ã®æ æ§ã§ã¯ã
ãã©ã€ããŒã®äŒžé·çæç©ã®åæã«äœ¿çšããé µçŽ ã
ã«ã©ã äžã§åºå®åããããšãã§ãããä»ã®åå¿æ
åã¯é£ç¶ããã«ã©ã ãšå ç±çšã³ã€ã«ãéãããã«
ãã³ãã䜿ã€ãŠé£ç¶çã«åŸªç°ãããããã«ããã
çæããæ žé žãé µçŽ ã倱掻ãããããšãªãç¹°ãè¿
ãå€æ§ãããã æ¬çºæã®ã®æŠç¥ãäžèšã«ç€ºãããããã§ã¯çžè£
çãªéãS+ããšãS-ãããæãææé åãã
ãå«ãäºééDNAãæ žé žãšããŠäœ¿çšãããŠããã
第ïŒã®åã³åŒãç¶ããŠèµ·ããåå¿ãµã€ã¯ã«ã§ã¯ã
åœåã®é³åäžã®åãªãªãŽãã¯ã¬ãªãããã©ã€ããŒ
ã®äŒžé·ã¯ããã©ã€ããŒã®ïŒã€ãšãšãã«ã®ã¿çµäºã
ãå¶éã®ãªãé·ãã®ãïŒã€ã®æ°ããssDNAåå
çæç©ãçæããã以åŸãé·éçæç©ããšåŒã¶ã
ããã®çæç©ã¯çŽç·çã«èç©ããã€ãŸãä»»ææ°ã®
ãµã€ã¯ã«ã®åŸã«ååšããéã¯ãµã€ã¯ã«æ°ã«æ¯äŸã
ãã ãã®ããã«çç£ãããé·éçæç©ã¯ãåŒãç¶ã
ãŠèµ·ãããµã€ã¯ã«ã®éäžæ¹åã¯ä»æ¹ã®ãªãªãŽãã¯
ã¬ãªãããã©ã€ããŒã®é³åãšããŠæ©èœããææé
åãS+ãåã¯ãS-ãã®ååãçæãããããã
ã®ååãäžæ¹åã¯ä»æ¹ã®ãªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã®é³åãšããŠæ©èœããæŽã«ä»ã®ãS+ãå
ã³ãS-ããçæããåŸã€ãŠãµã€ã¯ã«æ°ã«é¢é£ã
ãŠææ°çã«ããã®èç©ãçããããé£éåå¿ã
ç¶æãããã ãªãªãŽãã¯ã¬ãªããã®ãã€ããªãã€ãŒãŒã·ãšã³
ã«ãã圢æãããæå³ãããªãå¯çæç©ã¯ããã
èªèº«è§ŠåªæŽ»æ§ããªãïŒçšãªäŸãé€ãïŒãåŸã€ãŠçŽ
ç·çã«èç©ããã ãè¡šã æ°ããåæãããé·ãçæç©
ãè¡šã äžæ¹ã®ãã©ã€ããŒã®ãªãªãŽãã¯ã¬ãªããé åãš
å ±ã«çµãéåã³ä»æ¹ã®çžè£çé åã®åéã¯ãçç£
ããããšãæãŸããŠããç¹å®ã®æ žé žé åããã§
ããããšãåããã æ¬æ³ã®ã¹ãããã¯ããã©ã€ããŒïŒåã³ïŒãéå
è©Šè¬åã³ååšãããã¯ã¬ãªããã®éã«ãã€ãŠã®ã¿
éå®ããã以å€ãç¡éã«ç¹°ãè¿ãããšãã§ããã
æåã®æ žé žã¯è€è£œãããªãã®ã§ããã®éã¯å šå·¥çš
äžäžå®ã§ãããé·éçæç©ã¯æåã®æ žé žããã®ã¿
çç£ãããã®ã§ããã®éã¯çŽç·çã«å¢å ãããç¹
å®ã®é åã®éã¯ææ°çã«å¢å ãããåŸã€ãŠç¹å®ã®
é åã¯ãã®éãå¢å ããŠåªå¢ãªæåãšãªãããã®
ããšã¯æ¬¡è¡šã«ç€ºããã該衚ã¯ãµã€ã¯ã«ã®å¹çã
100ïŒ ã§ãããšããå Žåã®ïœãµã€ã¯ã«åŸã®çè«ç
ã«ååšããæåéãæ¯èŒãããã®ã§ããã ãè¡šã ãè¡šã åéã®æ žé žãé³åãšããŠäœ¿çšãããšããµã€ã¯ã«
ãããïŒã€ã®é·éçæç©ãçæããã æ¬æ³ã¯å¥œé©ãªçºçŸãã¯ã¿ãŒã«ç¹å®ã®æ žé žé åã
æ¿å ¥ããããã«ã¯ããŒã³åããã®ã«äœ¿çšã§ããã
該ãã¯ã¿ãŒã¯é©åãªå®¿äž»çç©ã圢質転æããŠæšæº
çãªçµã¿æãäœDNAæè¡ã«ããéºäŒåçæç©ã
çç£ããéã«äœ¿çšã§ããã æŽã«æ¬æ³ã¯ã€ã³ãããã®çªç¶å€ç°çšãšããŠäœ¿çš
ããããšãã§ããããªãªãŽããªãã·ãªããã¯ã¬ãª
ããã¯å¢å¹ ãããã¹ãDNAé åãšæ£ç¢ºã«çžè£ç
ã§ããå¿ èŠã¯ãªãããããã¯ãããªã¡ã©ãŒãŒé µçŽ
ãä»ã«äœ¿çšãããããããã®èªå°è©Šè¬ã«ãã€ãŠäŒž
é·ãããããã«ååãªçšåºŠã«ãéãšãã€ããªãã€
ãºããããšãã§ããã°ããã䜿çšãããã©ã€ããŒ
ãæåã®é³åãšæ£ç¢ºã«çžè£çã§ãªãå Žåã®ããªã¡
ã©ãŒãŒé£éåå¿ã®çæç©ã¯é³åããããããã©ã€
ããŒé åãæããããã«ããã€ã³ãããã®çªç¶å€
ç°ãå¯èœã«ãããåŒãç¶ããµã€ã¯ã«ã§ã¯ããã䌌
äžã®ãã¹ãã¢âãã©ã€ãã³ã°ãå¿ èŠãšãããªãã®
ã§ããã®çªç¶å€ç°ãæžãããšã®ãªãå¹çäžã§å¢å¹
ãããããã®ããã«çç£ãããçªç¶å€ç°äœã¯æšæº
çãªååçç©åŠçæè¡ã«ããé©åãªãã¯ã¿ãŒäžãž
æ¿å ¥ãããå€åããèçœè³ªãçç£ããèœåçã®å€
åããç¹è³ªããã®ãã¯ã¿ãŒã«äžããã äžè¿°ããå€åããDNAé åã圢æããæ¹æ³ã¯ã
ãã以äžã®é åå€åãèªçºãããããã«ç°ãªã€ã
ãã©ã€ããŒã䜿çšããŠè©²å€åããDNAã«å¯ŸããŠ
ç¹°ãè¿ãããšãã§ããããã®æ¹æ³ã§ã¯ãäžé£ã®çª
ç¶å€ç°é åãåŸã ã«çæãããããã§ããã®äžé£
ã®ãã®ã«æ°ããå ãããããã®ã§ã¯ãæåŸã®ãã®
ãšå ãã«ç°ãªãããšãã§ããããæåã®DNAæº
é åãšã¯éåžžã«å€§ããç°ãªãããšãã§ããããã®
æ¹æ³ã§ã¯ãéåžžã«å€§ããªãã¹ãããã®å Žåã«ãã©
ã€ããŒãæ©èœããªãããã«åäžã¹ãããã§ã¯è¡ã
ããšã®ã§ããªãå€åããæçµçã«ã¯äœãåºãããš
ãã§ããã æŽã«ãååãªéã®ãã©ã€ããŒãå¢å¹ ãããéã«
çžè£çã§ããé åãå«ãã®ã§ããã°ããã©ã€ããŒ
ã¯ãã®é åã®äžéšãšããŠçžè£çã§ãªãé åãå«ã
ããšãã§ãããäŸãã°é³åé åã«çžè£çã§ãªãæ ž
é žé åïŒäŸãã°ããã¢ãŒã¿ãŒããªã³ã«ãŒãã³ãŒã
é åçïŒããïŒã€åã¯äž¡æ¹ã®ãã©ã€ããŒã®5â²æ«ç«¯
ã«çµåãããããšãã§ããããã«ããå¢å¹ å·¥çšã®
çæç©ã«ãããä»å ããããšãã§ããã䌞é·ãã©
ã€ããŒãæ·»å ããåŸãçžè£çã§ãªãæ žé žæ¿å ¥éšã
å«ãæ°ããé³åã®ææéãåŸãããã«ååãªæ°ã®
ãµã€ã¯ã«ãå®æœãããããã«ããç°¡åãªæè¡ãçš
ããŠæ¯èŒççæéïŒäŸãã°ïŒæéåã¯ãã以äžïŒ
å ã«çµåããããæçã倧éã«çç£ããããšãå¯
èœã«ãªãã æ¬æ³ã¯ãäŒææ§çŸæ£ãéºäŒåæ§çŸæ£åã¯çŽ°èæ§
ã®çŸæ£ãäŸãã°çããšé¢é£ããç¹å®ã®æ žé žé åã
äŸãã°çºçéºäŒåãã®æ€åºåã³ïŒåã¯ç¹åŸŽä»ãã
å¯èœã«ããããã«äœ¿çšããããå¢å¹ ã¯ãäŸãã°è
å 现èããåŸãããDNAãçšããéç¶èµ€è¡ç貧
è¡ã®èå 蚺æçãåæã«å©çšã§ããæ žé žã®éãé
åžžã«å°ããå Žåã«æçšã§ãããå¢å¹ ã¯ãæ¬æ¥çã«
æ床ã®è¯ããªãéæŸå°æ§æ€åºæè¡ãçšããŠå°éã®
è©Šæãåæããå Žåãåã¯æŸå°æ§æè¡ãçšããã
è¿ éãªæ€åºãæãŸããå Žåã«ç¹ã«æçšã§ããã æ¬çºæã®ç®çã®ããã«ã¯ãéºäŒåæ§çŸæ£ã¯ãäŸ
ãã°éç¶èµ€è¡ç貧è¡ãå¢èæ§ç¹ç¶çãαâãµã©ã»
ãã¢ãβâãµã©ã»ãã¢çã®ãä»»æã®çç©äœããã®
ã²ãã DNAäžã®ç¹å®ã®æ¬ æåã³ïŒåã¯å€ç°ãå«
ããéç¶èµ€è¡ç貧è¡ã¯ãæ¬æ³ã«ãã奜é©ãªDNA
é åã®å¢å¹ ã®åŸã®ãªãªãŽããŒå¶éåæåã¯RFLP
ç¶åæãçµãŠå®¹æã«æ€åºããããšãã§ãããαâ
ãµã©ã»ãã¢ã¯é åãååšããªãããšã«ããæ€åºã
ãããšãã§ããβâãµã©ã»ãã¢ã¯çŸæ£ãèµ·ããã
ãå€ç°ã«è¿æ¥ããŠãªã³ã¯ããå€åœ¢æ§
ïŒpolymorplicïŒå¶ééšäœã®ååšã«ããæ€åºãã
ããšãã§ããã ãããå šãŠã®éºäŒåæ§çŸæ£ã¯é©åãªé åãå¢å¹
ãããããæŸå°æ§ãããŒãã䜿çšããã«ãµã¶ã³ã
ãããæ³ã«ããåæããŠæ€åºããããšãã§ããã
ãã®ãããªæ¹æ³ã§ã¯ãäŸãã°éåžžã«å°éã®ææé
åãå«ãçŸæ°Žããã®DNAã®å°éã®è©Šæãå¢å¹ ãã
å¶éé µçŽ ã§åæãããããŠãµã¶ã³ããããæ³ã§å
æãããå¢å¹ ã·ã°ãã«ããã€ã¬ãã«ãšããããšã«
ãããéæŸå°æ§æšäœã䜿çšããããšã容æã«ãª
ãã ä»ã®æ æ§ã§ã¯ãå°éã®DNAã䟿å©ãªã¬ãã«ãŸ
ã§å¢å¹ ãã次ã«æŽã«äŒžé·åå¿ãè¡ããããã®å Žå
容æã«æ€åºã§ãããã¯ã¬ãªããèªå°äœïŒäŸãã°
32Påã¯ããªãã³ã§ã©ãã«ãããã¯ã¬ãªããäžãª
ã³é žïŒãçŽæ¥æçµã®DNAçæç©ã«å°å ¥ãããã
ãå¶éåæåã³é»æ°æ³³ååæãããã¯ä»»æã®ä»ã®
奜é©ãªæ¹æ³ãçšããŠåæããããã®æè¡ã®ã¢ãã«
ç³»ã®äŸã第ïŒå³ã«ç€ºããŠããã 第ïŒå³ã®ã¢ãã ç³»ã«ç€ºããæŽã«ä»ã®æ æ§ã§ã¯ã
æ žé žã¯å¢å¹ ã®åã«ç¹å®ã®å¶éãšã³ããã¯ã¬ã¢ãŒãŒ
ã«æŽé²ãããåæãããé åã¯å¢å¹ ã§ããªãã®
ã§ãäºãå¶éé µçŽ ã§åŠçããDNAè©Šæã®ååšã«
ããããããå¢å¹ ãããæçãçŸããããšã¯ãå¢
å¹ ãããé åäžã«ãšã³ããã¯ã¬ã¢ãŒãŒã®éšäœããª
ãããšãæ瀺ãããå¢å¹ ãããé åãååšããã
åŠãã¯é©åœãªæ¹æ³ã§æ€åºããããšãã§ããã ãã®æè¡ã®å®éçãªé©çšæ¹æ³ã¯ãæ¬æ现æžãšãµ
ã€ããã«ããBiotechnology3å·»1008â1012é ã«
èšèŒãããŠãããªãªãŽããŒå¶éæè¡ãçšããŠéç¶
èµ€è¡ç貧è¡ã®æ€åºã容æã«ãã䜿çšã«ããäŸç€ºã
ãããšãã§ãããéç¶èµ€è¡ç貧è¡ã¯Î²âã°ããã³
éºäŒåã®ç¬¬ïŒã³ãã³ã®ïŒã€ã®å¡©åºå¯Ÿã®å€åã«ãã
çãããã¢ã°ããã³ã®çŸæ£ã§ããã第ïŒå³ã¯å€åœ¢
çŸè±¡ïŒpolymorphisnïŒé åäžã®æ£åžžåã³éç¶èµ€
è¡ç貧è¡ã®Î²âã°ããã³éºäŒåã®é åã瀺ããã®
ã§ãäžæ¬ç·ã¯æ£åžžéºäŒåã«ã®ã¿ååšããDdeéš
äœã®äœçœ®ã瀺ããäºæ¬ç·ã¯æ£åžžåã³éç¶èµ€è¡ç貧
è¡å¯Ÿç«éºäŒåãã®äž¡æ¹ã«ååšããéå€åœ¢æ§ã®
Hinféšäœã®äœçœ®ã瀺ãã第ïŒå³ã¯äž¡å¶ééšäœ
éšäœéã«ãããæå°ã§ç€ºãããéšåãã©ãã«ãã
ãŠãããããŒããçšããŠæ£åžžã®Î²âã°ããã³
DNAããªãªãŽããŒå¶ééè£ããæ¹æ³ã瀺ããã®
ã§ãããåã«èšèŒããããã«ããŠå¢å¹ ããã
DNAãå€æ§ãããã©ãã«ããããããŒããšã¢ã
ãŒã«ããããé µçŽ Ddeã¯DNAãåæ§æããã
Ddeéšäœã§éè£ãããã©ãã«ããããªã¯ã¿ããŒ
ãçããããããã¹ãã«äœ¿çšããæ¡ä»¶äžã§ã¯ããª
ã¯ã¿ããŒã¯ããŠãã¬ãã¯ã¹ããé¢ããã®ã«ååãª
çãã§ãããåŒãç¶ãé µçŽ Hinfã®æ·»å ã¯ä»ã
åéã§ãããªã¯ã¿ããŒã«äœã®åœ±é¿ãäžããªãã第
ïŒå³ã¯Î²âã°ããã³DNAã®éç¶èµ€è¡ç察ç«éºäŒ
åã«é©çšããåèšãšåãæ¹æ³ã瀺ããé µçŽ Dde
ã¯ãâã®å¡©åºå¯Ÿããã¹ããããããã®ã§ãã
ãããå¢å¹ ãããDNAãšã©ãã«ããããããŒã
ãšã§åœ¢æãããããŠãã¬ãã¯ã¹ãéè£ãããããš
ã¯ã§ããªãããããé µçŽ Hinfã¯ãã€ããªãã
å¶ééè£ããããã©ãã«ãããããªããŒãçæã
ãããå®éã«ã¯ãã®æ¹æ³ã¯ãç¹å®ã®ã·ã°ãã«ãã
ãããã®å¯Ÿç«éºäŒåã®ååšãšé¢é£ããã®ã§ãåäœ
ã®DNAãéæ§åã®ãã¢æ¥åäœããéç¶èµ€è¡ç貧
è¡åã®ãã¢æ¥åäœãåã¯éç¶èµ€è¡ç貧è¡åœ¢è³ªãæ
ãããããæ¥åäœã§ããããæ€èšºããããšãã§ã
ããäžè¿°ã®æ¹æ³ã䜿çšããŠé©åãªé åãå¢å¹ ãã
ãããšã«ããïŒã€ã®32Pã©ãã«ã®ã¿ãæãããã
ãŒããçšããŠåã³ããŒéºäŒåãè¿ éã«åæããã
ãšãã§ããã çš®ã ã®äŒææ§çŸæ£ã¯ãåå ãšãªã埮çç©ã«ç¹ç°
çã§ããç¹å®ã®DNAé åã®èšåºè©Šæäžã§ååšã«
ãã蚺æããããšãã§ããããããã¯ãµã«ã¢ã
ã©ãã¯ã©ããžã¢ããã€ã»ãªã¢çã®çŽ°èãèçããŒ
ã«ã¹çã®ããŒã«ã¹ããã©ãªã¢ã®åå ãšãªããã©ã¹
ã¢ãžãŠã ïŒPlasmodiumïŒçã®å¯çäœãå«ããã
ã¢ã«ã³ãŒã«äžããããç±³åœç¹èš±ç¬¬4358535å·ã¯ã
äŒææ§çŸæ£ã®èšºæçšã®ç¹å¥ãªDNAãã€ããªãã€
ãŒãŒã·ãšã³ãããŒãã®äœ¿çšã«ã€ãèšè¿°ããŠããã
ãã¢ã«ã³ãŒæ³ã«åºæã®åé¡ã¯ãææããæ£è ãã
ã®èšåºè©Šæäžã«ã¯æ¯èŒçå°ãªãæ°ã®ç åçç©ãã
ååšããããããããæœåºãããDNAã¯è©Šæäž
ã®å šDNAã®éåžžã«å°ããªéšåãæ§æããã®ã¿ã§
ãããšããããšã§ãããDNAè©Šæãåºå®åãã
ã€ããªãã€ãŒãŒã·ãšã³æ€åºããåã«åé¡ãšãªã€ãŠ
ããé åãç¹ç°çã«å¢å¹ ããããšã¯ããããã®æ¹
æ³ã®æ床ãšç¹ç°æ§ã倧ããæ¹è¯ããã äŒææ§çŸæ£ã®èšºæçšã«DNAãããŒããèšåºç
ã«ã«ãŒãã³åããŠäœ¿çšããããšã¯ãã¯ãŒãã®ãšãŒ
ãããç¹èš±ç¬¬63879å·ã«èšèŒãããŠããããã«é
æŸå°çã«ã©ãã«ããããããŒãã䜿çšããã®ãªã
ã°ã倧ãã«ç°¡ç¥åãããããã®æ¹æ³ã§ã¯ãããªã
ã³ãå«ãDNAãããŒããã¢ããžã³åã¯ããªãã³
ã«ç¹ç°çãªæäœã«çµåããè²çŽ äœ
ïŒchromogenicïŒé µçŽ ã«ããæ€åºãããããã®å
ã®æ€åºã¯äŸ¿å©ã§ããããæ¯èŒçäœæ床ã§ãããæ¬
æ³ã«ããç¹ç°çãªDNAå¢å¹ ãšå®å®ã«ã©ãã«ãã
ããããŒããçµã¿åãããããšã«ããããã¢ã«ã³
ãŒåã³ã¯ãŒãã®æ¹æ³ãã«ãŒãã³åããèšåºã«ãã
ãæçšãªæ¹æ³ã«ããã®ã«èŠæ±ããã䟿å©ããšæ床
ãæäŸããããšãã§ããã ãã®å¢å¹ å·¥çšã¯åäžã³ããŒã®ããéºäŒåããå
åãªéã®DNAã調補ããã®ã«å©çšããããšãã§
ããããã«ããèåãšããžãŠã ã®ãããªç°¡åãªé
ç¹ç°çãªDNAæè²ã«ãããããæ€åºã§ããçŽæ¥
DNA蚺æãè¡ãããšãã§ããã äŒææ§çŸæ£åã³çç©äœã®ã²ãã äžã®ç åçç°åžž
æ§ãæ€åºããã»ããæ¬æ³ã¯ä»»æã®ç åç¶æ ãšé¢é£
ããªãDNAå€åœ¢çŸè±¡ïŒããªã¢ã«ãã€ãºã ïŒãæ€
åºããããã«äœ¿çšããããšãã§ããã 次ã®å®æœäŸã¯äŸç€ºã®ããã«æ瀺ãããã®ã§ãã©
ã®ããã«ãæ¬çºæãéå®ããããšãæå³ãããã®
ã§ã¯ãªãããããã®å®æœäŸã§å šãŠã®ããŒã»ã³ãã¯
åºäœã®å Žåã¯ééã§ã液äœã®å Žåã¯å®¹éã§ããã
ä»ã«æå®ããªãéã枩床ã¯ææ°æž©åºŠã§ããã å®æœäŸ ïŒ æ¬¡ã®ãã¯ã¬ãªããé åãæãã25å¡©åºå¯Ÿé å 5â²CCTCGGCACCGTCACCCTGGATGCT3â² 3â²GGAGCCGTGGCAGTGGGACCTACGA5â² ïŒATCCããåŸãããpBR322ã®47å¡©åºå¯ŸFok
å¶éæçã«å«ãŸããïŒã次ã®ããã«èª¿è£œããã
47å¡©åºå¯Ÿæçãå«ãpBR322ã®FOkæ¶åç©ãã
äŸçµŠè ã§ããããŠãŒã€ã°ã©ã³ã瀟ã®æ瀺ã«ããæ¡
件ã«åŸã€ãŠpBR322Fokã§æ¶åããããšã«ãã
調補ããã䜿çšãããã©ã€ããŒã¯ã5â²d
ïŒCCTCGGCACCGïŒ3â²ãš5â²d
ïŒAGCATCCAGGGTGïŒ3â²ã§ãããéåžžã®æè¡
ã«ãã調補ããã25mMã®ãªã³é žã«ãªãŠã ãš
10mMã®å¡©åãã°ãã·ãŠã ãåã³100mMã®å¡©å
ãããªãŠã ããæãç·©è¡æ¶²ïŒPH7.5ïŒ33ÎŒã«2433
ãã³ã¢ã«ã®äžè¿°ã®åãã©ã€ããŒã2.4ãã³ã¢ã«ã®
pBR322ã®Fokæ¶åç©ã22ããã¢ã«ã®ããªãã·
ATPã22ããã¢ã«ã®ããªãã·CTPã19ããã¢ã«
ã®ããªãã·GTPåã³10ããã¢ã«ã®TTPãå ã
ãã æ··åç©ã85âã§åéå ç±ãã宀枩ãŸã§å·åŽã
ããE.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®ã¯ã¬ããŒ
æçã®ïŒåäœãå ãã枩床ã15åéç¶æãããã
ã®åŸå床85âã§ïŒåéå ç±ããå·åŽãããã¯ã¬ã
ãŒæçã®ïŒåäœãå床å ãã15åéåå¿ãè¡ã€
ããå ç±ãå·åŽåã³åå¿ã®åã¹ããããæŽã«11å
ç¹°ãè¿ããã æåŸã®ç¹°ãè¿ãã®åŸã5ÎŒãåå¿æ··åç©ãã
åãåºãããããã85âã§ïŒåéå ç±ãã宀枩ã«
å·åŽããã12.5ãã³ã¢ã«ã®Î±âP32ããªãã·ã·ã
ãžã³äžãªã³é žãšïŒåäœã®ã¯ã¬ããŒæçãå ãåå¿
ã15åéé²è¡ããããã©ãã«ãããçæç©ãããª
ã¢ã¯ãªã«ã¢ããã²ã«ã®é»æ°æ³³åã§ç¢ºèªããã13ãµ
ã€ã¯ã«åŸã«èŠãã匷ãã©ãã«ããããã³ãã®ã¿
ããæå³ãã25å¡©åºå¯Ÿé åã§ãã€ãã å®æœäŸ ïŒ å¢å¹ ãããã¹ãææã®é åã¯ãããã®Î²âã°ã
ãã³éºäŒåã«å«ãŸããã€éç¶èµ€è¡ç貧è¡ã«é¢ãã
MstIIéšäœã«äŒžã³ã94å¡©åºå¯Ÿã®é åã§ãã€ãã該
é åã¯ç¬¬ïŒå³ã«ç€ºããã¯ã¬ãªããé åãæããŠã
ãã ãã©ã€ããŒã®åæ 次ã®ïŒã€ã®ãªãªãŽããªãã·ãªããã¯ã¬ãªããã
ã©ã€ããŒãäžèšããæ¹æ³ãçšããŠèª¿è£œããã 5â²CACAGGGCAGTAACG3â²ãã©ã€ããŒïŒ¡ãå
ã³ 5â²TTTGCTTCTGACACA3â²ãã©ã€ããŒïŒ¢ ãªãŒãã¡ãŒã·ãšã³åãããåææ³ ããŠãŒã±ãŒãžãšã«ã«ãµãŒã¹æ³ïŒTetrahedron
Letters22å·»1859â1862é ïŒ1981幎ïŒã«åŸã€ãŠå
æãããžãšãã«ããªã¹ããªãã¢ããã€ããããã€
ãªãµãŒãSAMâïŒã䜿çšããŠå¶åŸ¡ããå€åã¬ã©
ã¹æ äœããèªå°ãããã¯ã¬ãªã·ããžæ¬¡ã ãšæ¿çž®ã
ãããã®æ¹æ³ã¯ããžã¯ãã«ã¡ã¿ã³äžã§ã®ããªã¯ã
ã«é ¢é žã«ããè±ããªãã«åãšæŽ»æ§ã®ããæ°ŽçŽ äŸäž
äœãšããŠãã³ãŸããªã¢ãŸãŒã«ã䜿çšããçž®ååã³
ããã©ãã€ãããã©ã³åã³ããªãžã³äžã§ã®ç¡æ°Žé ¢
é žãšãžã¡ãã«ã¢ããããªãžã³ã«ãããã€ããã³ã°
ãå«ãã§ãããïŒãµã€ã¯ã«ã®æéã¯çŽ30åã§ãã€
ããåã¹ãããã®åçã¯å®è³ªçã«åœéçã§ããã
è±ããªãã«åã®éã«è§£é¢ãããžã¡ããã·ããªãã«
ã¢ã«ã³ãŒã«ãéãåå åšã«ããæ€æ»ã§æ±ºå®ããã ãªãªãŽããªãã·ãªããã¯ã¬ãªã·ããè±ä¿è·å
ãã粟補ããæ¹æ³ åºäœæ äœãã«ã©ã ããåãåºãã1mlã®æ¿æ°Žé ž
åã¢ã³ã¢ããŠã ã«éé管äžå®€æž©ã§ïŒæéæããã
æ äœãæ¿Ÿéã§åãé€ããäžéšãä¿è·ããããªãªãŽ
ããªãã·ãªããã¯ã¬ãªãããå«ã溶液ã®æž©åºŠã55
âã«äžæãããïŒæéç¶æãããã¢ã³ã¢ãã¢ãå
ãé€ããæ®æž£ã調補çšããªã¢ã¯ãªã«ã¢ããã²ã«ã«
é©çšããã30ãã«ãïŒcmã§90åéé»æ°æ³³åãè¡
ããçæç©ãå«ããã³ããè¢å ãã¬ãŒãäžã®UV
ã·ã€ããŠã€ã³ã°ã§åå®ããã該ãã³ããåãå
ãã1mlã®èžçæ°Žã§äžæ©ãããŠïŒâã§æº¶åºããã
ãã®æº¶æ¶²ãã¢ã«ããã¯RP18ã«ã©ã ã«ãããPH6.0
ã®ïŒïŒ é ¢é žã¢ã³ã¢ããŠã ç·©è¡æ¶²äžïŒâ13ïŒ ã®ã¢ã»
ããããªã«ã§æº¶åºããããã®æº¶åºæ¶²ã¯260nmã®çŽ«
å€åžåã§ã¢ãã¿ãŒããé©åãªãã©ã¯ã·ãšã³ãé
ããåºå®ããéã§ã®çŽ«å€åžåã§å®éåæãããã€
宀枩äžã§æžå§é å¿æ©äžã§èžçºãã也ç¥ããã ãªãªãŽããªãã·ãªããã¯ã¬ãªããã®ç¹åŸŽä»ã 粟補ãããªãªãŽãã¯ã¬ãªããã®ãã¹ã溶液ãã
ãªãã¯ã¬ãªãããããŒãŒåã³Î³32PâATPã§32Pã©
ãã«ããããã®ã©ãã«ããååç©ã50ãã«ãïŒcm
ã§45åéé»æ°æ³³åã«ãããåŸã14â20ïŒ ã®ããªã¢
ã¯ãªã«ã¢ããã²ã«ã®ãªãŒãã©ãžãªã°ã©ãã€ãŒã§ç¢º
èªããããã®æ¹æ³ã§ã¯ååéã確èªããããšãã§
ãããããæ¯ãžãšã¹ãã©ãŒãŒãšçŽ°èæ§ã¢ã«ã«ãªã
ãªã¹ãã¢ã¿ãŒãŒã䜿çšããŠãªãªãŽããªãã·ãªãã
ã¯ã¬ãªããããã¯ã¬ãªã·ãã«æ¶åãããããŠæ¬¡ã¯
éçžHPLCã«ã©ã ã䞊ã³ã«10ïŒ ã¢ã¯ãªããããªã«
åã³ïŒïŒ é ¢é žã¢ã³ã¢ããŠã 移åçžã䜿çšããŠãèª
å°ããããã¯ã¬ãªã·ããåé¢ãå®éããããšã«ã
ãå¡©åºçµæã決å®ããã DNAæº ïŒ¡ å šããéæ§åDNAã®æœåº æ£åžžã®Î²âã°ããã³ã®ããã²ãã DNAãã¢æ¥
åäœããã¹ãããã©ãŒãã«ããProc.Nat.Acad.
Sci.ã®72å·»5966â5970é ã«èšèŒãããæè¡ãçšã
ãŠã»ã«ã©ã€ã³Molt4ïŒããŠãŒãã³ã»ãžãšããã€ã
ã¯ã»ããŠãŒã¿ã³ãã»ã»ã«ã»ã¬ããžããªãŒããå ¥æ
ããGM2219cãšåå®ããïŒããæœåºããã  ã¯ããŒã³åããã°ããã³éºäŒåã®é æ æ£åžžã®Î²âã°ããã³éºäŒåã®1.9kbã®BamHIæ
çãã³ã¹ããpECllããåé¢ããpBR322ã®Bam
HIéšäœã«æ¿å ¥ããïŒãœããã³ãã®GeneïŒå·»287
â305é ïŒ1980幎ïŒïŒãåæ40å¡©åºå¯ŸãããŒããšã
ã€ããªãã€ãºããé åãå«ããã®æçã¯ã第ïŒå
ã³ç¬¬ïŒã®ãšã¯ãœã³ã第ïŒã®ã€ã³ããã³ã䞊ã³ã«éº
äŒåã®5â²ã®ãã©ã³ãã³ã°ïŒflankingïŒé åãå«ã
ïŒããŒã³ãã®Cell15å·»1157â1174é ïŒããã®ã¯ããŒ
ã³ã¯pBR328ïŒHbAãšåä»ããããATCC第
39698å·ãšããŠ1984幎ïŒæ25æ¥ã«å¯èšãããã βâã°ããã³ã®éç¶èµ€è¡ç貧è¡å¯Ÿç«éºäŒåã®å¯Ÿ
å¿ãã1.9kbã®BamHIæçã¯ã³ã¹ããpF12ãã
åé¢ãããäžè¿°ã®éãã¯ããŒã³åãããããã®ã¯
ããŒã³ã¯pBR328ïŒHbSãšåä»ããããATCC第
39699å·ãšããŠ1984幎ïŒæ25æ¥ã«å¯èšãããã åçµã¿æããã©ã¹ãããE.ã³ãŒãªãŒMM294
ïŒATCC第39607å·ïŒãžåœ¢è³ªå€æãããããŠå¢æ®ã
ãããã  ã¯ããŒã³åãããã°ããã³éºäŒåã®MstIIã«
ããæ¶å ããããã®å šéã100ÎŒgã§ããpBR328ïŒHbA
ãšpBR328ïŒHbSãåç¬ã§20åäœã®MstIIïŒããŠãŒ
ã€ã³ã°ã©ã³ããã€ãªã©ã瀟ïŒãšãšãã«16æé37
âã150mMã®NaClã12mMã®Tris HClïŒPH7.5ïŒã
12mMã®MgCl2ã1mMã®ãžããªã¹ã¬ã€ããŒã¹
ïŒDTTïŒåã³100ÎŒgïŒmlã®ãŠã·è¡æž ã¢ã«ããã³
ïŒBSAïŒäžã§æ¶åãããçæç©ã¯ãããã
pBR328ïŒHbAïŒMstIIåã³pBR328ïŒHbSïŒMst
IIãšåä»ããã ããªã¡ã©ãŒãŒã®é£éåå¿ 60mMé ¢é žãããªãŠã ã30mMããªã¹âã¢ã»ã
ãŒãåã³10mMé ¢é žãã°ãã·ãŠã ãå«ãPH8.0ã®
ç·©è¡æ¶²100ÎŒãž100ãã³ã¢ã«ã®ãã©ã€ããŒïŒ¡ïŒïœ
ïŒCACAGGGCACTAACGïŒã®é åïŒã100ãã³ã¢
ã«ã®ãã©ã€ããŒïŒ¢ïŒïœ
ïŒTTTGCTTCTGACACAïŒã®é åïŒåã³1000
ãã³ã¢ã«ã®ããªãã·ATPãããªãã·CTPãããª
ãã·GTPåã³TTPãå«ã2ÎŒã®æº¶æ¶²ãå ããã
äžè¿°ãããäžèšã®DNAæºãå ããã 10ÎŒgã®å šããéæ§åDNAïŒåå¿ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbAïŒåå¿ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbSïŒåå¿ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbAïŒMstLLïŒåå¿
ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbBïŒMstIIïŒåå¿ïŒ éæšçDNAïŒåå¿ïŒ åŸãããå溶液ã100âã§ïŒåéå ç±ãïŒåé
ã§å®€æž©ãŸã§å·åŽãããã®åŸE.ã³ãŒãªãŒDNAããª
ã¡ã©ãŒãŒã®ã¯ã¬ããŒæçã®ïŒåäœãå«ã1ÎŒã
å ãããååå¿ã¯10åéè¡ãããã®åŸãã©ã€ã
ãŒããã¯ã¬ãªããåã³DNAãå ããå ç±ããå·
åŽããããªã¡ã©ãŒãŒãå ãããããŠåå¿ããããµ
ã€ã¯ã«ãåå¿ïŒ©ã«ã€ããŠã¯19åãåå¿âã«ã€
ããŠã¯ïŒåç¹°ãè¿ããã 第ïŒãµã€ã¯ã«ã®åãåã³ååå¿ã®æåŸã®ãµã€ã¯
ã«ã®åŸã§åãåºãããåå¿åã³ã®ã¢ãªã³ãŒã
ïŒãã€ã¯ããªããã«ããPH8.3ã®0.089Mããªã¹ç¡Œ
é žå¡©ç·©è¡æ¶²äžã§ã2.5mMEDTAäžã§ã12ïŒ ããª
ã¢ã¯ãªã«ã¢ããã²ã«ã«å ããããã®ã²ã«ã25ãã«
ãïŒcmãïŒæéé»æ°æ³³åãããåºçžæ äœãšããŠæ©
èœãããã€ãã³èãžç§»ãããããŠãPH7.4ã§30ïŒ
ã®ããªã«ã ã¢ããã3xSSPEã5xãã³ãã«ãåã³
ïŒïŒ ã®ããã·ã«ç¡«é žãããªãŠã äžã§ãæšæºçæè¡
ãçšããŠèª¿è£œãã次åŒïŒ 5â²dïŒTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCA
AGïŒ3â² ã®32Pã§ã©ãã«ããã40å¡©åºå¯Ÿã®åææçã§æ€ç¥
ããã第ïŒå³ã¯ãåå¿åã³çšã®æ€ç¥ãããã
ã€ãã³èã®ãªãŒãã©ãžãªã°ã©ãã§ãããã¬ãŒã³ïŒ
ã¯0.1ãã³ã¢ã«ã®58å¡©åºå¯Ÿã®å¯Ÿç §åææçã§ãã
ã®ãã¡ã®ïŒã€ã®éã¯äžèšãããŒããšçžè£çã§ã
ããã¬ãŒã³ïŒã¯ç¬¬ïŒã®å¢å¹ ãµã€ã¯ã«ã®åã®4ÎŒ
ã®åå¿ïŒã®æ¶²ã§ãããã¬ãŒã³ïŒã¯20åã®å¢å¹ ãµã€
ã¯ã«åŸã®4ÎŒã®åå¿ïŒã®æ¶²ã§ãããã¬ãŒã³ïŒã¯
ïŒåã®å¢å¹ ãµã€ã¯ã«åŸã®4ÎŒlã®åå¿ã®æ¶²ã§ããã
ã¬ãŒã³ïŒã¯ÎŒâ32Pâããªãã·NTPåã³ããªã¡ã©
ãŒãŒã§ã©ãã«ãããpBR322ïŒããŠãŒã€ã³ã°ã©ã³
ããã€ãªã©ã瀟ïŒã®FokïŒããŠãŒã€ã³ã°ã©ã³ã
ãã€ãªã©ã瀟ïŒããæãååéæšæºã§ãããã¬ãŒ
ã³ïŒã¯ã20ãµã€ã¯ã«åŸåå¿æ··åç©ïŒ©ã¯é©åãªåå
éãæããç¹å®ã®é åã倧éã«å«ã¿ãä»ã®æ€åºã§
ããçæç©ããªãããšã瀺ããŠãããïŒãµã€ã¯ã«
åŸã®åå¿æ··åç©ãã¬ãŒã³ïŒã«ç€ºãéãåºçºç©è³ª
ã§ããæ žé žãšä»ã®çæç©ã®ä»ã«ãã®çæç©ãå«ã
ã§ããã ïŒãµã€ã¯ã«åŸã®åå¿ããã®æ¶²5.0ÎŒã«äžè¿°
ã®åãã©ã€ããŒïŒãã³ã¢ã«ãå ããã溶液ãïŒå
é100âã«å ç±ã宀枩ãžæ»ãããããããïŒãã³
ã¢ã«ã®Î±â32Pâããªãã·ATPãαâ32Pâããª
ãã·CTPãαâ32Pããªãã·GTPåã³Î±â32Pâ
TTPã䞊ã³ã«ïŒåäœã®ã¯ã¬ãâæçãå ããã
æçµçãªå®¹ç©ã10ÎŒã§ããå¡©æ¿åºŠãäžèšããé
ãã§ããåå¿ã10åéè¡ããããããªã¡ã©ãŒãŒæŽ»
æ§ã¯60âã§20åéå ç±ãããšå€±ããããåå¿â
ã®åå¿æ¶²4ÎŒãã0.089Mããªã¹ç¡Œé žå¡©ç·©è¡æ¶²ã
2.5mMEDTAäžã§12ïŒ ããªã¢ã¯ãªã«ã¢ããã²ã«
ã«å ããããã®ã²ã«ã25ãã«ãïŒcmãïŒæéé»æ°
æ³³åããããã®åŸãªãŒãã©ãžãªã°ã©ãåŠçããã 第ïŒå³ã¯ãé»æ°æ³³åã®ãªãŒãã©ãžãªã°ã©ãã§ã
ããã¬ãŒã³ïŒã¯ååéæšæºãã¬ãŒã³ïŒã¯åå¿ã
ã¬ãŒã³ïŒã¯åå¿ãã¬ãŒã³ïŒã¯åå¿åã³ã¬ãŒã³
ïŒã¯åå¿ã§ãããå¯Ÿç §ãšããŠã®DNAã䌎ãªã
ãªãåå¿ã®ã¬ãŒã³ã¯ã¬ãŒã³ã®ã©ãã«ãã€ã¡ãŒãž
ãæããªããå³ãããæšçDNAããäºæ³ããã
94å¡©åºå¯Ÿæçã¯ãç¡å·ã®Î²âã°ãããªã³DNAé
åãå¢å¹ çšã«äœ¿çšã§ãããšãã®ã¿ååšã§ããããš
ãåããïŒã€ãŸãã¬ãŒã³ïŒã®pBR328ïŒHbAãã¬
ãŒã³ïŒã®pBR328ïŒHbSåã³ã¬ãŒã³ïŒã®
pBR328ïŒHbSïŒMstIIïŒãMstIIã«ããæ¶åã¯
pBR328ïŒHbAã94å¡©åºå¯Ÿé åäžã§åæãããã
ãå¢å¹ ã§ããªãããã«ãã94å¡©åºå¯Ÿã®ãã³ãã¯ã¬
ãŒã³ïŒã«çŸããªããããã«å¯ŸããpBR328ïŒHbS
ã®94å¡©åºå¯Ÿé åã¯ãã©ã¹ãããMstIIã§æ¶åãã
ãŠãåæãããåŸã€ãŠç¬¬ïŒå³ã«ç€ºãããã«å¢å¹ ã«
å©çšã§ããã 第ïŒå³ã¯94å¡©åºå¯Ÿé åãå¢å¹ ããïŒãµã€ã¯ã«ã®
é£éåå¿ã瀺ããã®ã§ãããPCO1ãšPCO2ã¯ã
ã©ã€ããŒïŒ¡åã³ïŒ¢ã§ãããå³ã®æ°ã¯ãµã€ã¯ã«ã瀺
ããå·Šã®æ°ã¯ç¹å®ã®ååãçç£ããããµã€ã¯ã«æ°
ã瀺ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ããããã¢ã°ããã³éºäŒåäžã®å¯Ÿç«
éºäŒåMstIIéšäœãå«ã110å¡©åºå¯Ÿé åã®å¢å¹ ã
瀺ãã®ã§ããã ãã©ã€ããŒã¯å®æœäŸïŒã®æè¡ã§èª¿è£œããããã®
ã§ããã1.0ãã€ã¯ãã°ã©ã ã®å šããDNAã100
ãã³ã¢ã«ã®ïœ
ïŒACACAACTGTGTTCACTAGCïŒåã³100ã
ã³ã¢ã«ã®ïœïŒCAACTTCATCCACGTTCACCïŒ
ã以äžã®ãããª100ÎŒlã®æº¶æ¶²ã«æº¶è§£ãããã 1.5mMåïŒã€ã®ããªãã·ãªããã¯ã¬ãªã·ãäž
ãªã³é ž 30mMPH7.9ã®ããªã¹ã¢ã»ããŒãç·©è¡æ¶² 60mMé ¢é žãããªãŠã 10mMé ¢é žãã°ãã·ãŠã 25mMãžããªã¹ã¬ã€ããŒã« ãã®æº¶æ¶²ã100âã§ïŒåéå ç±ããè¿ éã«25â
ã«äžããŠïŒåéå ç±ãããã®åŸDNAããªã¡ã©ãŒ
ãŒã®ã¯ã¬ããŒæç2.5åäœãå ãããããªã¡ã©ãŒ
ãŒã®åå¿ã25âã§ïŒåéè¡ãããã®åŸå ç±ãå·
åŽãã¯ã¬ããŒæçã®æ·»å åã³åå¿ãæãã ãç¹°ã
è¿ããã åãµã€ã¯ã«ã®å¹çã70âã§ã15ãµã€ã¯ã«è¡ã€
ãŠãβâã°ããã³éºäŒåã®ææã®110å¡©åºå¯Ÿæç
1.4ããšãã¢ã«ãåæããã å®æœäŸ ïŒ æ¬å®æœäŸã¯ããããã¢ã°ããã³éºäŒåã®å¯Ÿç«éº
äŒåäžã®MstIIéšäœãå«ã240å¡©åºå¯Ÿé åã®å¢å¹
ã瀺ããã®ã§ããããã®é åã¯ãMcoãHinf
åã³MstIIå¶ééšäœãå«ãã§ããã PHã8.0ã§ã60mMé ¢é žãããªãŠã ã30mMã
ãªã¹ã¢ã»ããŒãåã³10mMé ¢é žãã°ãã·ãŠã ã®æ··
åç©ïŒ0.1ãã³ã¢ã«ã®pBR328ïŒHbAãå«ãïŒã«ã 100ãã³ã¢ã«ã®ïœ
ïŒGGTTGGCCAATCTACTCCCAGGïŒãã©ã€
ããŒã 100ãã³ã¢ã«ã®ïœ
ïŒTAACCTTGATACCAACCTGCCCïŒãã©ã€
ããŒã å1000ãã³ã¢ã«ã®ããªãã·ATPãããªãã· CTPãããªãã·GTPåã³TTP ãå«ã2ÎŒã®æº¶æ¶²ïŒ¡ãå ããã ïŒã€ã®ãã©ã€ããŒã¯å®æœäŸïŒã«èšèŒããæè¡ã§
調補ããã溶液ã100âã§ïŒåéå ç±ãã空æ°äž
ã§ïŒåéå·åŽãããã®åŸE.ã³ãŒãªãŒDNAããªã¡
ã©ãŒãŒã®ã¯ã¬ããŒæçïŒåäœãå«ã液1ÎŒãå
ãããåå¿ã10åéé²è¡ããããã®åŸæº¶æ¶²ïŒ¡ã®æ·»
å ãå ç±ãå·åŽãããªã¡ã©ãŒãŒã®æ·»å åã³åå¿ã
ããªããµã€ã¯ã«ãïŒåç¹°ãè¿ãããåå¿æ¶²5.0ÎŒ
ã«ãäžèšã®åãªãªãŽãã¯ã¬ãªãããã©ã€ããŒïŒã
ã³ã¢ã«ãå ããã溶液ã10âã§ïŒåéå ç±ãã宀
æž©ãŸã§äžãããã®åŸããããïŒãã³ã¢ã«ã®Î±â
32Pâã©ãã«ãããããªãã·ãªããã¯ã¬ãªã·ãäž
ãªã³é žåã³ïŒåäœã®ã¯ã¬ããŒæçãå ãããæçµ
çãªå®¹éã10ÎŒã§å¡©æ¿åºŠãäžèšã®éãã§ããå
å¿ã10åéé²è¡ããããããªã¡ã©ãŒãŒæŽ»æ§ã¯60â
ã§20åéå ç±ãããšå€±æŽ»ããã2ÎŒã®ã¢ãªã³ãŒ
ããNcoãHinfåã³MstIIã§æ¶åããPH8.3ã®
0.089Mããªã¹ã¢ã»ããŒãç·©è¡æ¶²ã0.25mMEDTA
äžã§12ïŒ ããªã¢ã¯ãªã«ã¢ããã²ã«ã«å ãããã²ã«
ã25ãã«ãïŒcmã§ïŒæéé»æ°æ³³åããããªãŒãã©
ãžãªã°ã©ãåŠçããã第ïŒå³ã¯é»æ°æ³³åã®ãªãŒã
ã©ãžãªã°ã©ãã瀺ããããã§ã¬ãŒã³ïŒã¯ååéæš
æºãã¬ãŒã³ïŒã¯é µçŽ ã®æ¶åã䌎ããªããã®ïŒç¡å·
ã®240å¡©åºå¯ŸïŒãã¬ãŒã³ïŒã¯Ncoã«ããæ¶å
ïŒ131åã³109å¡©åºå¯ŸïŒãã¬ãŒã³ïŒã¯MstIIã«ããæ¶
åïŒ149åã³91å¡©åºå¯ŸïŒããããŠã¬ãŒã³ïŒã¯Hinf
ã«ããæ¶åïŒ144åã³96å¡©åºå¯ŸïŒã§ããããªãŒ
ãã©ãžãªã°ã©ãã¯240å¡©åºå¯Ÿåå¿ã®å¢å¹ ãããã®
ãšäžèŽããã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãé次çæ¶åã«ããéç¶èµ€è¡ç貧è¡
ãæ€åºããããã®æ¬çºæã®æ¹æ³ã®äœ¿çšã瀺ããã®
ã§ããã ãªãªãŽããªãã·ãªããã¯ã¬ãªããã®åæåã³
ãªã³é žå 5â²*
CTGACTCCTGAGGAGAAGTCTGCCGTTA
ïŒâ²ã®é åã®ã©ãã«ããã
DNAãããŒãïŒ*ãã©ãã«ãæå³ããïŒRS06ã
åã³RS06ãšïŒã€ã®å¡©åºå¯Ÿããã¹ãããããŠããã
3â²GACAGAGGTCACCTCTTCAGACGGCAA
ïŒâ²ã®é åã®ã©ãã«ãããŠ
ã
ãªããããã¯ãªãªãŽããŒRS10ããå®æœäŸïŒïŒïŒ
ã®æ¹æ³ã«åŸã€ãŠåæããããããŒãRS06ã¯ãã
ã®ïŒãã³ã¢ã«ãã70mMããªã¹ç·©è¡æ¶²ïŒPH7.6ïŒã
10mM MgCl2ã1.5mMã¹ãã«ãã³åã³2.5mMãž
ããªã¹ã¬ã€ããŒã«ãå«ãåå¿å®¹é40ÎŒäžã®ïŒå
äœã®T4ããªãã¯ã¬ãªãããããŒãŒïŒããŠãŒã€ã³
ã°ã©ããã€ãªã©ãïŒåã³50ãã³ã¢ã«ã®Î³â32Pâ
ATPïŒããŠãŒã€ã³ã°ã©ã³ãããŠãŒã¯ã¬ã¢ãçŽ
7200CiïŒmMïŒãšæ¥è§Šãããããšã«ããã©ãã«ã
ããå šå®¹éã25mMEDTAã§100ÎŒã«èª¿ç¯ãã
ããªã¹âEDTAïŒTEïŒç·©è¡æ¶²ïŒ10mMããªã¹ç·©è¡
液ã0.1mMEDTAãPH8.0ïŒã«ãã平衡åããã
ãã€ãªã©ãã補ã®1mlã®Bio Gel âïŒã¹ãã³é
æã«ã©ã äžã§ããã¢ãã€ã¹ããMolecular
Cloning464â465é ïŒ1982幎ïŒã«èšèŒããŠããæ¹
æ³ã«åŸã€ãŠç²Ÿè£œãããã©ãã«ããããããŒãã¯ã
ããªã¹âç¡Œé žâEDTAïŒTBEïŒç·©è¡æ¶²ïŒ89mMã
ãªã¹ã89mMç¡Œé žã2.5mMEDTAãPH8.3ïŒäž18
ïŒ ã®ããªã¢ã¯ãªã«ã¢ããã²ã«ïŒ19ïŒïŒã®ã¢ã¯ãªã«
ã¢ããïŒBISãšãã€ãªã©ããïŒäžã§500vhrã«ãŠé»
æ°æ³³åããŠããã«ç²Ÿè£œããããªãŒãã©ãžãªã°ã©ã
ã«ããäœçœ®ããã®åŸãã©ãã«ããããããŒããå«
ãéšåãåãåããç²ç ãã0.2mlã®TEç·©è¡æ¶²äž
ãžäžæ©ãããŠïŒâã§æº¶åºããããåå¿çæç©ã®
TCAæ²æŸ±ã¯æ¯æŽ»æ§ã4.9CiïŒããªã¢ã«ã§ãããæ
çµçæ¿åºŠã20ãã³ã¢ã«ïŒmlã§ããããšã瀺ããŠ
ããã ã©ãã«ãããªãRS10ããããã³ã°ãªãªãŽããŒ
ã¯ã200ãã³ã¢ã«ïŒmlã®æ¿åºŠã§äœ¿çšããã 现èç³»ããã®ããã²ãã DNAã®åé¢ å®è³ªçã«ã¹ãããã©ãŒãã®PNAS79å·»5966â
5970é ïŒ1982幎ãMolt4ã«ã€ããŠïŒã«èšèŒã®æ¹æ³
åã³ããã¢ãã€ã¹ãã®Molecular Cloning280â
281é ïŒ1982幎ïŒã«èšèŒã®æ¹æ³ã䜿çšããŠã
Molt4ãSCâïŒåã³GM2064ã®ãªã³ãçç³»ããé«
ååã®ã²ãã DNAãåé¢ããã Molt4ïŒããŠãŒãã³ã»ããŠãŒã¿ã³ãã»ã»ã«ã»ã
ããžããªãŒïŒGM2219CïŒã¯æ£åžžã®Î²âã°ããã³
ã«ã€ããŠãã¢æ¥åäœã®ïŒŽçŽ°èç³»ã§ããããããŠ
ATCC1985幎ïŒæ19æ¥ã«å¯èšãããSCâïŒã¯é
ç¶èµ€è¡ç貧è¡å¯Ÿç«éºäŒåã«ã€ããŠãã¢æ¥åäœã®
EBVã§åœ¢è³ªå€æããã现èç³»ã§ããã
GM2064ïŒããŠãŒãã³ã»ããŠãŒã¿ã³ãã»ã»ã«ã»ã
ããžããªãŒïŒGM2064ïŒã¯èå ãã¢ã°ããã³ã®éº
äŒçãªæ°žç¶æ§ïŒHPFHïŒã«ã€ããŠãã¢æ¥åäœã§
ããåäœåœååé¢ãããβâåã¯ÎŽâã°ããã³éº
äŒåé åãå«ãã§ããªããå šãŠçŽ°èç³»ã¯10ïŒ ã®ç
èå è¡æž ãå«ãRPMIâ1640äžã«ç¶æãããã èšåºè¡æ¶²è©Šæããã®ããã²ãã DNAã®åé¢ æ¢ç¥ã®éç¶çŽ°èãã€ãªã€ãŒïŒASïŒããã®CH12
ãšåä»ããããèšåºè¡æ¶²è©Šæãã«ã«ããªã«ãã¢å·
ãªãŒã¯ã©ã³ãã®å°å ç é¢ã®ãã«ãã©ã ã»ã«ãã³å
士ããåŸãããã³ãã«ã°ãã®Prc.Nat.Acad.Sci.
75å·»5553â5556é ïŒ1978幎ïŒã«èšèŒãããŠããæ¹
æ³ã®å€æ³ã䜿çšããŠãäž»ã«æ«æ¢¢ã®è¡æ¶²ãªã³ãçã
ãæãããã€ãŒã³ãŒãéšåããã²ãã DNAã調
補ããã 现èãã5mlã®ããªã¹âEDTAâNaCl
ïŒTENNïŒç·©è¡æ¶²ïŒPHïŒã®10mMããªã¹ãPHïŒã
1mMMEDTAã10mMNaClïŒäžã«åæžæ¿ãã
0.2mgïŒmlã®ãããã€ããŒãŒã0.5ïŒ ã®SDSã«èª¿ç¯
ãããããŠ37âã§äžæ©ã€ã³ããŠããŒããããéå¡©
çŽ é žãããªãŠã ã0.7Mã«å ãããããŠçŽ°è溶解
ç©ã宀枩ã§ïŒâïŒæéç©ããã«æ¯ãšãããã现è
溶解ç©ãããšããŒã«ãšã¯ããããªã«ã ã®ïŒïŒïŒæ··
åç©30mlã§æœåºããç¶ããŠã¯ããããªã«ã 30ml
ã§æœåºãã次ã«ãšã¿ããŒã«ã§æ žé žãæ²æŸ±ãããã
ãã¬ããã2mlã®TEç·©è¡æ¶²ã«åæžæ¿ããã
RNaseã0.005mgïŒmlã«å ããã37âã§ïŒæéæ¶
åãããåŸãDNAãåéã®ããšããŒã«ãããšã
ãŒã«ïŒã¯ããããªã«ã ãåã³ã¯ããããªã«ã ã§ã
ãããäžåºŠãã€æœåºãããšã¿ããŒã«ã§æ²æŸ±ãã
ããDNAã0.5mlã®TEç·©è¡æ¶²ã«åæžæ¿ããã
260nmã®åžåã«ããæ¿åºŠã決å®ããã βâã°ããã³é åãéžæçã«å¢å¹ ããããã®
ããªã¡ã©ãŒãŒé£éåå¿ ïŒãã€ã¯ãã°ã©ã ã®ã²ãã DNAãã10mMã
ãªã¹ç·©è¡å€ïŒPH7.5ïŒã50mMNaClã
10mMMgCl2ã150ãã³ã¢ã«ã®é å ïœïŒCACAGGGCACTAACGïŒã®ãã©ã€ããŒïŒ¡ã
åã³é å ïœïŒCTTTGCTTCTGCACAïŒã®ãã©ã€ããŒïŒ¢ã
å«ãåå¿å®¹é100ÎŒã®åœå溶液äžã§å¢å¹ ããã
ã€èžçºãé²ãããçŽ100ÎŒåã®é±æ²¹ã§è¢«èŠããã åDNAè©Šæã«ã€ããïŒãµã€ã¯ã«ã次ã®ïŒã¹ã
ããããæãå¢å¹ ã®ããã®15ãµã€ã¯ã«ãè¡ã€ãã (1) ïŒåé95âã§ç±ãããã¯ã»ããäžã§å€æ§ã
ãã (2) ç±ãããã¯ã»ãããçŽã¡ã«30âã«ç§»ãïŒåé
ãã©ã€ããŒãšã²ãã DNAãã¢ããŒãªã³ã°ãã
ããã«ããã (3) E.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®ã¯ã¬ããŒ
æçïŒããŠãŒã€ã³ã°ã©ã³ããã€ãªã©ãïŒïŒåäœ
ãšããªãã·ATPãããªãã·CTPãããªãã·
GTPåã³TTPããããïŒããã¢ã«ãå«ãÎŒ
ã®æº¶æ¶²ïŒ10mMããªã¹ïŒPH7.5ïŒã50mMNaClã
10mMMgCl2ãåã³4mMãžããªã¹ã¬ã€ããŒã«
ããæãç·©è¡æ¶²äžïŒãå ããããã®äŒžé·åå¿ã
30âã«ãŠ10åéè¡ã€ãã æåŸã®ãµã€ã¯ã«ã®åŸã95âã«ïŒåéç¶æããŠ
åå¿ãåæ¢ããããé±æ²¹ã¯0.2mlã®ã¯ããããª
ã«ã ã§æœåºããŠå»æ£ãããæåŸã®åå¿æ¶²ã®å®¹é
ã¯130ÎŒã§ãã€ãã ãããŒãåã³DdeLïŒHinfIã«ããå¢å¹ ãã
ã²ãã DNAã®ãã€ããªãã€ãŒãŒã·ãšã³ïŒæ¶å 25ãã€ã¯ããªããã«ã®å¢å¹ ãããã²ãã DNA
ããšã¿ããŒã«ã§æ²æŸ±ãããåéã®TEç·©è¡æ¶²äžã«
åæžæ¿ããã10ãã€ã¯ããªããã«ïŒ154ngã®ã²ã
ã DNAãšåçã®åå¢å¹ äœãå«ãïŒã1.5mlã®ãã€
ã¯ãããŠãŒãžç®¡ã«å ¥ãããããŠ20ÎŒã®TEç·©è¡
液ã«ããæåŸã®å®¹éã30ÎŒãšãããè©Šæãé±æ²¹
ã§è¢«èŠããŠ95âã§10åéå€æ§ãããã©ãã«ããã
RS06ãããŒã0.02ãã³ã¢ã«ãå«ã0.6MMaCI10
ãã€ã¯ããªããã«ã管ã«å ããç©ããã«æ··åãã
çŽã¡ã«56âã®ç±ãããã¯ã«ç§»ããŠïŒæéãããã
ã©ãã«ããŠããªãRS10ããããã³ã°ãªãªãŽããŒ
ïŒãã€ã¯ããªããã«ïŒ0.8ãã³ã¢ã«ïŒãå ããæŽ
ã«10åéåã枩床ã§ãã€ããªãã€ãŒãŒã·ãšã³ãç¶
ãããïŒãã€ã¯ããªããã«ã®60mMMgCl2ïŒ0.1
ïŒ BSAåã³1ÎŒã®DelïŒ10åäœãããŠãŒã€ã³ã°
ã©ã³ããã€ãªã©ãïŒãå ããåã¢ããŒãªã³ã°ãã
ãDNAã56âã§30åéæ¶åãããïŒãã€ã¯ããª
ããã«ã®HinfïŒ10åäœãããŠãŒã€ã³ã°ã©ã³ãã
ã€ãªã©ãïŒãå ããæŽã«30åã€ã³ããŠããŒãã
ãã4ÎŒã®75mMEDTAãš6ÎŒã®ãã©ããã³ã°
ææãæçµå®¹ç©ã61ÎŒã«ãªãããã«åå¿æ··åç©
ã«å ããŠåå¿ãçµäºããã é±æ²¹ãïŒ2mlã®ã¯ããããªã«ã ã§æœåºãã18ÎŒ
ã®åå¿æ··åç©ïŒ45nmã®ã²ãã DNAïŒãããŒã
ã¢ãŒSE200è£ çœ®äžã®30ïŒ ããªã¢ã¯ãªã«ã¢ããã®ã
ãã²ã«ïŒ19ïŒïŒããã€ãªã©ãïŒã«è² è·ããããã®
ã²ã«ãããã¢ããšããŒã«ãã«ãŒææã®å端ãåœå
ã®äœçœ®ãã3.0cmåããŸã§çŽ300ãã«ãã§ïŒæéé»
æ°æ³³åãããã該ã²ã«ã®å端ã®1.5cmã¯åãé€ã
ããæ®ãã®ã²ã«ã¯ïŒæ¥éâ70âã§åŒ·åã¹ã¯ãªãŒã³
ã¯æãããã åçã®æ€èšïŒç¬¬ïŒå³ïŒ åã¬ãŒã³ã¯45ngã®å¢å¹ ãããã²ãã DNAãå«
ãã§ãããã¬ãŒã³ïŒ¡ã¯Mol4DNAããã¬ãŒã³ïŒ¢ã¯
CH12ããã¬ãŒã³ïŒ£ã¯SCâïŒããåã¬ãŒã³ïŒ€ã¯
GM2064ãå«ãã§ãããMolt4ã¯ã现èåœããïŒ
ã³ããŒã®Î²AéºäŒåãæããæ£åžžã®åäœã®éºäŒåå
CAAã§ãããCH12ã¯ã现èåœããïŒåã®Î²AãšïŒ
åã®Î²SéºäŒåãæããéç¶çŽ°èãã€ãªã¢ããã®èš
åºçšè©ŠæïŒASïŒã§ããããããŠSCâïŒã¯çŽ°èåœ
ããã³ããŒã®Î²Sãæããéç¶è¡çè¡è²§è¡åäœã®éº
äŒååãæå³ãããGM2064ã¯Î²âåã¯ÎŽâã°ã
ãã³é åãå«æããããã¬ãã€ãå¯Ÿç §ãšããŠååš
ããã åçããåããããã«Ddeã§éè£ããããβA
ç¹ç°çã§ãããªã¯ã¿ããŒã¯Î²AéºäŒåãå«ãDNA
ã«ã®ã¿ååšãïŒã¬ãŒã³ïŒ¡åã³ïŒ¢ïŒãHinfLã§éè£
ããããβSç¹ç°æ§ãæããããªããŒã¯ãβSéºäŒå
ãå«ãDNAã«ã®ã¿ååšããïŒã¬ãŒã³ïŒ¢åã³ïŒ£ïŒã
ããªããŒåã³ãªã¯ã¿ããŒã®äž¡è ã®ååšïŒã¬ãŒã³
ïŒã¯éç¶èµ€è¡ç貧è¡ãã€ãªã¢ã瀺ããã®ã§ã
ãããªã¯ã¿ããŒã®ã¿ãçããæ£åžžã®åäœïŒã¬ãŒã³
ïŒåã³ããªããŒã®ã¿ã瀺ãéç¶èµ€è¡ç貧è¡ã«ã
ãã€ãŠããåäœïŒã¬ãŒã³ïŒ£ïŒããåºå¥ãããã æ¯èŒã®ãããäžèšå®éšãå¢å¹ ãããŠããªãã²ã
ã DNAãçšããŠç¹°ãè¿ãè¡ããå¢å¹ ãè¡ããšæ€
åºæ床ãå°ãªããšã1000åå¢å ããããšãåãã€
ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãã©ãã«ããããããŒãã䜿çšãã
ããšãªãå šããDNAäžã®å šã粟補ãããŠãªãå
äžã³ããŒéºäŒåãã²ã«äžã§çŽæ¥æ€åºããæ¹æ³ã瀺
ããã®ã§ããã å®æœäŸïŒã«èšèŒããæè¡ãçšããβâã°ãããª
ã³éºäŒåã®ç¬¬ïŒãšã¯ãœã³äžã®é åããã®110å¡©åº
察æçããå šããDNA10ãã€ã¯ãã°ã©ã ãã20
ãµã€ã¯ã«ã§å¢å¹ ããããã®20ãµã€ã¯ã«åŸã«çç£ã
ãã110å¡©åºå¯Ÿæçã¯ãèåãšããžãŠã ã«ãã容
æã«æè²ãããŠã²ã«äžã§èŠãããšãã§ããã é åã¯ãæåã«å¶éé µçŽ Ddeã«ããåæãã
ããšãé åãβâã°ããã³ã®ïŒ³å¯Ÿç«éºäŒåäžã«ã
ããå Žåã®ããã«é µçŽ ã«ããèªèãããå¶ééšäœ
ãå«ãŸãªããã®ã§ãªãéããå¢å¹ ãããªãã€ãã å®æœäŸ ïŒ A.ããβâã°ããã³ïŒ¡å¯Ÿç«éºäŒåããã®1.9kb
æ¿å ¥éšãå«æããåèš100ããšã ãã¢ã«ã®
pBR328ã500CiïŒã¢ã«ã§ããåαâ32Pâããªã
ã·NTPã50ããã¢ã«ãã€ãåã³å®æœäŸïŒã§äœ¿çš
ããåãã©ã€ããŒïŒããã¢ã«ãã100ÎŒã®30mM
ããªã¹âã¢ã»ããŒãïŒPH7.9ïŒã60mMé ¢é žãããª
ãŠã ã100mMãžããªã¹ã¬ã€ããŒã«åã³10mMé ¢
é žãã°ãã·ãŠã ãå«ã溶液äžã«æº¶ãããããã®æº¶
液ã100âã«ããŠïŒåå ç±ãã25âã«ãŠïŒåå·åŽ
ããã4.5åäœã®E.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©
åã³0.09åäœã®ç¡æ©ããããªã¹ãã¢ã¿ãŒãŒãå ã
ãŠåå¿æ··åç©äžã§ãããªã³é žãçããã®ãé²æ¢
ãããã®åŸåå¿ã25âã§ïŒåéé²è¡ãããæŽã«å
ç±ãå·åŽãé µçŽ ã®æ·»å åã³åå¿ã®ãµã€ã¯ã«ãïŒå
ç¹°ãè¿ãããååæãµã€ã¯ã«ã®åŸã10ÎŒã®ã¢ãª
ã³ãŒããåãåºã1ÎŒã®600mMEDTAã«å ã
ãããããããã90mMã®ããªã¹ãã¬ãŒãåã³
2.5mMã®EDTAäžãPH8.3ã§14ïŒ ã®ããªã¢ã¯ãªã«
ã¢ããã²ã«äžã§24ãã«ãïŒcmã2.5æéã§åæã
ããæäœã®çµäºããã²ã«ã¯ã0.5ÎŒgïŒmlã®èåãš
ããžãŠã ãå ããåãç·©è¡æ¶²ã«20å浞ããåœåã®
ç·©è¡æ¶²ã§æŽæµããèµ€ãã€ã«ã¿ãŒãçšããŠçŽ«å€ç·äž
ã§åçãæ®åœ±ããã çç£ããã110å¡©åºå¯Ÿæçã¯çŽ«å€ç·ãã²ã«ãã
åãåºãããããŠã¯ã¬ã³ã³ãæŸå°ã«ããä¿æ°ã
ããããµã€ã¯ã«æ°ãæå³ããïœããµã€ã¯ã«æ¯ã®
éšåçåçã§ããåŒ pmolesïŒ10ÎŒïŒ0.01ïŒïŒïŒïœïŒNâyNâïŒïŒã ã«ããŒã¿ãäžèŽãããããšããè©Šã¿ã¯ãïœã
0.619ã§ãããšãã«æ¥œèŠ³çãªãã®ãšãªããããã¯ã
ååãªå¢å¹ ãèµ·ãã€ãŠããããšãæ瀺ããŠããã B.åããªãã·NTPã100ããã¢ã«ãã€100ÎŒã®
åå¿æº¶æ¶²ã«å ããæŸå°æ§ã©ãã«ãè¡ãããåãµã€
ã¯ã«æ¯ã«æ¶²ãåãåºããªãã€ã以å€ã¯ãäžèšãšå
ãå®éšãç¹°ãè¿ããã10ãµã€ã¯ã«åŸã«åå¿ç©ãïŒ
åé沞隰ãããŠåå¿ãåæ¢ããã57âãïŒæéã§
åãã€ããªãã€ãŒãŒã·ãšã³ãè¡ã€ãã 110å¡©åºå¯Ÿçæç©ã®é åãããã®8ÎŒlã®ã¢ãªã³ãŒã
ãã1ÎŒã®ãŠã·è¡æž ã¢ã«ããã³ïŒïŒmgïŒmlïŒãš
1ÎŒã®å¥œé©ãªå¶éé µçŽ ïŒHinfIãMnlãMstIIã
NcoïŒãå ããŠå¶éåæãã37âã§15æéåå¿
ãããŠç¢ºèªãããPAGEã¯ãäžè¿°ã®éãè¡ã€ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãpBR328ãšpBR322ã®çš®ã ã®æç
ãå¢å¹ ããããã«ç°ãªã€ããã©ã€ããŒã䜿çšãã
äŸã瀺ãã  次ã®ãã©ã€ããŒã䜿ãpBR328ã®130å¡©åºå¯Ÿ
æçã調補ããããšä»¥å€ã¯å®æœäŸ7Aãšåãã
ãã«å®éšãç¹°ãè¿ããã ïœïŒTTTGCTTCTGACACAACTGTGTTCACTAGCïŒåã³ ïœïŒGCCTCACCACCAACTTCATCCACGTTCACCïŒ ïŒ¢ 次ã®ãã©ã€ããŒãçšããããšä»¥å€ã¯å®æœäŸ
7Aãšåãããã«å®éšãç¹°ãè¿ãpBR328ã®262
å¡©åºå¯Ÿæçã調補ãããåå¿æéã¯ãµã€ã¯ã«åœ
ãã20åã§ãã€ãã ïœïŒGGTTGGCCAATCTACTCCCAGGïŒ
åã³ ïœïŒTGGTCTCCTTAAACCTGTCTTGïŒ ïŒ£ ããβâã°ããã³ïŒ³å¯Ÿç«éºäŒåããã®1.9kb
ã®æ¿å ¥éšãå«ãã100ããšã ãã¢ã«ã®pBR328
ã®MstIIæ¶åç©ãåœåã®é³åãšããŠçšãã以å€
ã¯ãå®æœäŸ8Bãšåæ§ã«å®éšãè¡ã€ãã該ãã©
ã¹ããã¯MstIIã«ããæ°ååæãããããå¢å¹
ãã¹ãé åã®å åŽã§ã¯åæãèµ·ãããªãã€ãã
æŽã«ã䜿çšãããã©ã€ããŒã¯æ¬¡ã®éãã§ã240
å¡©åºå¯Ÿæçãçç£ããã ïœïŒGGTTGGCCAATCTACTCCCAGGïŒ
åã³ ïœïŒTAACCTTGATACCAACCTGCCCïŒ ïŒ€ 100ããšã ãã¢ã«ã®pBR322ã®Nruæ¶åç©ã
é³åãšããŠçšãã100ÎŒã®åå¿æ¶²äžã§åããª
ãã·NTPã200ããã¢ã«äœ¿çšãã次ã®ãã©ã€ã
ãŒã䜿çšããŠpBR322ãã500å¡©åºå¯Ÿæçãç
ç£ãã以å€ã¯å®æœäŸ7Bãšåæ§ã«å®éšãè¡ã€ãã ïœïŒTAGGCGTATCACGAGGCCCTïŒåã³ ïœïŒCTTCCCCATCGGTGATGTCGïŒ åå¿æéã¯37âã§ãµã€ã¯ã«åœãã20åã§ãã€
ããæåŸã®åãã€ããªãã€ãŒãŒã·ãšã³ã¯57âã§15
æéè¡ã€ããé»æ°æ³³åã¯ïŒïŒ ã¢ã¬ããŒã¹ã²ã«äžã§
è¡ã€ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãã€ã³ãããå€ç°ãå¢å¹ ãããã»ã°
ã¡ã³ãã«å°å ¥ããããããªæ¬çºææ¹æ³ãäŸç€ºãã
ãã®ã§ããã  Nruã§çŽç·åããpBR322åèš100ããšã ã
ã¢ã«ãïŒããã¢ã«ã®75å¡©åºå¯Ÿæçãçæããã
ãã«èšèšãããããããæ¬¡åŒ ïœïŒCGCATTAAAGCTTATCGATGïŒåã³ ïœïŒTAGGCGTATCACGAGGCCCTïŒ ã®ãã©ã€ããŒããããã100ããã¢ã«ã®åããª
ãã·NTPããPHïŒã®40mMã®ããªã¹ã
20mMMgCl2ã5mMã®ãžããªã¹ã¬ã€ããŒã«å
ã³ïŒmgïŒmlã®ãŠã·è¡æž ã¢ã«ããã³ã®æº¶æ¶²100ÎŒ
äžã§æ··åããããã®æ··åç©ã100âã«ããŠïŒ
åéå ç±ãã氎济äž23âã0.5åéå·åŽãã次
ã«4.5åäœã®ã¯ã¬ããŒæçãš0.09åäœã®ç¡æ©ã
ãããªã¹ãã¢ã¿ãŒãŒãå ããåå¿ãïŒåéè¡ã€
ããå ç±ãå·åŽãé µçŽ æ·»å åã³åå¿ãµã€ã¯ã«ã
ïŒåç¹°ãè¿ããã10åç®ã®åå¿ãµã€ã¯ã«ã¯åçµ
ã«ããçµäºãããåå¿æ··åç©ã®ã¢ãªã³ãŒã8ÎŒ
ãïŒïŒ ã¢ã¬ããŒã¹ã²ã«ã«é©çšããèåãšããž
ãŠã ã«ããèŠèŠåããã  ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãšããŠæ¬¡åŒã®
ãã®ã䜿çšãã以å€ã¯å®æœäŸ9Aãšåæ§ã®å®éš
ãç¹°ãè¿ããã ïœïŒCGCATTAAAGCTTATCGATGïŒåã³ ïœïŒAATTAATACGACTCACTATAGGGAGATAGGCGTATCACGA
GGCCCTïŒ ãããã®ãã©ã€ããŒã¯101å¡©åºå¯Ÿãçç£ããã
ãã«èšèšããããã®ïŒïŒçªç®ã®ãã©ã€ããŒäž
ã®ïŒ26ãã¯ã¬ãªããã¯pBR322ã«ã¯ååšããª
ãããããã®ãã¯ã¬ãªããã¯T7ããã¢ãŒã¿ãŒ
ã®é åãè¡šããã®ã§ãããããpBR322ããã®
75å¡©åºå¯Ÿé åã«ã20ã®çžè£çå¡©åºãš26å¡©åºã®
5â²åŽäŒžé·éšãšãæãããã©ã€ããŒã䜿çšããŠé£
çµããããã®æ¹æ³ã¯ïŒæéããå°ãªãæéã§å®
æœããããšãã§ãã100ããšã ãã¢ã«ã®
pBR322ããæ¯èŒççŽç²ãª101å¡©åºå¯ŸæçïŒã
ã³ã¢ã«ãçç£ããããšãã§ããã T7ããã¢ãŒã¿ãŒã¯RNA転åãéå§ãããã
ãã«äœ¿çšã§ãããT7ããªã¡ã©ãŒãŒã101å¡©åºå¯Ÿ
æçã«å ããŠåéRNAãçæããããããšã
ã§ããã  ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãšããŠäžèšã®
ãã®ã䜿çšããŠãpBR322ãã1000å¡©åºå¯Ÿæç
ã調補ãã以å€ã¯å®æœäŸ8Dãšåæ§ã«å®éšãç¹°
ãè¿ããã ïœïŒTAGGCGTATCACGAGGCCCTïŒåã³ ïœïŒCCAGCAAGACGTAGCCCAGCïŒ ïŒ€ äžèš9Cãšåæ§ã®å®éšãç¹°ãè¿ãããäœãã
ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãšããŠäžèšã®ã
ã®ã ïœïŒTAGGCGTATCACGAGGCCCTïŒåã³ ïœïŒAATTAATACGACTCACTATAGGGAGATAGGCGTATCACGA
GGCCCTïŒ äœ¿çšããŠ1026察æçã調補ãããïŒçªç®ã®ãã©
ã€ããŒ26ãã¯ã¬ãªããã¯pBR322ã«ã¯ååšããã
äžèšã®T7ããã¢ãŒã¿ãŒã瀺ããã®ã§ããããã®
ããã¢ãŒã¿ãŒã¯ãpBR322ããã®1000å¡©åºå¯Ÿæç
ã«é£æ¥ããŠæ¿å ¥ãããã ãããã®çµæã¯ãé³åéãšå®å šã«ãããããŠã
ãªããããã«ããããããååã«ãã€ããªãã€ãº
ããŠé µçŽ çã«äŒžé·ãããã©ã€ããŒã¯ãåœåã®é³å
ã«å¯Ÿå¿ããéããããããã©ã€ããŒã®éãå«ãé·
éçæç©ãçæãããããšããããšãæ瀺ããã
é·éçæç©ã¯ã€ã³ãããå€ç°ãçãããã第ïŒã®
ãã©ã€ããŒçšã®é³åãšããŠã®åœ¹å²ãæããããã®
åŸã®ãµã€ã¯ã«ã§ã¯ãæŽã«å€ãã®ãã¹ãã¢ãããã©
ã€ãã³ã°ãèŠæ±ãããªãã®ã§ãå¹çãæžå°ããã
ãšãªããã®å€ç°ã¯å¢å¹ ãããããã®å Žåãã®5â²æ«
端ã«çžè£çã§ãªã䌞é·éšåããããã©ã€ããŒãã
è€è£œãããã¹ãé³åã«é£æ¥ããŠçæç©ã«æ°ããé
åãæ¿å ¥ããããã«äœ¿çšãããã å®æœäŸ 10 æ¬å®æœäŸã¯åã³ããŒéºäŒåãå¢å¹ ãããéã«ã
ãã¯ã°ã©ãŠã³ããæžå°ãããããã«ãã¹ãç¶ã«
ïŒnestedïŒã»ãããããã©ã€ããŒã䜿çšããããš
ãäŸç€ºãããã®ã§ããã éæ§åβâã°ããã³å¯Ÿç«éºäŒåã«ã€ããŠãã¢æ¥
åäœã§ããå šããDNAã«å¯ŸããŠã20ãµã€ã¯ã«ã®
å¢å¹ ã次ã®ããã«è¡ã€ãã10ÎŒgã®DNAãããã
ã200ãã³ã¢ã«ã®æ¬¡åŒã®ãã©ã€ããŒã ïœïŒACACAACTGTGTTCACTAGCïŒåã³ ïœïŒCAACTTCATCCACGTTCACCïŒ äžŠã³ã«100ããã¢ã«ãã€ã®dNTPãã100ÎŒã®
30mMããªã¹âã¢ã»ããŒãã60mMã®é ¢é žãããª
ãŠã ã10mMã®ãžããªã¹ã¬ã€ããŒã«ãåã³10mM
ã®é ¢é žãã°ãã·ãŠã äžã§100âã«ãŠïŒåéå ç±ãã
25âã«ïŒåéäžããŠããããŠïŒåäœã®ã¯ã¬ããŒæ
çãšãšãã«ïŒåéåŠçãããå ç±ãå·åŽãã¯ã¬ã
ãŒè©Šè¬ã®æ·»å ã®ãµã€ã¯ã«ã19åç¹°ãè¿ããã10ÎŒ
ã®æ¶²äœãåå¿æ··åç©ããåãåºããæŽã«10åã®
å¢å¹ ã®ããã®ãµã€ã¯ã«ã次ã®åãã©ã€ããŒãçšã
ãŠè¡ã€ãã ïœ
ïŒCAGACACCATGGTGCACCTGACTCCTGïŒ
åã³ ïœïŒCCCCACAGGGCAGTAACGGCAGACTTCTCCïŒ ãããã¯ãäžèšã§çç£ããã110å¡©åºå¯Ÿæçäžã«
å«ãŸãã58å¡©åºå¯Ÿæçãå¢å¹ ãããå¢å¹ ãã¹ãæ
åŸã®10åã®ãµã€ã¯ã«ã¯ã10ÎŒã®ã¢ãªã³ãŒããã
äžèšããåããªãã·NTP100ããã¢ã«ãšåãã©ã€
ããŒ200ãã³ã¢ã«ãå«ã90ÎŒã®æ°ããããªã¹â
ã¢ã»ããŒãç·©è¡æ¶²ã«åžéããããšã«ããéæãã
ããšãã§ãããåå¿æ¡ä»¶ã¯äžèšã®éããšããã10
ãµã€ã¯ã«ã®åŸ10ÎŒã®ã¢ãªã³ãŒãïŒåœåã®DNA
ã®100ããã°ã©ã ã«å¯Ÿå¿ïŒãïŒïŒ ã®Nuã·ãŒã
ïŒFMC瀟ïŒã¢ã¬ããŒã¹ã²ã«ã«å ããèåãšããžãŠ
ã ã䜿ã€ãŠèŠèŠåããã 第ïŒïŒå³ã¯ã玫å€ç·ã§çºå ãããåŸæ¥æ³ã®éã
èµ€ããã€ã«ã¿ãŒãéããŠåçæ®åœ±ããäžèšã²ã«ã
瀺ããã®ã§ãããã¬ãŒã³ïŒã¯ååéã®ããŒã«ãŒã§
ãããã¬ãŒã³ïŒã¯äžèšåå¿ã®ã¢ãªã³ãŒãã§ããã
ã¬ãŒã³ïŒã¯åœåã®éæ§åDNAãå¢å¹ ã®åã«Dde
ã«ããéè£ãããããšä»¥å€ã¯äžèšãããã®ãšå
ãåå¿ã®ã¢ãªã³ãŒãã§ãããã¬ãŒã³ïŒã¯éç¶èµ€è¡
ç貧è¡Î²âã°ããã³å¯Ÿç«éºäŒåã«ã€ããŠãã¢æ¥å
äœã§ããããDNAãå¢å¹ ã®åã«Ddeã§åŠçã
ãããšä»¥å€ã¯äžèšãšåæ§ãªåå¿ã®ã¢ãªã³ãŒãã§ã
ãïŒéç¶èµ€è¡ç貧è¡å¯Ÿç«éºäŒåã¯å¢å¹ ãããæç
å ã«Ddeéšäœãå«ãŸãªãïŒãã¬ãŒã³ïŒã¯é®ã®ç²Ÿ
åDNAã§ããDNAã眮ãæãã以å€ã¯äžèšãšå
æ§ã®åå¿ã®ã¢ãªã³ãŒãã§ãããã¬ãŒã³ïŒã¯å¢å¹ åŸ
åå¿æ¶²ãDdeã§åŠçããããšä»¥å€ã¯äžèšãšåæ§
ãªåå¿ã®ã¢ãªã³ãŒãã§ããïŒDdeã¯58å¡©åºå¯Ÿã®
éæ§åçæç©ã27å¡©åºäœåã³34å¡©åºäœã®æçã«å€
æããïŒãã¬ãŒã³ïŒã¯å¢å¹ åŸDdeã§åŠçããã¬
ãŒã³ïŒã®ææã®ã¢ãªã³ãŒãã§ããïŒ58å¡©åºå¯Ÿã®é
ç¶èµ€è¡ç貧è¡çæç©ã¯Ddeãå«ãŸãªãïŒã ã¢ã¬ããŒã¹ã²ã«ã®èåãšããžãŠã æè²ã®ã¿ã䜿
çšããŠããDNAã®ïŒãã€ã¯ãã°ã©ã ããã®åã³
ããŒéºäŒåã代衚ãã58å¡©åºå¯Ÿæçãæ€åºããã
ãã«ã¯ãçŽ500000åã«å¢å¹ ããããšãå¿ èŠã§ã
ããããã¯ãããã§ïŒã€ã®ãªãªãŽãã¯ã¬ãªããã®
ãã¹ãç¶ã»ããã䜿çšããŠéæããããšãã§ã
ãã第ïŒã®ã»ããã¯110å¡©åºå¯Ÿæçãå¢å¹ ããå
éšã®ãã¹ãç¶ã»ããã¯ã第ïŒïŒå³ã«ç€ºãããã«äŸ¿
å©ã«æ€åºã§ããã¬ãã«ã«ãªããŸã§ãã®çæç©ã®ãµ
ããŒæçãå¢å¹ ãããå è¡ããå¢å¹ å·¥çšã§å¢å¹ ã
ããé åäžã«å«ãŸããåä»ã®ãã©ã€ããŒã®äŒžé·ç
æç©äžã«ãå«ãŸããããå°ããªé åããã©ã€ããŒ
ã䜿ã€ãŠå¢å¹ ããæ¬æ³ã¯ãäŸãã°ã³ããŒãã®
PNAS80å·»278é ïŒ1983幎ïŒåã³ã¬ã¢ãªãŒãã®
PNAS80å·»4045é ïŒ1983幎ïŒã«èšèŒãããŠããã
ãã«æŸå°æ§åäœäœåã¯éæŸå°æ§åäœäœãããŒãã®
ãã€ããªãã€ãŒãŒã·ãšã³ã®æ¹æ³è«ã«é Œãããšãª
ããβâã°ããã³ã®åº§ã«ãããéæ§åãéç¶èµ€è¡
ç貧è¡å¯Ÿç«éºäŒåããåºå¥ããããšãå¯èœã«ã
ãã å®æœäŸ 11 æ¬æ³ã¯æ£è ã®DNAè©Šæäžã®äŸãã°ã¯ã©ããžã¢
ã®ãããªäŒææ§çŸæ£ãšé¢é£ããç¹å®ã®é åããæ
æã®å¢å¹ ãããé åãå«ãããªãã³åããããã€
ããªãã€ãŒãŒã·ãšã³ãããŒãã䜿çšããã€åè¿°ã®
ç±³åœç¹èš±ç¬¬4358535å·ã«èšèŒãããæ¹æ³ã䜿çšã
ãŠæ€åºããéã«æçšã§ããããšãæåŸ ããããã
ãªãã³åããããã€ããªãã€ãŒãŒã·ãšã³ãããŒã
ã¯ãäžéšãäºééãšãªã€ãDNAã«ã次åŒã®ã¹ã
ãŒãµãŒã¢ãŒã ãä»ããŠããªãã³ã«çµåãã4â²âã¡
ãã¬ã³çœ®æâïŒïŒïŒïŒâïŒâããªã¡ãã«ããœã©ã¬
ã³ãæ¿å ¥ããã€å ãç §å°ããããšã«ãã調補ãã
ããšãã§ããã åŒäžïŒ²ã¯âåã¯CHOåºã§ãããRâ³ã¯âã§
ãããïœã¯ïŒãïŒã®æ°ã§ããããããŠïœã¯ïŒãïŒ
ã®æ°ã§ããããããŒãäžã®ããªããã«åºã®æ€åº
ã¯ããšã³ãŸãã€ãªã±ã 瀟ã«ããåžè²©ãããŠããã¹
ãã¬ãã¿ããžã³âé žæ§ããªã¹ãã¢ã¿ãŒãŒè€åäœã
çšããŠããã³ãã¬ããã«è£œé è ã瀺ããŠããæ€åº
æ¹æ³ã«ããéæããããšãã§ããããã€ããªãã€
ãŒãŒã·ãšã³ãããŒãã¯ãæ€åºçšè€åäœãšã®çµåã
åã³ããã«ç¶ãé žæ§ãã¹ãã¢ã¿ãŒãŒã«ãã觊åªã
ããåå¿ïŒãã®åå¿ãæ²æŸ±æ§è²çŽ ãçæããïŒã«
åºãæ²æŸ±ããæè²ã¹ããããšããŠèŠãããšãã§ã
ãã ææã®å¯èš 现èç³»SCâïŒïŒCTCCïŒ0082ïŒã¯ã1985幎ïŒæ
19æ¥ãç±³åœã20852ãã¡ãªãŒã©ã³ãå·ããã¯ãã«
ããŒã¯ããŒã³ãã©ã€ã12301ã«æåšããã¢ã¡ãªã«
ã³ã»ã¿ã€ãã»ã«ã«ãã€ãŒã»ã³ã¬ã¯ã·ãšã³
ïŒATCCïŒã«ATTTåççªå·ç¬¬CRL8756å·ãšããŠ
å¯èšããããSCâïŒã®å¯èšã¯ãATCCãšæ¬ç¹èš±
åºé¡äººã®ã·ãŒã¿ã¹ã»ã³ãŒãã¬ãŒã·ãšã³ãšã®éã®å¥
çŽã«åŸã€ãŠè¡ããããATCCãšã®å¥çŽã¯ãæ¬å¯èš
ãèšèŒããã€ç¹å®ããç±³åœç¹èš±ãçºè¡ãããå Žå
åã¯ç±³åœåã¯å€åœç¹èš±åºé¡ãå ¬è¡ã«å ¬åãããå Ž
ååã¯å ¬éãããå Žåã®ããããæ©ãæ¹ãæ¥ããš
ãã«ãã®çŽ°èç³»ã®åå«ãå ¬è¡ããããæ°žç¶çã«å©
çšã§ããããã«ããããã«æäŸããæŽã«æ¬çŽ°èç³»
ãå©çšãããããšã«ã€ããŠã¯ãç±³åœç¹èš±åæšå±é·
å®ãç±³åœç¹èš±æ³ç¬¬122æ¡åã³ããã«é¢ããé·å®ã®
ã«ãŒã«ïŒ37CFR1ã14æ¡ãç¹ã«886OG638ã«é¢é£
ããŠå«ãïŒã«åŸã€ãŠæš©éãæã€ãŠæ±ºå®ãã人éã«
察ããŠãè¡ããæ¬åºé¡ã®è·å人ã¯ããå¯èšãã现
èç³»ã奜é©ãªæ¡ä»¶äžã§å¹é€ããã«ããããããã
æ»æ» ãã倱ãããæå·ãããšãã¯éç¥ãåããŠã
ãè¿ éã«åã现èç³»ã®è²æå¹é€åºãšçœ®ãæããã
ãšã«åæããã çºãããšãæ¬çºæã¯ãŸãïŒã€åã¯ãã以äžã®ç¹
å®ã®æ žé žãããã©ã€ããŒã®äŒžé·ã«ããçç£ããã
çæç©ãåŒãç¶ã次ã®ãã©ã€ããŒã®äŒžé·åå¿ã®é³
åãšããŠã®åœ¹å²ãæãããããªé£éåå¿ãçšããŠ
å¢å¹ ãããããšã«ããæ žé žäžã®é åãæ€åºããã
ãã«ããæ¹æ³ãæäŸãããæ¬æ³ã¯åœåã«ã»ãã®å
ãã®éããå«ãŸããŠããªãæ žé žé åãæ€åºããã
ãã«ç¹ã«æçšã§ãããæŽã«å¢å¹ æ³ã¯ååã¯ããŒã
ã³ã°ã«ã䜿çšããããšãã§ããã
ãã®æ¹æ³ã«é¢ããããã詳现ã«ã¯æ¬çºæã¯ãäžã
ãããDNAåã¯RNAé åããåæã«ååšããé
ã«æ¯èŒããŠãã倧éã®ä»»æã®ç¹å®ã®æ žé žé åãç
æããããæ¹æ³ã«é¢ããã該DNAåã¯RNAã¯å
éåã¯äºééã§ãã€ãŠããããæ¯èŒççŽç²ãªçš®ã§
ãã€ãŠãæ žé žã®æ··åç©ã®äžæåã§ãã€ãŠãããã
æ¬çºæã®æ¹æ³ã§ã¯ãææã®æ žé žé åã®å¢å¹ ãéæ
ããããã«åå¿ãç¹°ãè¿ãè¡ãããã«ããã ãåŸæ¥ã®æè¡ã ç¹ã«èšºæäžã®çšéã®ããã«ã¯ãæšçæ žé žé åã¯
åé¡ã®DNAåã¯RNAã®ã»ãã®å ããªéšåã§ãã
ããšããããéåäœäœæšèåã¯æ«ç«¯æšèãªãªãŽã
ã¯ã¬ãªãããããŒãã䜿çšããã®ã§ã¯ãã®ååšã
æ€åºããããšã¯å°é£ã§ããããããŒãæ€åºã·ã¹ã
ã ã®æ床ãåäžãããããã«å€ãã®åŽåãè²»ãã
ããŠããããçŸåšå©çšã§ããæ¹æ³ãçšããŠå®¹æã«
æ€åºã§ããã«å åãªéãåŸãããã«ãæšçé åã
å¢å¹ ãããããªç 究ã¯æ®ã©è¡ãããŠããªãã æ žé žãåãããããããã¯æ¢åã®é åããåæ
ããæ¹æ³ãããã€ãã®æç®ã«èšèŒãããŠãããã
ããã®æ¹æ³ã¯ãå®å šã«ç¹å®ãããé åã®äžããã
ãæ žé žã倧éã«çç£ããããšãå¯èœã«ãããã®ã§
ããã æ žé žãåãããåæããïŒã€ã®æ¢ç¥æ¹æ³ã¯ãã
ã¯ã¬ãªã·ãèªå°äœããã®æ žé žã®ææ©åæãå«ãã
ã®ã§ããããã®åæã¯æº¶æ¶²äžåã¯åºäœæ äœäžã§è¡
ããããææ©åæã®ïŒã€ã®ã¿ã€ãã¯ãªã³é žããªãš
ã¹ãã«æ³ã§ãããããã¯éºäŒåæçåã¯çãéºäŒ
åã調補ããããã«å©çšãããããªã³é žããªãšã¹
ãã«æ³ã§ã¯ããªãªãŽãã¯ã¬ãªããã調補ããã次
ã«ããã¯çµåãããŠããé·éã®æ žé žã圢æããã
ãã®æ¹æ³ã¯ãS.A.ããŒã©ã³ã¯ãã«ãããMeth.
Enzymol.68å·»90é ïŒ1979幎ïŒåã³ç±³åœç¹èš±ç¬¬
435627å·ã«é瀺ãããŠããã該ç¹èš±ã¯ããœããã¹
ã¿ãã³éºäŒåã®åæãšã¯ããŒãã³ã°ãé瀺ããŠã
ãã ææ©åæã®ç¬¬ïŒã®ã¿ã€ãã¯ãªã³é žãžãšã¹ãã«æ³
ã§ãããããã¯ãã©ã³ã¹ãã¢ãŒRNAéºäŒåã®èª¿
補ã«å©çšãããŠããããã®æ¹æ³ã¯E.L.ãã©ãŠã³ã
ã«ããMeth.Enzymol.68å·»109é ïŒ1979幎ïŒã«é
瀺ãããŠããããªã³é žããªãšã¹ãã«æ³ãšåããã
ã«ããªã³é žãžãšã¹ãã«æ³ããªãªãŽãã¯ã¬ãªããã®
åæãå«ã¿ãããããå®è³ªçã«çµåãããŠææã®
æ žé žã圢æãããã äžèšããåãããã®åææ³ã¯æ žé žã®é·éãåæ
ããããã«å©çšãããããæ žé žã倧éåæããã
ãã®å®çšçæ¹æ³ã§ã¯ãªããäž¡æ³ãšãåŽåãšæéã
æ¶è²»ãé«äŸ¡ãªè£ 眮ãšè©Šè¬ãå¿ èŠãšããã€å šäœåç
ãäœããå šäœåçãäœãã®ã¯ããªãªãŽãã¯ã¬ãªã
ãã®åæãšããããçµåããåå¿ãéå¹ççã§ã
ãããšã«èµ·å ãããé·éã®æ žé žãåæããéãã
ãã¯çéã®æ žé žã倧éã«åæããå Žåã§ãããã
å€ãã®ãªãªãŽãã¯ã¬ãªãããåæãå€ãã®çµåå
å¿ãè¡ãããšãèŠæ±ããããåŸã€ãŠãããã®æ¹æ³
ã¯ä»»æã§ææã®æ žé žã倧éã«åæããã«ã¯å®çšç
ã§ã¯ãªãã åãã«ååšããå°éã®æ žé žãã倧éã®æ žé žãç
ç£ããæ¹æ³ãååšããããããã®æ¹æ³ã¯å¥œé©ãªå®¿
䞻系å ã§ã®æ žé žã®ã¯ããŒãã³ã°ãå«ã¿ãããã§ã¯
ææã®æ žé žã¯å®¿äž»ã®åœ¢è³ªå€æã«äœ¿çšããã奜é©ãª
ãã¯ã¿ãŒäžã«æ¿å ¥ãããã宿䞻ãå¹é€ããããšã
ã¯ã¿ãŒãè€è£œãããææã®æ žé žã®ã³ããŒãçç£ã
ãããæ žé žæçã®ãµãã¯ããŒãã³ã°ã«ã€ããŠã¯ã
T.ããã¢ãã¹ãã«ãããã³ãŒã«ãã»ã¹ããªã³
ã°ã»ã©ãã©ããªãŒã®Molecular Cloning390â401
é ïŒ1982幎ïŒã«ç°¡åã«èšè¿°ãããŠããããã®æè¡
ã«ã€ããŠã¯ç±³åœç¹èš±ç¬¬4416988å·åã³4403036å·ã«
ãèšè¿°ãããŠããã ç±³åœç¹èš±ç¬¬4293652å·ã«èšèŒãããŠããæ žé žã®
第ïŒã®åææ³ã¯ãäžè¿°ã®ææ©åæãšååã¯ããŒã
ã³ã°æ³ãåããããã®ã§ããã該æ³ã§ã¯ãææã®
æ žé žé åãäœãäžããã®ã«å¿ èŠãªå¥œé©ãªæ°ã®ãªãª
ãŽãã¯ã¬ãªãããåãã«åæãã次ã«ãããã次
ã®æ¿å ¥ã®åã«å¢æ®ã«ããå¢å¹ ããããã¯ã¿ãŒã«æ¿
å ¥ããã ãçºæã解決ããããšããåé¡ç¹ã æ¬çºæã¯ããã®ååã¯ããŒãã³ã°æ³ã«å¹Ÿããã®
é¡äŒŒæ§ãæããŠããããããæ¬çºæã¯ãããªãç
ç©ã®ç¹æ®ããå«ãŸããåŸã€ãŠç¹æ®ã«äŒŽã€ãŠèµ·ãã
åŸãå±éºãäžéœåãåé¿ããããšãã§ãããæ¬çº
æã¯ææã®æ žé žãšé¢é£ããªãæ žé žã®åæãå¿ èŠãš
ãããåŸã€ãŠæ¬çºæã«ããã°è€éãªçç©åŠçæ··å
ç©ããã³ã¹ãããããŠçæç©ã粟補ããããšãå
é¿ã§ããã æ¬çºæã¯ãã©ã€ããŒãšéåè©Šè¬ãçšããŠïŒçš®ã®
æ žé žåã¯è€æ°ã®æ žé žã®æ··åç©äžã«ååšããïŒåã¯
ïŒä»¥äžã®ç¹å®ã®æ žé žé åãå¢å¹ ããæ¹æ³ã«é¢ã
ãããã©ã€ããŒã¯å¢å¹ ãããã¹ãé åã®æ«ç«¯ãå®
ãããããŠïŒã€ã®ãã©ã€ããŒã®äŒžé·çæç©ã¯ãä»
ã®ãã©ã€ããŒãšãã€ããªãã€ãºãããšãã«ææã®
ç¹å®ã®æ žé žé åã®çæã®ããã®é³åãšãªããåã
ã®éãèµ·ããããããŠãã®ããã»ã¹ã¯æå®éã®é
åãçæãããŸã§å¿ èŠãªã ãç¹°ãè¿ããããæšç
é åãã倧éã®æ žé žãæ¯èŒççæéã§çç£ããã
ãã«ã¯ãæ¬æ¹æ³ã¯äžèšã®åŸæ¥æ³ããå¹ççã§ãã
ãšæåŸ ããããæ¬æ¹æ³ã¯æ žé žæ··åç©ã«å ãããå«
ãŸããŠããªãæ žé žçš®ãå¢å¹ ãã該皮ãå¹ççã«æ€
åºããããã«ç¹ã«æçšã§ããã ãåé¡ç¹ã解決ããããã®æ段ã ããã«è©³ããã¯ããã®çºæã¯ãæ žé žåã¯æ žé žæ··
åç©äžã«ååšããå°ãªããšãïŒçš®ã®ç¹å®ã®æ žé žé
åãå¢å¹ ããæ¹æ³ãæäŸãããã®å Žåãåæ žé žã¯
åãé·ãåã¯ç°ãé·ãã®ïŒã€ã®å¥åã®çžè£çãªé
ããæãããããŠåèšã®æ¹æ³ã¯ã (a) åèšéããïŒä»¥äžã®ãªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã«ããåŠçããŠãå¢å¹ ãããã¹ãæ žé žé
åã«ã€ããŠè©²æ žé žé åã®éã«çžè£çãªãã©ã€ã
ãŒã®äŒžé·çæç©ãåæããããã§ãåèšãã©ã€
ããŒã¯ãç¹å®ã®æ žé žé åã®éãšå®è³ªçã«çžè£ç
ã§ãããäžã€å¢å¹ ãããã¹ãæ žé žé åã®äž¡ç«¯ã
èŠå®ããåãã©ã€ããŒããåæããã䌞é·çæ
ç©ããã®çžè£äœããåé¢ãããå Žåã«æŽãªãå
æã®ããã®é³åãšããŠæ©èœããããšãã§ããã
ãã«éžæããïŒ (b) åèšãã©ã€ããŒäŒžé·çæç©ãããããåæã
ããé³åããåé¢ããŠåéååãçæãããïŒ
ãã㊠(c) 段é(b)ããçããåéååã段é(a)ã®ãã©ã€
ããŒã«ããåŠçããŠã段é(b)ã«ãããŠçæãã
ååéååãé³åãšããŠçšããŠãã©ã€ããŒäŒžé·
çæç©ãåæããïŒ ããšãå«ãã§æãã ãããã®æ®µéã¯é次çã«åã¯åæã«è¡ãããšã
ã§ãããããã«ã段é(b)åã³(c)ã¯é åã®ææã®ã¬
ãã«ã®å¢å¹ ãåŸããããŸã§å埩ããããšãã§ã
ãã ãã®çºæã¯ãå®å šã«ç¹å®ãããé åã®æ¢åã®æ ž
é žãå€éã«è£œé ããããã®ã¿ãªãããååšããã
ãšã¯ç¥ãããŠããããããå®å šã«ã¯ç¹å®ãããŠã
ãªãæ žé žé åã補é ããããã«ãæçšã§ãããã
ããã®å Žåã«ããå¢å¹ ãããã¹ãé åã®æåã®ã³
ããŒã¯å ¥æå¯èœã§ãªããã°ãªããªããäœãããã¯
çŽç²ã§ããå¿ èŠã¯ãªããåã¯å¥åã®ïŒdiscreteïŒ
ååã§ããå¿ èŠã¯ãªãã ãå ·äœçãªèª¬æã ãã©ã€ããŒããããŒããæ€åºãã¹ããªãªãŽããŒ
æçããªãªãŽããŒå¯Ÿç §äœãåã³æšèãããŠããªã
ããããã³ã°ãªãªãŽããŒã«é¢ããŠäœ¿çšãããããª
ãªãŽãã¯ã¬ãªããããšããçšèªã¯ãïŒåã¯ãã以
äžã®å¥œãŸããã¯ïŒããå€ãã®ããªãã·ãªããã¯ã¬
ãªããåã¯ãªããã¯ã¬ãªããããæãååãšããŠ
å®çŸ©ãããããã®æ£ç¢ºãªå€§ããã¯å€ãã®å åã«äŸ
åãããã®å°åã¯ãªãªãŽãã¯ã¬ãªããã®ç©¶æ¥µçãª
æ©èœãšçšéã«äŸåããã ããã§äœ¿çšãããããã©ã€ããŒããšããçšèª
ã¯ã粟補ãããå¶éæ¶åç©ãšããŠèªç¶ã«ååšãã
ããã¯åæçã«èª¿è£œããããªãªãŽãã¯ã¬ãªããã
æå³ãããã®ãã©ã€ããŒã¯ãäŸãã°å¥œé©ãªæž©åºŠå
ã³PHã§ãã¯ã¬ãªãããšDNAããªã¡ã©ãŒãŒã®ãã
ãªéåè©Šè¬ãååšãããããªæ žé žéã«çžè£çãªã
ã©ã€ããŒã®äŒžé·çæç©ã®åæãèªçºãããæ¡ä»¶äž
ã«çœ®ããããšãã«åæéå§ç¹ãšããŠæ©èœããããš
ãã§ããã該ãã©ã€ããŒã¯å¢å¹ å¹çãæ倧ã«ãã
ããåéã§ããããšã奜ãŸãããããã®ä»£ããã«
äºééã§ãã€ãŠããããäºééã§ãããšããã©ã€
ããŒã¯äŒžé·çæç©ã調補ããããã«äœ¿çšãããå
ã«ãŸããã®éãåé¢ããããã«åŠçãããããã©
ã€ããŒã¯ãªãªãŽããªãã·ãªããã¯ã¬ãªããã§ãã
ããšã奜ãŸããããã©ã€ããŒã¯ãéåè©Šè¬ã®ååš
äžã§äŒžé·çæç©ã®åæãéå§ããããã«ååãªé·
ãã§ãªããã°ãªããªãããã©ã€ããŒã®æ£ç¢ºãªé·ã
ã¯ã枩床ããã©ã€ããŒæºãå«ãå€ãã®å åã«äŸå
ãããäŸãã°ãç®çãšããé åã®è€éãã«äŸåã
ãŠãªãªãŽãã¯ã¬ãªãããã©ã€ããŒã¯å žåçã«ã¯15
ããïŒåã¯ããããå€ãã®ãã¯ã¬ãªãããå«ã
ããããå°ãªããã¯ã¬ãªãããå«ããã®ã§ãã€ãŠ
ããããçããã©ã€ããŒååã¯ãé³åãšãšãã«å
åå®å®ãªãã€ããªãè€åäœã圢æããããã«ãã
ãäœã枩床ãèŠæ±ããã ãã©ã€ããŒã¯å¢å¹ ãããã¹ãåç¹å®ã®é åã®ç°
ãªãéãšãå®è³ªçãã«çžè£çã§ããããã«éžæã
ããããã®ããšã¯ãã©ã€ããŒã¯ããããã®éãšã
ã€ããªãã€ãºããã«ååã«çžè£çã§ãªããã°ãªã
ãªãããšãæå³ãããåŸã€ãŠãã©ã€ããŒã®é åã¯
é³åã®é åãæ£ç¢ºã«åæ ããå¿ èŠã¯ãªããäŸãã°
çžè£çã§ãªããã¯ã¬ãªããæçãããã©ã€ããŒã®
é åã®æ®éšãéã«çžè£çã§ããããã«ãã©ã€ããŒ
ã®ïŒâ²æ«ç«¯ã«çµåãããŠãããã代ããã«ããã©
ã€ããŒã®é åãå¢å¹ ãããã¹ãéã®é åãšååãª
çžè£æ§ãæããŠããŠããããšãã€ããªãã€ãºãã
ããã«ãã€ãŠä»æ¹ã®ãã©ã€ããŒã®äŒžé·çæç©åæ
é³åã圢æãããªãã°ãçžè£çã§ãªãå¡©åºåã¯ã
ãé·ãé åããã©ã€ããŒå ã«æ£åšããŠããŠãã
ãã æ¬çºæã§äœ¿çšãããå¶éãšã³ããã¯ã¬ã¢ãŒãŒã
åã³ãå¶éé µçŽ ããšããçšèªã¯ãäºééDNAã
ç¹å®ã®æ žé žé ååã¯ãã®è¿åã§åæãããããªçŽ°
èæ§é µçŽ ãæå³ããã æ¬çºæã§äœ¿çšããããDNAã®å€åœ¢çŸè±¡ããšã
ãçšèªã¯ãDNAäžã®ã®ç¹å®éšäœã«ïŒåã¯ããã
ãå€ãã®ç°ãªã€ããã¯ã¬ãªããé åãååšã§ãã
ç¶æ ãæå³ããã ãå¶éæçé·ãã®å€åœ¢çŸè±¡ïŒRALPïŒããšãã
çšèªã¯ãç¹å®ã®å¶éãšã³ããã¯ã¬ã¢ãŒãŒã«ããæ¶
åã«ãã圢æãããå¶éæçã®é·ãã«åäœéã®çž
éãããããšãæå³ããã æ¬çºæã¯ãæ žé žäžã«ååšãããšæãããïŒåã¯
ãã以äžã®ææã®ç¹å®ã®æ žé žé åãå¢å¹ ããæ¹æ³
ã«é¢ãããæ¬æ³ã«ããã°å€§éã®ç¹å®ã®é åã調補
ã§ããã®ã§ãæ¬çºæã¯DNAåã¯ã¡ãã»ã³ãžã€ãŒ
RNAã®ã¯ããŒãã³ã°å¹çãæ¹è¯ãããã€æšçé
åãå¢å¹ ããŠãã®æ€åºã容æã«ããããã«äœ¿çšã
ãããšãã§ããããã®çºæã¯ãŸããäžå®å šãªååŠ
åæããçããæ žé žã®æ··åç©ããææã®é åãå€
éã«åŸãããã«ãæçšã§ããã äžè¬ã«ãæ¬çºæã®æ¹æ³ã¯ãçšããããåå¿ã¹ã
ããã®æ°ã«é¢é£ããŠææ°çãªåéã§å°ãªããšãïŒ
ã€ã®ç¹å®ã®æ žé žé åãçç£ããé£éåå¿ãå«ã¿ã
該é åã¯(a)å¿ èŠãšãããæ«ç«¯ãããããšãã€ããª
ãã€ãºãããªãªãŽãã¯ã¬ãªãããåæã§ããã«å
åãªçšåºŠã«è©³çŽ°ã«ç¥ãããŠããã(b)é£éåå¿ãé
å§ããããã«å°éã®é åãå ¥æå¯èœã§ããããšã
æ¡ä»¶ãšãªããé£éåå¿ã§åŸãããçæç©ã¯ã䜿çš
ããç¹å®ã®ãã©ã€ããŒã®æ«ç«¯ã«å¯Ÿå¿ããæ«ç«¯ãæ
ãããããªåå¥çãªæ žé žã®ããŠãã¬ãã¯ã¹ã§ã
ãã 粟補ãããç¶æ ã§ã粟補ãããŠããªãç¶æ ã§ã
ããä»»æã®æ žé žæºããææã®ç¹å®ã®æ žé žé åãå«
ããšæãããã®ã§ããã°ãåºçºæ žé žãšããŠäœ¿çšã§
ãããåŸã€ãŠæ¬æ³ã§ã¯ãäŸãã°åéã§ãã€ãŠãäº
ééã§ãã€ãŠãããDNAåã¯RNAäŸãã°ã¡ãã»
ã³ãžã€ãŒRNAã䜿çšããããšãã§ãããæŽã«ã
ãããïŒã€ã®éãå«ãDNAâRNAã®ãã€ããªã
ã䜿çšããŠãããããããã®æ žé žã®æ··åç©ã䜿çš
ããŠããããåå è¡ããå¢å¹ åå¿ã«ãããŠåãã
åã¯ç°ãªã€ããã©ã€ããŒãçšããŠçç£ãããæ žé ž
ã䜿çšããŠããããå¢å¹ ãã¹ãç¹å®ã®æ žé žé åã¯
倧ããªååã®äžéšã§ãã€ãŠããããç¹å®ã®é åã
æ žé žå šäœãæ§æããããã«ã¯ããããåå¥çãªå
åãšããŠååšããŠããŠããããå¢å¹ ãã¹ãé åã¯
åãããçŽç²ãªç¶æ ã§ååšããå¿ èŠã¯ãªãã該é
åã¯ãè€éãªæ··åç©ã®å°éšåãäŸãã°å šãã
DNAäžã®Î²âã°ããã³éºäŒåãåã¯ç¹å®ã®çç©
çè©Šæã®æ¥µãå ãã®éšåã®ã¿ãæ§æããç¹å®ã®åŸ®
çç©ã«èµ·å ããæ žé žé åã®éšåã§ãã€ãŠãããã
åºçºç©è³ªãšããŠã®æ žé žã¯ãåããåã¯ç°ãªã€ãïŒ
以äžã®ææã®ç¹å®ã®æ žé žé åãå«ãã§ããŠãã
ããåŸã€ãŠæ¬çºæã®æ¹æ³ã¯ãïŒã€ã®ç¹å®ã®æ žé žé
åã倧éã«çç£ããã ãã§ãªããåããåã¯ç°ãª
ã€ãæ žé žååäžã«äœçœ®ããïŒä»¥äžã®ç°ãªã€ãç¹å®
ã®æ žé žé åã®åæå¢å¹ ã«ãæçšã§ããã æ žé žã¯ãäŸãã°pBR322ã®ãããªãã©ã¹ããã
ã¯ããŒã³åãããDNAåã¯RNAãåã¯çŽ°èãé µ
æ¯ãããŒã«ã¹åã³æ€ç©ãåç©ãªã©ã®é«çŽçç©çã®
èªç¶ã«ããDNAåã¯RNAçã®ä»»ææºããåŸãã
ãšãã§ãããDNAåã¯RNAã¯ãäŸãã°ããã¢ã
ã¹ãã«ããMolecular Cloningã®280ãã281é
ïŒ1982幎ïŒã«èšèŒãããŠãããããªçš®ã ã®æè¡ã«
ãããè¡ã絚æ¯åã¯çŸè现èçã®ã®çµèç©è³ªãã
æœåºããããšãã§ããã æ¬çºææ¹æ³ã«ãããä»»æã®ç¹å®ã®æ žé žé åãç
ç£ããããšãã§ãããé åã®äž¡æ«ç«¯ã®ååãªæ°ã®
å¡©åºãåå詳现ã«åãã€ãŠãããããã«ããææ
ã®é åã®ç°ãã¹ã©ã€ãã«å¯Ÿãããã€è©²é åã«æ²¿ã€
ã次ã®ãããªçžå¯Ÿäœçœ®ã«ãã€ããªãã€ãºããïŒã€
ã®ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒã調補ããããš
ãã§ããã°ãããããªãã¡ãïŒã€ã®ãã©ã€ããŒã
ãåæ䌞é·ããçæç©ããé³åïŒçžè£äœïŒããå
é¢ããããšãã«ãéå®ãããé·ãã®æ žé žã«ä»ã®ã
ã©ã€ããŒã䌞é·ãããããã®é³åãšããŠã®åœ¹å²ã
æãã°ãããé åã®äž¡æ«ç«¯ã®å¡©åºã«é¢ããç¥èã
å¢å ããã»ã©ç®çãšããæ žé žé åã®ããã®ãã©ã€
ããŒã®ç¹ç°æ§ã倧ãããªããåŸã€ãŠæ¬æ³ã®æå¹æ§
ã倧ãããªãã以åŸäœ¿çšãããã©ã€ããŒãšããçš
èªã¯ãç¹ã«å¢å¹ ãã¹ãæçã®æ«ç«¯é åã«é¢ããæ
å ±ã«ããããã®æå³ããããå Žåã«ã¯ãïŒãã倧
ããæ°ã®ãã©ã€ããŒãæå³ãããã®ãšç解ããã
ã¹ãã§ãããäŸãã°ãæ žé žé åãèçœè³ªé åã®æ
å ±ããæšæž¬ã§ããå ŽåãéºäŒåã³ãŒãã®çž®éã«èµ·
å ããå šãŠã®å¯èœãªã³ãã³å€åã瀺ãé åãå«ã
ãã©ã€ããŒãéããŠåéçšãšããŠäœ¿çšããããã®
ãããªéåã®ãã¡ã®ïŒã€ã®ãã©ã€ããŒã¯ãå¢å¹ ã
ã¹ãææé åã®æ«ç«¯ãšäžèŽããã ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒã¯ä»»æã®å¥œé©ãª
æ¹æ³ãäŸãã°äžèšãããªã³é žããªãšã¹ãã«æ³åã³
ãªã³é žãžãšã¹ãã«æ³åã¯ãããã®ãªãŒãã¡ãŒã·ãš
ã³åãããæ¹æ³ã䜿çšããŠèª¿è£œããããšãã§ã
ãããã®ãããªãªãŒãã¡ãŒã·ãšã³åãããæ¹æ³ã®
ãã¡ïŒã€ã«ããã°ãããŠãŒã±ãŒãžãã«ãã
Tetrahedron Letters22å·»1859â1862é ã«èšèŒã
ããŠããéãããžãšãã«ããªã¹ããªãã¢ããã€ã
ãåºçºç©è³ªãšããŠäœ¿çšããŠåæããããšãã§ã
ãã修食ãããåºäœæ äœäžã§ã®ãªãªãŽãã¯ã¬ãªã
ãåæã®ïŒã€ã®æ¹æ³ãç±³åœç¹èš±ç¬¬4458066å·ã«èš
èŒãããŠãããçç©æºïŒäŸãã°å¶éãšã³ããã¯ã¬
ã¢ãŒãŒæ¶åç©ïŒããåé¢ãããã©ã€ããŒã䜿çšã
ãããšãå¯èœã§ããã ç¹å®ã®æ žé žé åã¯ã該é åãé³åãšããŠå«ãæ ž
é žã䜿çšããŠçç£ããããæ žé žãïŒã€ã®éãå«ã
ã§ãããšãã¯ãå¥ã®ã¹ããããšããŠã§ããã©ã€ã
ãŒã®äŒžé·çæç©ã®åæãšåæã§ãããããè©²æ žé ž
ã¯é³åãšããŠäœ¿çšãããåã«éãåé¢ããå¿ èŠã
ããããã®éåé¢ã¯ãç©ççãååŠçåã³é µçŽ ç
æ¹æ³ãå«ãä»»æã®å¥œé©ãªå€æ§æ³ã«ããè¡ãããšã
ã§ãããæ žé žã®éãåé¢ããïŒã€ã®ç©ççæ¹æ³
ã¯ãå®å šã«ïŒ99ïŒ ä»¥äžïŒå€æ§ããããŸã§æ žé žãå
ç±ããããšãå«ããå žåçãªå ç±å€æ§ã¯80ãã
150âã§ïŒãã10åéå ç±ããããšãå«ããéã®
åé¢ã¯ãããªã«ãŒãŒãåã¯ããªã«ãŒãŒæŽ»æ§ãæã
ãªãATPã®ååšäžã§DNAãå€æ§ããããã®ãšã
ãŠç¥ãããé µçŽ RecAãšããŠç¥ãããé µçŽ é¡ãã
ã®ïŒé µçŽ ã«ããèªçºãããããšãã§ãããããªã«
ãŒãŒã§æ žé žã®éãåé¢ããã®ã«å¥œé©ãªåå¿æ¡ä»¶ã¯
ã¯ãŒã³ ãããã³ ããŒãªã³ã°ã«ãã
CSHQuantitative Biologyã®43ãã63é ïŒ1978
幎ïŒã«èšèŒãããRecAã䜿çšããæè¡ã¯ãC.ã©
ãã€ã³ã°ã«ããAnn.Rev.Geneticsã®16å·»405ãã
437é ã«èšèŒãããŠããã å¢å¹ ãã¹ãé åãå«ãåœåã®æ žé žãåéã§ãã
ãšããã®çžè£äœãããã«ïŒã€åã¯ã€ã®ãªãªãŽãã¯
ã¬ãªãããã©ã€ããŒãå ããŠåæããã奜é©ãªå
äžãã©ã€ããŒãå ãããããšããã©ã€ããŒãéå
è©Šè¬åã³åŸè¿°ããïŒã€ã®ãã¯ã¬ãªããã®ååšäžã§
ãã©ã€ããŒäŒžé·çæç©ãåæããããçæç©ã¯éš
åçã«åéæ žé žãšçžè£çã§ãæ žé žéãšãã€ããªã
ã€ãºããŠé·ãã®ç°ãªãããŠãã¬ãã¯ã¹ã圢æãã
ããã¯äžèšããéãåéã«åé¢ãããçžè£çãªïŒ
ã€ã®åé¢ãããéãšãªãã代ããã«ïŒã€ã®å¥œé©ãª
ãã©ã€ããŒãåéã«å ããŠåå¿ãè¡ãããšãã§ã
ãã åœåã®æ žé žãå¢å¹ ãã¹ãé åãæ§æãããªã
ã°ããã©ã€ããŒã®äŒžé·çæç©ã¯åœåã®æ žé žã®éãš
å®å šã«çžè£çãšãªãããã€ããªãã€ãºããŠåãé·
ãã®éããæãããŠãã¬ãã¯ã¹ã圢æããããã¯
åé¢ãããŠåéã®ååãšãªãã æ žé žã®çžè£çãªéãåé¢ãããšãåœåã®æ žé žã
äºééã§ãã€ãŠãåéã§ãã€ãŠãããã®éã¯ä»ã®
æ žé žéã®åæçšé³åãšããŠå®¹æã«äœ¿çšããããšã
ã§ããããã®åæã¯ä»»æã®å¥œé©ãªæ¹æ³ãçšããŠè¡
ãããšãã§ãããéåžžããã¯å¥œãŸããã¯PHãïŒã
ãïŒãæã奜ãŸããã¯ïŒã§ããç·©è¡æ°Žæº¶æ¶²äžã§èµ·
ããã奜ãŸããã¯éå°ã®ã¢ã«æ¯ïŒã¯ããŒã³åãã
ãæ žé žã«ã€ããŠã¯ãéåžžãã©ã€ããŒå¯Ÿé³åã
1000ïŒïŒããããŠã²ãã ã®æ žé žã«ã€ããŠã¯éåžžã
ã©ã€ããŒå¯Ÿé³åã106ïŒïŒïŒã®ïŒã€ã®ãªãªãŽãã¯
ã¬ãªãããã©ã€ããŒãåé¢ãããé³åéãå«ãç·©
è¡æ°Žæº¶æ¶²äžã«å ããããããæ¬æ³ã蚺æççšéã«
䜿çšããå Žåã«ã¯çžè£çãªéã®éã¯æ¢ç¥ã§ã¯ãªã
ããšãç解ãã¹ãã§ãããåŸã€ãŠçžè£çãªéã®é
ã«é¢é£ãããã©ã€ããŒã®éã確信ããã€ãŠæ±ºå®ã
ãããšã¯ã§ããªãããããå®éã«ã¯ãå¢å¹ ãã¹ã
é åãè€éãªé·éã®æ žé žéã®æ··åç©äžã«å«ãŸãã
å Žåã«ã¯ãå ãããããã©ã€ããŒã®éã¯çžè£çãª
éïŒé³åïŒã®éãããéåžžã¢ã«éå°ãšãããæ¬æ³
ã®å¹çãæ¹è¯ããããã«ã¯ã倧ããªéå°ã¢ã«æ¯ãš
ããããšã奜ãŸããã ããªãã·ãªããã¯ã¬ãªã·ãäžãªã³é žã§ããããª
ãã·ATPãããªãã·CTPãããªãã·GTPåã³
TTPã®ååãªéãåææ··åç©ã«å ããçæãã
溶液ãçŽ90â10âã§çŽïŒãã10åã奜ãŸããã¯ïŒ
ããïŒåéå ç±ããããã®å ç±æéã®åŸã溶液ã®
枩床ããã©ã€ããŒã®ãã€ããªãã€ãŒãŒã·ãšã³ã«å¥œ
é©ãªå®€æž©ãŸã§äžããããã®å·åŽããæ··åç©ã«ãã©
ã€ããŒäŒžé·åå¿ãèªå°ãåã¯è§Šåªããããã®é©åœ
ãªè¬å€ïŒèªå°è©Šè¬åã¯éåè©Šè¬ãšç§°ããïŒãå
ããåŸæ¥ç¥ãããŠããæ¡ä»¶äžã§åå¿ãè¡ãããã
ãã®ã®åæåå¿ã¯ã宀枩ãããããè¶ãããšéå
è©Šè¬ãå¹ççã«æ©èœããªã枩床ãŸã§ã®éã§è¡ãã
ãããšãã§ãããåŸã€ãŠäŸãã°DNAããªã¡ã©ãŒ
ãŒãéåè©Šè¬ãšããŠäœ¿çšãããšãã¯ã枩床ãéåžž
40â以äžã«äžæãããªããæã奜ãŸããã¯åå¿ã¯
宀枩ã«ãããŠèµ·ããã éåè©Šè¬ïŒèªå°è©Šè¬ïŒã¯ããã©ã€ããŒã®äŒžé·ç
æç©ã®åæãéæã§ãããã®ãªãã°ãé µçŽ ãå«ã
ã©ã®ãããªååç©ã§ãç³»ã§ãããããã®ç®çã®ã
ãã®å¥œé©ãªé µçŽ ã¯ãäŸãã°E.ã³ãŒãªãŒDNAããª
ã¡ã©ãŒãŒïŒ©ãE.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®
ã¯ã¬ããŒæçãT4DNAããªã¡ã©ãŒãŒãä»ã®å ¥æ
ã§ããDNAããªã¡ã©ãŒãŒãé転åé µçŽ åã³èç±
æ§é µçŽ ãå«ãä»ã®é µçŽ ãå«ã¿ããããã¯å¥œé©ãªæ
æ§ã§ã®ãã¯ã¬ãªããã®çµåãä¿é²ããåæ žé žéãš
çžè£çã§ãããã©ã€ããŒã®äŒžé·çæç©ã圢æã
ããäžè¬ã«åæã¯åãã©ã€ããŒã®ïŒâ²æ«ç«¯ããå§
ãŸããåæãçµäºãããŸã§é³åéã«æ²¿ã€ãŠ5â²æ«ç«¯
æ¹æ³ã«åãã€ãŠé²è¡ããç°ãªã€ãé·ãã®ååãç
æããããããäžè¿°ã®æ¹æ³ãšåãæ¹æ³ãçšããŠ
5â²æ«ç«¯ã§åæãå§ããä»ã®æ¹æ³ã«åãã€ãŠåå¿ã
é²è¡ãããè©Šè¬ãããã æ°ãã«åæãããéãšãããšçžè£æ§ãæããæ ž
é žéã¯ãæ¬æ³ã®ãã®åŸã®ã¹ãããã«ãããŠäœ¿çšã
ããäºééååã圢æããã次ã®ã¹ãããã§ã¯ã
äºééååã®éã¯äžè¿°ã®ä»»æã®æé ãçšããŠåé¢
ãããåéååãæäŸããã æ°ããªæ žé žã該åéååäžã§åæããããè¿œå
ã®èªå°è©Šè¬ããã¯ã¬ãªããåã³ãã©ã€ããŒããäž
èšã«èŠå®ããæ¡ä»¶äžã§åå¿ãé²è¡ãããããã«å¿
èŠãªãã°å ããŠãããããªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã®äžæ«ç«¯ããå床åæãå§ãŸãããããŠé³
åã®åéã«æ²¿ã€ãŠé²è¡ããŠä»ã®æ žé žãçæããã
ãã®ã¹ãããã®åŸã«ããã䌞é·çæç©ã®ååã¯ïŒ
ã€ã®ãã©ã€ããŒãçµåããç¹å®ã®æ žé žé åããæ
ã€ãŠããã éåé¢ãšäŒžé·çæç©åæã®ã¹ãããã¯ãç¹å®ã®
æ žé žé åãæå®éçç£ãããŸã§å¿ èŠãªã ãã®åæ°
ç¹°ãè¿ãããšãã§ãããåŸã«ãã詳现ã«èšèŒãã
ããã«ãç¹å®ã®æ žé žé åã¯ææ°çã«èç©ãããæ
åã®æ žé žåã¯æ žé žã®æ··åç©ããïŒä»¥äžã®ç¹å®ã®æ ž
é žé åãçç£ããããšãæãŸããå Žåã¯ã奜é©ãª
æ°ã®ç°ãªã€ããªãªãŽãã¯ã¬ãªãããã©ã€ããŒã䜿
çšãããäŸãã°ïŒã€ã®ç°ãªã€ãç¹å®ã®æ žé žé åã
çæããå Žåã«ã¯ãïŒã€ã®ãã©ã€ããŒã䜿çšã
ãããã©ã€ããŒã®ãã¡ã®ïŒã€ã¯ç¹å®ã®æ žé žé åã®
ãã¡ã®ïŒã€ã«é¢ãããã®ã§ãä»ã®ïŒã€ã®ãã©ã€ã
ãŒã¯ç¬¬ïŒã®ç¹å®ã®æ žé žé åã«é¢ãããã®ã§ããã
ããã«ãããïŒã€ã®ç°ãªã€ãç¹å®ã®é åãæ¬æ³ã
çšããŠææ°çã«çç£ããåŸããæ¬çºæã¯ãåã¹ã
ããåŸã«æ°ããè©Šè¬ãå ãã段éçæ¹æ³ãåã¯å š
ãŠã®è©Šè¬ãåæã®ã¹ãããã§å ããåæçæ¹æ³ã
åã¯ããäžããããæ°ã®ã¹ãããã®åŸã«æ°ããè©Š
è¬ãå ããäžéšæ®µéçã§äžéšåæçã§ããæ¹æ³ã®
ãããã«ãã€ãŠãè¡ãããšãã§ãããç±åŠçã®ã
ãã«éåè©Šè¬ãäžæŽ»æ§åããéåé¢æ¹æ³ãæ¡çšã
ãå Žåã«ã¯ãç±ã«å¯ŸããŠäžå®å®ã§ããé µçŽ ã®å Žå
ãããã§ããããã«ãåéåé¢ã¹ãããåŸã«éå
è©Šè¬ãè£å ããããšãå¿ èŠã§ãããããªã«ãŒãŒã®
ãããªé µçŽ çæ段ãå«ãå€æ°ã®ç²Ÿè£œãããæåã
éåé¢ã¹ãããã§äœ¿çšããå Žåã¯ãåæçæ¹æ³ã
䜿çšããããšãã§ãããåæçæ¹æ³ã§ã¯ãåå¿æ··
åç©ã¯ãææã®é åãå«ãæ žé žéã®ä»ã«ãéåé¢
é µçŽ ïŒäŸãã°ããªã«ãŒãŒïŒãrATPã®ãããªéå
é¢é µçŽ ãžã®é©åãªãšãã«ã®ãŒäŸçµŠæºãïŒã€ã®ãã¯
ã¬ãªãããã¢ã«éå°ã®ãªãªãŽãã¯ã¬ãªãããã©ã€
ããŒåã³E.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®ã¯ã¬
ããŒæçã®ãããªèªå°è©Šè¬ãå«ãããšãã§ããã
åæçæ¹æ³ã§å€æ§ã®ããã«ç±ã䜿çšãããšãã¯ã
èªå°è©Šè¬ã«äŸåããã奜ãŸãã65â90âã®é«æž©ã§
æ©èœããç±å®å®æ§ããªã¡ã©ãŒãŒçã®ç±å®å®æ§èªå°
è©Šè¬ã䜿çšãããã®æž©åºŠã§æ žé žã¯å¹³è¡ç¶æ ã«ãã
åéãšäºééããæã€ãŠãããé·ãã®çãæ žé žã«
ã¯ãçŽ50âçšåºŠã®äœæž©ãæ¡çšããããã©ã®çšåºŠã®
é«æž©ã䜿çšã§ãããã¯ããã®æž©åºŠã§é µçŽ ã倱掻ã
ãããããã¯ãã©ã€ããŒã®ãã€ããªãã€ãŒãŒã·ãš
ã³ãäžååãªçšåºŠããèµ·ãããªããã©ããã«äŸå
ããããã®ãããªç±å®å®æ§é µçŽ ã¯ãäŸãã°A.S.ã«
ã¬ãã€ã³ãã«ããBiokhimiya45å·»644â651é
ïŒ1980幎ïŒã«èšèŒãããŠãããæ¬æ³ã®åã¹ããã
ã¯ãå šãŠã®è©Šè¬ãå§ãããååšããã«ããããã
ããç¶ããŠèµ·ãããå¿ èŠãªãã°è¿œå ã®è©Šè¬ãå ã
ãŠããããé©åãªé·ãã®æéãçµéããŠææéã®
ç¹å®ã®æ žé žé åãçæããåŸãä»»æã®å ¬ç¥æ¹æ³ã§
é µçŽ ã倱掻ããããåå¿æåãåé¢ãããããŠå
å¿ãåæ¢ãããã æ¬çºææ¹æ³ã¯é£ç¶çã«è¡ã€ãŠãããããªãŒãã¡
ãŒã·ãšã³åãããæ¹æ³ã®äžæ æ§ãšããŠãåå¿ãã
å€æ§åºåãè©Šè¬æ·»å åºååã³åå¿åºåãéã€ãŠãµ
ã€ã¯ã«ããããããªæ¹æ³ããããä»ã®æ æ§ã§ã¯ã
ãã©ã€ããŒã®äŒžé·çæç©ã®åæã«äœ¿çšããé µçŽ ã
ã«ã©ã äžã§åºå®åããããšãã§ãããä»ã®åå¿æ
åã¯é£ç¶ããã«ã©ã ãšå ç±çšã³ã€ã«ãéãããã«
ãã³ãã䜿ã€ãŠé£ç¶çã«åŸªç°ãããããã«ããã
çæããæ žé žãé µçŽ ã倱掻ãããããšãªãç¹°ãè¿
ãå€æ§ãããã æ¬çºæã®ã®æŠç¥ãäžèšã«ç€ºãããããã§ã¯çžè£
çãªéãS+ããšãS-ãããæãææé åãã
ãå«ãäºééDNAãæ žé žãšããŠäœ¿çšãããŠããã
第ïŒã®åã³åŒãç¶ããŠèµ·ããåå¿ãµã€ã¯ã«ã§ã¯ã
åœåã®é³åäžã®åãªãªãŽãã¯ã¬ãªãããã©ã€ããŒ
ã®äŒžé·ã¯ããã©ã€ããŒã®ïŒã€ãšãšãã«ã®ã¿çµäºã
ãå¶éã®ãªãé·ãã®ãïŒã€ã®æ°ããssDNAåå
çæç©ãçæããã以åŸãé·éçæç©ããšåŒã¶ã
ããã®çæç©ã¯çŽç·çã«èç©ããã€ãŸãä»»ææ°ã®
ãµã€ã¯ã«ã®åŸã«ååšããéã¯ãµã€ã¯ã«æ°ã«æ¯äŸã
ãã ãã®ããã«çç£ãããé·éçæç©ã¯ãåŒãç¶ã
ãŠèµ·ãããµã€ã¯ã«ã®éäžæ¹åã¯ä»æ¹ã®ãªãªãŽãã¯
ã¬ãªãããã©ã€ããŒã®é³åãšããŠæ©èœããææé
åãS+ãåã¯ãS-ãã®ååãçæãããããã
ã®ååãäžæ¹åã¯ä»æ¹ã®ãªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã®é³åãšããŠæ©èœããæŽã«ä»ã®ãS+ãå
ã³ãS-ããçæããåŸã€ãŠãµã€ã¯ã«æ°ã«é¢é£ã
ãŠææ°çã«ããã®èç©ãçããããé£éåå¿ã
ç¶æãããã ãªãªãŽãã¯ã¬ãªããã®ãã€ããªãã€ãŒãŒã·ãšã³
ã«ãã圢æãããæå³ãããªãå¯çæç©ã¯ããã
èªèº«è§ŠåªæŽ»æ§ããªãïŒçšãªäŸãé€ãïŒãåŸã€ãŠçŽ
ç·çã«èç©ããã ãè¡šã æ°ããåæãããé·ãçæç©
ãè¡šã äžæ¹ã®ãã©ã€ããŒã®ãªãªãŽãã¯ã¬ãªããé åãš
å ±ã«çµãéåã³ä»æ¹ã®çžè£çé åã®åéã¯ãçç£
ããããšãæãŸããŠããç¹å®ã®æ žé žé åããã§
ããããšãåããã æ¬æ³ã®ã¹ãããã¯ããã©ã€ããŒïŒåã³ïŒãéå
è©Šè¬åã³ååšãããã¯ã¬ãªããã®éã«ãã€ãŠã®ã¿
éå®ããã以å€ãç¡éã«ç¹°ãè¿ãããšãã§ããã
æåã®æ žé žã¯è€è£œãããªãã®ã§ããã®éã¯å šå·¥çš
äžäžå®ã§ãããé·éçæç©ã¯æåã®æ žé žããã®ã¿
çç£ãããã®ã§ããã®éã¯çŽç·çã«å¢å ãããç¹
å®ã®é åã®éã¯ææ°çã«å¢å ãããåŸã€ãŠç¹å®ã®
é åã¯ãã®éãå¢å ããŠåªå¢ãªæåãšãªãããã®
ããšã¯æ¬¡è¡šã«ç€ºããã該衚ã¯ãµã€ã¯ã«ã®å¹çã
100ïŒ ã§ãããšããå Žåã®ïœãµã€ã¯ã«åŸã®çè«ç
ã«ååšããæåéãæ¯èŒãããã®ã§ããã ãè¡šã ãè¡šã åéã®æ žé žãé³åãšããŠäœ¿çšãããšããµã€ã¯ã«
ãããïŒã€ã®é·éçæç©ãçæããã æ¬æ³ã¯å¥œé©ãªçºçŸãã¯ã¿ãŒã«ç¹å®ã®æ žé žé åã
æ¿å ¥ããããã«ã¯ããŒã³åããã®ã«äœ¿çšã§ããã
該ãã¯ã¿ãŒã¯é©åãªå®¿äž»çç©ã圢質転æããŠæšæº
çãªçµã¿æãäœDNAæè¡ã«ããéºäŒåçæç©ã
çç£ããéã«äœ¿çšã§ããã æŽã«æ¬æ³ã¯ã€ã³ãããã®çªç¶å€ç°çšãšããŠäœ¿çš
ããããšãã§ããããªãªãŽããªãã·ãªããã¯ã¬ãª
ããã¯å¢å¹ ãããã¹ãDNAé åãšæ£ç¢ºã«çžè£ç
ã§ããå¿ èŠã¯ãªãããããã¯ãããªã¡ã©ãŒãŒé µçŽ
ãä»ã«äœ¿çšãããããããã®èªå°è©Šè¬ã«ãã€ãŠäŒž
é·ãããããã«ååãªçšåºŠã«ãéãšãã€ããªãã€
ãºããããšãã§ããã°ããã䜿çšãããã©ã€ããŒ
ãæåã®é³åãšæ£ç¢ºã«çžè£çã§ãªãå Žåã®ããªã¡
ã©ãŒãŒé£éåå¿ã®çæç©ã¯é³åããããããã©ã€
ããŒé åãæããããã«ããã€ã³ãããã®çªç¶å€
ç°ãå¯èœã«ãããåŒãç¶ããµã€ã¯ã«ã§ã¯ããã䌌
äžã®ãã¹ãã¢âãã©ã€ãã³ã°ãå¿ èŠãšãããªãã®
ã§ããã®çªç¶å€ç°ãæžãããšã®ãªãå¹çäžã§å¢å¹
ãããããã®ããã«çç£ãããçªç¶å€ç°äœã¯æšæº
çãªååçç©åŠçæè¡ã«ããé©åãªãã¯ã¿ãŒäžãž
æ¿å ¥ãããå€åããèçœè³ªãçç£ããèœåçã®å€
åããç¹è³ªããã®ãã¯ã¿ãŒã«äžããã äžè¿°ããå€åããDNAé åã圢æããæ¹æ³ã¯ã
ãã以äžã®é åå€åãèªçºãããããã«ç°ãªã€ã
ãã©ã€ããŒã䜿çšããŠè©²å€åããDNAã«å¯ŸããŠ
ç¹°ãè¿ãããšãã§ããããã®æ¹æ³ã§ã¯ãäžé£ã®çª
ç¶å€ç°é åãåŸã ã«çæãããããã§ããã®äžé£
ã®ãã®ã«æ°ããå ãããããã®ã§ã¯ãæåŸã®ãã®
ãšå ãã«ç°ãªãããšãã§ããããæåã®DNAæº
é åãšã¯éåžžã«å€§ããç°ãªãããšãã§ããããã®
æ¹æ³ã§ã¯ãéåžžã«å€§ããªãã¹ãããã®å Žåã«ãã©
ã€ããŒãæ©èœããªãããã«åäžã¹ãããã§ã¯è¡ã
ããšã®ã§ããªãå€åããæçµçã«ã¯äœãåºãããš
ãã§ããã æŽã«ãååãªéã®ãã©ã€ããŒãå¢å¹ ãããéã«
çžè£çã§ããé åãå«ãã®ã§ããã°ããã©ã€ããŒ
ã¯ãã®é åã®äžéšãšããŠçžè£çã§ãªãé åãå«ã
ããšãã§ãããäŸãã°é³åé åã«çžè£çã§ãªãæ ž
é žé åïŒäŸãã°ããã¢ãŒã¿ãŒããªã³ã«ãŒãã³ãŒã
é åçïŒããïŒã€åã¯äž¡æ¹ã®ãã©ã€ããŒã®5â²æ«ç«¯
ã«çµåãããããšãã§ããããã«ããå¢å¹ å·¥çšã®
çæç©ã«ãããä»å ããããšãã§ããã䌞é·ãã©
ã€ããŒãæ·»å ããåŸãçžè£çã§ãªãæ žé žæ¿å ¥éšã
å«ãæ°ããé³åã®ææéãåŸãããã«ååãªæ°ã®
ãµã€ã¯ã«ãå®æœãããããã«ããç°¡åãªæè¡ãçš
ããŠæ¯èŒççæéïŒäŸãã°ïŒæéåã¯ãã以äžïŒ
å ã«çµåããããæçã倧éã«çç£ããããšãå¯
èœã«ãªãã æ¬æ³ã¯ãäŒææ§çŸæ£ãéºäŒåæ§çŸæ£åã¯çŽ°èæ§
ã®çŸæ£ãäŸãã°çããšé¢é£ããç¹å®ã®æ žé žé åã
äŸãã°çºçéºäŒåãã®æ€åºåã³ïŒåã¯ç¹åŸŽä»ãã
å¯èœã«ããããã«äœ¿çšããããå¢å¹ ã¯ãäŸãã°è
å 现èããåŸãããDNAãçšããéç¶èµ€è¡ç貧
è¡ã®èå 蚺æçãåæã«å©çšã§ããæ žé žã®éãé
åžžã«å°ããå Žåã«æçšã§ãããå¢å¹ ã¯ãæ¬æ¥çã«
æ床ã®è¯ããªãéæŸå°æ§æ€åºæè¡ãçšããŠå°éã®
è©Šæãåæããå Žåãåã¯æŸå°æ§æè¡ãçšããã
è¿ éãªæ€åºãæãŸããå Žåã«ç¹ã«æçšã§ããã æ¬çºæã®ç®çã®ããã«ã¯ãéºäŒåæ§çŸæ£ã¯ãäŸ
ãã°éç¶èµ€è¡ç貧è¡ãå¢èæ§ç¹ç¶çãαâãµã©ã»
ãã¢ãβâãµã©ã»ãã¢çã®ãä»»æã®çç©äœããã®
ã²ãã DNAäžã®ç¹å®ã®æ¬ æåã³ïŒåã¯å€ç°ãå«
ããéç¶èµ€è¡ç貧è¡ã¯ãæ¬æ³ã«ãã奜é©ãªDNA
é åã®å¢å¹ ã®åŸã®ãªãªãŽããŒå¶éåæåã¯RFLP
ç¶åæãçµãŠå®¹æã«æ€åºããããšãã§ãããαâ
ãµã©ã»ãã¢ã¯é åãååšããªãããšã«ããæ€åºã
ãããšãã§ããβâãµã©ã»ãã¢ã¯çŸæ£ãèµ·ããã
ãå€ç°ã«è¿æ¥ããŠãªã³ã¯ããå€åœ¢æ§
ïŒpolymorplicïŒå¶ééšäœã®ååšã«ããæ€åºãã
ããšãã§ããã ãããå šãŠã®éºäŒåæ§çŸæ£ã¯é©åãªé åãå¢å¹
ãããããæŸå°æ§ãããŒãã䜿çšããã«ãµã¶ã³ã
ãããæ³ã«ããåæããŠæ€åºããããšãã§ããã
ãã®ãããªæ¹æ³ã§ã¯ãäŸãã°éåžžã«å°éã®ææé
åãå«ãçŸæ°Žããã®DNAã®å°éã®è©Šæãå¢å¹ ãã
å¶éé µçŽ ã§åæãããããŠãµã¶ã³ããããæ³ã§å
æãããå¢å¹ ã·ã°ãã«ããã€ã¬ãã«ãšããããšã«
ãããéæŸå°æ§æšäœã䜿çšããããšã容æã«ãª
ãã ä»ã®æ æ§ã§ã¯ãå°éã®DNAã䟿å©ãªã¬ãã«ãŸ
ã§å¢å¹ ãã次ã«æŽã«äŒžé·åå¿ãè¡ããããã®å Žå
容æã«æ€åºã§ãããã¯ã¬ãªããèªå°äœïŒäŸãã°
32Påã¯ããªãã³ã§ã©ãã«ãããã¯ã¬ãªããäžãª
ã³é žïŒãçŽæ¥æçµã®DNAçæç©ã«å°å ¥ãããã
ãå¶éåæåã³é»æ°æ³³ååæãããã¯ä»»æã®ä»ã®
奜é©ãªæ¹æ³ãçšããŠåæããããã®æè¡ã®ã¢ãã«
ç³»ã®äŸã第ïŒå³ã«ç€ºããŠããã 第ïŒå³ã®ã¢ãã ç³»ã«ç€ºããæŽã«ä»ã®æ æ§ã§ã¯ã
æ žé žã¯å¢å¹ ã®åã«ç¹å®ã®å¶éãšã³ããã¯ã¬ã¢ãŒãŒ
ã«æŽé²ãããåæãããé åã¯å¢å¹ ã§ããªãã®
ã§ãäºãå¶éé µçŽ ã§åŠçããDNAè©Šæã®ååšã«
ããããããå¢å¹ ãããæçãçŸããããšã¯ãå¢
å¹ ãããé åäžã«ãšã³ããã¯ã¬ã¢ãŒãŒã®éšäœããª
ãããšãæ瀺ãããå¢å¹ ãããé åãååšããã
åŠãã¯é©åœãªæ¹æ³ã§æ€åºããããšãã§ããã ãã®æè¡ã®å®éçãªé©çšæ¹æ³ã¯ãæ¬æ现æžãšãµ
ã€ããã«ããBiotechnology3å·»1008â1012é ã«
èšèŒãããŠãããªãªãŽããŒå¶éæè¡ãçšããŠéç¶
èµ€è¡ç貧è¡ã®æ€åºã容æã«ãã䜿çšã«ããäŸç€ºã
ãããšãã§ãããéç¶èµ€è¡ç貧è¡ã¯Î²âã°ããã³
éºäŒåã®ç¬¬ïŒã³ãã³ã®ïŒã€ã®å¡©åºå¯Ÿã®å€åã«ãã
çãããã¢ã°ããã³ã®çŸæ£ã§ããã第ïŒå³ã¯å€åœ¢
çŸè±¡ïŒpolymorphisnïŒé åäžã®æ£åžžåã³éç¶èµ€
è¡ç貧è¡ã®Î²âã°ããã³éºäŒåã®é åã瀺ããã®
ã§ãäžæ¬ç·ã¯æ£åžžéºäŒåã«ã®ã¿ååšããDdeéš
äœã®äœçœ®ã瀺ããäºæ¬ç·ã¯æ£åžžåã³éç¶èµ€è¡ç貧
è¡å¯Ÿç«éºäŒåãã®äž¡æ¹ã«ååšããéå€åœ¢æ§ã®
Hinféšäœã®äœçœ®ã瀺ãã第ïŒå³ã¯äž¡å¶ééšäœ
éšäœéã«ãããæå°ã§ç€ºãããéšåãã©ãã«ãã
ãŠãããããŒããçšããŠæ£åžžã®Î²âã°ããã³
DNAããªãªãŽããŒå¶ééè£ããæ¹æ³ã瀺ããã®
ã§ãããåã«èšèŒããããã«ããŠå¢å¹ ããã
DNAãå€æ§ãããã©ãã«ããããããŒããšã¢ã
ãŒã«ããããé µçŽ Ddeã¯DNAãåæ§æããã
Ddeéšäœã§éè£ãããã©ãã«ããããªã¯ã¿ããŒ
ãçããããããã¹ãã«äœ¿çšããæ¡ä»¶äžã§ã¯ããª
ã¯ã¿ããŒã¯ããŠãã¬ãã¯ã¹ããé¢ããã®ã«ååãª
çãã§ãããåŒãç¶ãé µçŽ Hinfã®æ·»å ã¯ä»ã
åéã§ãããªã¯ã¿ããŒã«äœã®åœ±é¿ãäžããªãã第
ïŒå³ã¯Î²âã°ããã³DNAã®éç¶èµ€è¡ç察ç«éºäŒ
åã«é©çšããåèšãšåãæ¹æ³ã瀺ããé µçŽ Dde
ã¯ãâã®å¡©åºå¯Ÿããã¹ããããããã®ã§ãã
ãããå¢å¹ ãããDNAãšã©ãã«ããããããŒã
ãšã§åœ¢æãããããŠãã¬ãã¯ã¹ãéè£ãããããš
ã¯ã§ããªãããããé µçŽ Hinfã¯ãã€ããªãã
å¶ééè£ããããã©ãã«ãããããªããŒãçæã
ãããå®éã«ã¯ãã®æ¹æ³ã¯ãç¹å®ã®ã·ã°ãã«ãã
ãããã®å¯Ÿç«éºäŒåã®ååšãšé¢é£ããã®ã§ãåäœ
ã®DNAãéæ§åã®ãã¢æ¥åäœããéç¶èµ€è¡ç貧
è¡åã®ãã¢æ¥åäœãåã¯éç¶èµ€è¡ç貧è¡åœ¢è³ªãæ
ãããããæ¥åäœã§ããããæ€èšºããããšãã§ã
ããäžè¿°ã®æ¹æ³ã䜿çšããŠé©åãªé åãå¢å¹ ãã
ãããšã«ããïŒã€ã®32Pã©ãã«ã®ã¿ãæãããã
ãŒããçšããŠåã³ããŒéºäŒåãè¿ éã«åæããã
ãšãã§ããã çš®ã ã®äŒææ§çŸæ£ã¯ãåå ãšãªã埮çç©ã«ç¹ç°
çã§ããç¹å®ã®DNAé åã®èšåºè©Šæäžã§ååšã«
ãã蚺æããããšãã§ããããããã¯ãµã«ã¢ã
ã©ãã¯ã©ããžã¢ããã€ã»ãªã¢çã®çŽ°èãèçããŒ
ã«ã¹çã®ããŒã«ã¹ããã©ãªã¢ã®åå ãšãªããã©ã¹
ã¢ãžãŠã ïŒPlasmodiumïŒçã®å¯çäœãå«ããã
ã¢ã«ã³ãŒã«äžããããç±³åœç¹èš±ç¬¬4358535å·ã¯ã
äŒææ§çŸæ£ã®èšºæçšã®ç¹å¥ãªDNAãã€ããªãã€
ãŒãŒã·ãšã³ãããŒãã®äœ¿çšã«ã€ãèšè¿°ããŠããã
ãã¢ã«ã³ãŒæ³ã«åºæã®åé¡ã¯ãææããæ£è ãã
ã®èšåºè©Šæäžã«ã¯æ¯èŒçå°ãªãæ°ã®ç åçç©ãã
ååšããããããããæœåºãããDNAã¯è©Šæäž
ã®å šDNAã®éåžžã«å°ããªéšåãæ§æããã®ã¿ã§
ãããšããããšã§ãããDNAè©Šæãåºå®åãã
ã€ããªãã€ãŒãŒã·ãšã³æ€åºããåã«åé¡ãšãªã€ãŠ
ããé åãç¹ç°çã«å¢å¹ ããããšã¯ããããã®æ¹
æ³ã®æ床ãšç¹ç°æ§ã倧ããæ¹è¯ããã äŒææ§çŸæ£ã®èšºæçšã«DNAãããŒããèšåºç
ã«ã«ãŒãã³åããŠäœ¿çšããããšã¯ãã¯ãŒãã®ãšãŒ
ãããç¹èš±ç¬¬63879å·ã«èšèŒãããŠããããã«é
æŸå°çã«ã©ãã«ããããããŒãã䜿çšããã®ãªã
ã°ã倧ãã«ç°¡ç¥åãããããã®æ¹æ³ã§ã¯ãããªã
ã³ãå«ãDNAãããŒããã¢ããžã³åã¯ããªãã³
ã«ç¹ç°çãªæäœã«çµåããè²çŽ äœ
ïŒchromogenicïŒé µçŽ ã«ããæ€åºãããããã®å
ã®æ€åºã¯äŸ¿å©ã§ããããæ¯èŒçäœæ床ã§ãããæ¬
æ³ã«ããç¹ç°çãªDNAå¢å¹ ãšå®å®ã«ã©ãã«ãã
ããããŒããçµã¿åãããããšã«ããããã¢ã«ã³
ãŒåã³ã¯ãŒãã®æ¹æ³ãã«ãŒãã³åããèšåºã«ãã
ãæçšãªæ¹æ³ã«ããã®ã«èŠæ±ããã䟿å©ããšæ床
ãæäŸããããšãã§ããã ãã®å¢å¹ å·¥çšã¯åäžã³ããŒã®ããéºäŒåããå
åãªéã®DNAã調補ããã®ã«å©çšããããšãã§
ããããã«ããèåãšããžãŠã ã®ãããªç°¡åãªé
ç¹ç°çãªDNAæè²ã«ãããããæ€åºã§ããçŽæ¥
DNA蚺æãè¡ãããšãã§ããã äŒææ§çŸæ£åã³çç©äœã®ã²ãã äžã®ç åçç°åžž
æ§ãæ€åºããã»ããæ¬æ³ã¯ä»»æã®ç åç¶æ ãšé¢é£
ããªãDNAå€åœ¢çŸè±¡ïŒããªã¢ã«ãã€ãºã ïŒãæ€
åºããããã«äœ¿çšããããšãã§ããã 次ã®å®æœäŸã¯äŸç€ºã®ããã«æ瀺ãããã®ã§ãã©
ã®ããã«ãæ¬çºæãéå®ããããšãæå³ãããã®
ã§ã¯ãªãããããã®å®æœäŸã§å šãŠã®ããŒã»ã³ãã¯
åºäœã®å Žåã¯ééã§ã液äœã®å Žåã¯å®¹éã§ããã
ä»ã«æå®ããªãéã枩床ã¯ææ°æž©åºŠã§ããã å®æœäŸ ïŒ æ¬¡ã®ãã¯ã¬ãªããé åãæãã25å¡©åºå¯Ÿé å 5â²CCTCGGCACCGTCACCCTGGATGCT3â² 3â²GGAGCCGTGGCAGTGGGACCTACGA5â² ïŒATCCããåŸãããpBR322ã®47å¡©åºå¯ŸFok
å¶éæçã«å«ãŸããïŒã次ã®ããã«èª¿è£œããã
47å¡©åºå¯Ÿæçãå«ãpBR322ã®FOkæ¶åç©ãã
äŸçµŠè ã§ããããŠãŒã€ã°ã©ã³ã瀟ã®æ瀺ã«ããæ¡
件ã«åŸã€ãŠpBR322Fokã§æ¶åããããšã«ãã
調補ããã䜿çšãããã©ã€ããŒã¯ã5â²d
ïŒCCTCGGCACCGïŒ3â²ãš5â²d
ïŒAGCATCCAGGGTGïŒ3â²ã§ãããéåžžã®æè¡
ã«ãã調補ããã25mMã®ãªã³é žã«ãªãŠã ãš
10mMã®å¡©åãã°ãã·ãŠã ãåã³100mMã®å¡©å
ãããªãŠã ããæãç·©è¡æ¶²ïŒPH7.5ïŒ33ÎŒã«2433
ãã³ã¢ã«ã®äžè¿°ã®åãã©ã€ããŒã2.4ãã³ã¢ã«ã®
pBR322ã®Fokæ¶åç©ã22ããã¢ã«ã®ããªãã·
ATPã22ããã¢ã«ã®ããªãã·CTPã19ããã¢ã«
ã®ããªãã·GTPåã³10ããã¢ã«ã®TTPãå ã
ãã æ··åç©ã85âã§åéå ç±ãã宀枩ãŸã§å·åŽã
ããE.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®ã¯ã¬ããŒ
æçã®ïŒåäœãå ãã枩床ã15åéç¶æãããã
ã®åŸå床85âã§ïŒåéå ç±ããå·åŽãããã¯ã¬ã
ãŒæçã®ïŒåäœãå床å ãã15åéåå¿ãè¡ã€
ããå ç±ãå·åŽåã³åå¿ã®åã¹ããããæŽã«11å
ç¹°ãè¿ããã æåŸã®ç¹°ãè¿ãã®åŸã5ÎŒãåå¿æ··åç©ãã
åãåºãããããã85âã§ïŒåéå ç±ãã宀枩ã«
å·åŽããã12.5ãã³ã¢ã«ã®Î±âP32ããªãã·ã·ã
ãžã³äžãªã³é žãšïŒåäœã®ã¯ã¬ããŒæçãå ãåå¿
ã15åéé²è¡ããããã©ãã«ãããçæç©ãããª
ã¢ã¯ãªã«ã¢ããã²ã«ã®é»æ°æ³³åã§ç¢ºèªããã13ãµ
ã€ã¯ã«åŸã«èŠãã匷ãã©ãã«ããããã³ãã®ã¿
ããæå³ãã25å¡©åºå¯Ÿé åã§ãã€ãã å®æœäŸ ïŒ å¢å¹ ãããã¹ãææã®é åã¯ãããã®Î²âã°ã
ãã³éºäŒåã«å«ãŸããã€éç¶èµ€è¡ç貧è¡ã«é¢ãã
MstIIéšäœã«äŒžã³ã94å¡©åºå¯Ÿã®é åã§ãã€ãã該
é åã¯ç¬¬ïŒå³ã«ç€ºããã¯ã¬ãªããé åãæããŠã
ãã ãã©ã€ããŒã®åæ 次ã®ïŒã€ã®ãªãªãŽããªãã·ãªããã¯ã¬ãªããã
ã©ã€ããŒãäžèšããæ¹æ³ãçšããŠèª¿è£œããã 5â²CACAGGGCAGTAACG3â²ãã©ã€ããŒïŒ¡ãå
ã³ 5â²TTTGCTTCTGACACA3â²ãã©ã€ããŒïŒ¢ ãªãŒãã¡ãŒã·ãšã³åãããåææ³ ããŠãŒã±ãŒãžãšã«ã«ãµãŒã¹æ³ïŒTetrahedron
Letters22å·»1859â1862é ïŒ1981幎ïŒã«åŸã€ãŠå
æãããžãšãã«ããªã¹ããªãã¢ããã€ããããã€
ãªãµãŒãSAMâïŒã䜿çšããŠå¶åŸ¡ããå€åã¬ã©
ã¹æ äœããèªå°ãããã¯ã¬ãªã·ããžæ¬¡ã ãšæ¿çž®ã
ãããã®æ¹æ³ã¯ããžã¯ãã«ã¡ã¿ã³äžã§ã®ããªã¯ã
ã«é ¢é žã«ããè±ããªãã«åãšæŽ»æ§ã®ããæ°ŽçŽ äŸäž
äœãšããŠãã³ãŸããªã¢ãŸãŒã«ã䜿çšããçž®ååã³
ããã©ãã€ãããã©ã³åã³ããªãžã³äžã§ã®ç¡æ°Žé ¢
é žãšãžã¡ãã«ã¢ããããªãžã³ã«ãããã€ããã³ã°
ãå«ãã§ãããïŒãµã€ã¯ã«ã®æéã¯çŽ30åã§ãã€
ããåã¹ãããã®åçã¯å®è³ªçã«åœéçã§ããã
è±ããªãã«åã®éã«è§£é¢ãããžã¡ããã·ããªãã«
ã¢ã«ã³ãŒã«ãéãåå åšã«ããæ€æ»ã§æ±ºå®ããã ãªãªãŽããªãã·ãªããã¯ã¬ãªã·ããè±ä¿è·å
ãã粟補ããæ¹æ³ åºäœæ äœãã«ã©ã ããåãåºãã1mlã®æ¿æ°Žé ž
åã¢ã³ã¢ããŠã ã«éé管äžå®€æž©ã§ïŒæéæããã
æ äœãæ¿Ÿéã§åãé€ããäžéšãä¿è·ããããªãªãŽ
ããªãã·ãªããã¯ã¬ãªãããå«ã溶液ã®æž©åºŠã55
âã«äžæãããïŒæéç¶æãããã¢ã³ã¢ãã¢ãå
ãé€ããæ®æž£ã調補çšããªã¢ã¯ãªã«ã¢ããã²ã«ã«
é©çšããã30ãã«ãïŒcmã§90åéé»æ°æ³³åãè¡
ããçæç©ãå«ããã³ããè¢å ãã¬ãŒãäžã®UV
ã·ã€ããŠã€ã³ã°ã§åå®ããã該ãã³ããåãå
ãã1mlã®èžçæ°Žã§äžæ©ãããŠïŒâã§æº¶åºããã
ãã®æº¶æ¶²ãã¢ã«ããã¯RP18ã«ã©ã ã«ãããPH6.0
ã®ïŒïŒ é ¢é žã¢ã³ã¢ããŠã ç·©è¡æ¶²äžïŒâ13ïŒ ã®ã¢ã»
ããããªã«ã§æº¶åºããããã®æº¶åºæ¶²ã¯260nmã®çŽ«
å€åžåã§ã¢ãã¿ãŒããé©åãªãã©ã¯ã·ãšã³ãé
ããåºå®ããéã§ã®çŽ«å€åžåã§å®éåæãããã€
宀枩äžã§æžå§é å¿æ©äžã§èžçºãã也ç¥ããã ãªãªãŽããªãã·ãªããã¯ã¬ãªããã®ç¹åŸŽä»ã 粟補ãããªãªãŽãã¯ã¬ãªããã®ãã¹ã溶液ãã
ãªãã¯ã¬ãªãããããŒãŒåã³Î³32PâATPã§32Pã©
ãã«ããããã®ã©ãã«ããååç©ã50ãã«ãïŒcm
ã§45åéé»æ°æ³³åã«ãããåŸã14â20ïŒ ã®ããªã¢
ã¯ãªã«ã¢ããã²ã«ã®ãªãŒãã©ãžãªã°ã©ãã€ãŒã§ç¢º
èªããããã®æ¹æ³ã§ã¯ååéã確èªããããšãã§
ãããããæ¯ãžãšã¹ãã©ãŒãŒãšçŽ°èæ§ã¢ã«ã«ãªã
ãªã¹ãã¢ã¿ãŒãŒã䜿çšããŠãªãªãŽããªãã·ãªãã
ã¯ã¬ãªããããã¯ã¬ãªã·ãã«æ¶åãããããŠæ¬¡ã¯
éçžHPLCã«ã©ã ã䞊ã³ã«10ïŒ ã¢ã¯ãªããããªã«
åã³ïŒïŒ é ¢é žã¢ã³ã¢ããŠã 移åçžã䜿çšããŠãèª
å°ããããã¯ã¬ãªã·ããåé¢ãå®éããããšã«ã
ãå¡©åºçµæã決å®ããã DNAæº ïŒ¡ å šããéæ§åDNAã®æœåº æ£åžžã®Î²âã°ããã³ã®ããã²ãã DNAãã¢æ¥
åäœããã¹ãããã©ãŒãã«ããProc.Nat.Acad.
Sci.ã®72å·»5966â5970é ã«èšèŒãããæè¡ãçšã
ãŠã»ã«ã©ã€ã³Molt4ïŒããŠãŒãã³ã»ãžãšããã€ã
ã¯ã»ããŠãŒã¿ã³ãã»ã»ã«ã»ã¬ããžããªãŒããå ¥æ
ããGM2219cãšåå®ããïŒããæœåºããã  ã¯ããŒã³åããã°ããã³éºäŒåã®é æ æ£åžžã®Î²âã°ããã³éºäŒåã®1.9kbã®BamHIæ
çãã³ã¹ããpECllããåé¢ããpBR322ã®Bam
HIéšäœã«æ¿å ¥ããïŒãœããã³ãã®GeneïŒå·»287
â305é ïŒ1980幎ïŒïŒãåæ40å¡©åºå¯ŸãããŒããšã
ã€ããªãã€ãºããé åãå«ããã®æçã¯ã第ïŒå
ã³ç¬¬ïŒã®ãšã¯ãœã³ã第ïŒã®ã€ã³ããã³ã䞊ã³ã«éº
äŒåã®5â²ã®ãã©ã³ãã³ã°ïŒflankingïŒé åãå«ã
ïŒããŒã³ãã®Cell15å·»1157â1174é ïŒããã®ã¯ããŒ
ã³ã¯pBR328ïŒHbAãšåä»ããããATCC第
39698å·ãšããŠ1984幎ïŒæ25æ¥ã«å¯èšãããã βâã°ããã³ã®éç¶èµ€è¡ç貧è¡å¯Ÿç«éºäŒåã®å¯Ÿ
å¿ãã1.9kbã®BamHIæçã¯ã³ã¹ããpF12ãã
åé¢ãããäžè¿°ã®éãã¯ããŒã³åãããããã®ã¯
ããŒã³ã¯pBR328ïŒHbSãšåä»ããããATCC第
39699å·ãšããŠ1984幎ïŒæ25æ¥ã«å¯èšãããã åçµã¿æããã©ã¹ãããE.ã³ãŒãªãŒMM294
ïŒATCC第39607å·ïŒãžåœ¢è³ªå€æãããããŠå¢æ®ã
ãããã  ã¯ããŒã³åãããã°ããã³éºäŒåã®MstIIã«
ããæ¶å ããããã®å šéã100ÎŒgã§ããpBR328ïŒHbA
ãšpBR328ïŒHbSãåç¬ã§20åäœã®MstIIïŒããŠãŒ
ã€ã³ã°ã©ã³ããã€ãªã©ã瀟ïŒãšãšãã«16æé37
âã150mMã®NaClã12mMã®Tris HClïŒPH7.5ïŒã
12mMã®MgCl2ã1mMã®ãžããªã¹ã¬ã€ããŒã¹
ïŒDTTïŒåã³100ÎŒgïŒmlã®ãŠã·è¡æž ã¢ã«ããã³
ïŒBSAïŒäžã§æ¶åãããçæç©ã¯ãããã
pBR328ïŒHbAïŒMstIIåã³pBR328ïŒHbSïŒMst
IIãšåä»ããã ããªã¡ã©ãŒãŒã®é£éåå¿ 60mMé ¢é žãããªãŠã ã30mMããªã¹âã¢ã»ã
ãŒãåã³10mMé ¢é žãã°ãã·ãŠã ãå«ãPH8.0ã®
ç·©è¡æ¶²100ÎŒãž100ãã³ã¢ã«ã®ãã©ã€ããŒïŒ¡ïŒïœ
ïŒCACAGGGCACTAACGïŒã®é åïŒã100ãã³ã¢
ã«ã®ãã©ã€ããŒïŒ¢ïŒïœ
ïŒTTTGCTTCTGACACAïŒã®é åïŒåã³1000
ãã³ã¢ã«ã®ããªãã·ATPãããªãã·CTPãããª
ãã·GTPåã³TTPãå«ã2ÎŒã®æº¶æ¶²ãå ããã
äžè¿°ãããäžèšã®DNAæºãå ããã 10ÎŒgã®å šããéæ§åDNAïŒåå¿ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbAïŒåå¿ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbSïŒåå¿ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbAïŒMstLLïŒåå¿
ïŒ 0.1ãã³ã¢ã«ã®pBR328ïŒHbBïŒMstIIïŒåå¿ïŒ éæšçDNAïŒåå¿ïŒ åŸãããå溶液ã100âã§ïŒåéå ç±ãïŒåé
ã§å®€æž©ãŸã§å·åŽãããã®åŸE.ã³ãŒãªãŒDNAããª
ã¡ã©ãŒãŒã®ã¯ã¬ããŒæçã®ïŒåäœãå«ã1ÎŒã
å ãããååå¿ã¯10åéè¡ãããã®åŸãã©ã€ã
ãŒããã¯ã¬ãªããåã³DNAãå ããå ç±ããå·
åŽããããªã¡ã©ãŒãŒãå ãããããŠåå¿ããããµ
ã€ã¯ã«ãåå¿ïŒ©ã«ã€ããŠã¯19åãåå¿âã«ã€
ããŠã¯ïŒåç¹°ãè¿ããã 第ïŒãµã€ã¯ã«ã®åãåã³ååå¿ã®æåŸã®ãµã€ã¯
ã«ã®åŸã§åãåºãããåå¿åã³ã®ã¢ãªã³ãŒã
ïŒãã€ã¯ããªããã«ããPH8.3ã®0.089Mããªã¹ç¡Œ
é žå¡©ç·©è¡æ¶²äžã§ã2.5mMEDTAäžã§ã12ïŒ ããª
ã¢ã¯ãªã«ã¢ããã²ã«ã«å ããããã®ã²ã«ã25ãã«
ãïŒcmãïŒæéé»æ°æ³³åãããåºçžæ äœãšããŠæ©
èœãããã€ãã³èãžç§»ãããããŠãPH7.4ã§30ïŒ
ã®ããªã«ã ã¢ããã3xSSPEã5xãã³ãã«ãåã³
ïŒïŒ ã®ããã·ã«ç¡«é žãããªãŠã äžã§ãæšæºçæè¡
ãçšããŠèª¿è£œãã次åŒïŒ 5â²dïŒTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCA
AGïŒ3â² ã®32Pã§ã©ãã«ããã40å¡©åºå¯Ÿã®åææçã§æ€ç¥
ããã第ïŒå³ã¯ãåå¿åã³çšã®æ€ç¥ãããã
ã€ãã³èã®ãªãŒãã©ãžãªã°ã©ãã§ãããã¬ãŒã³ïŒ
ã¯0.1ãã³ã¢ã«ã®58å¡©åºå¯Ÿã®å¯Ÿç §åææçã§ãã
ã®ãã¡ã®ïŒã€ã®éã¯äžèšãããŒããšçžè£çã§ã
ããã¬ãŒã³ïŒã¯ç¬¬ïŒã®å¢å¹ ãµã€ã¯ã«ã®åã®4ÎŒ
ã®åå¿ïŒã®æ¶²ã§ãããã¬ãŒã³ïŒã¯20åã®å¢å¹ ãµã€
ã¯ã«åŸã®4ÎŒã®åå¿ïŒã®æ¶²ã§ãããã¬ãŒã³ïŒã¯
ïŒåã®å¢å¹ ãµã€ã¯ã«åŸã®4ÎŒlã®åå¿ã®æ¶²ã§ããã
ã¬ãŒã³ïŒã¯ÎŒâ32Pâããªãã·NTPåã³ããªã¡ã©
ãŒãŒã§ã©ãã«ãããpBR322ïŒããŠãŒã€ã³ã°ã©ã³
ããã€ãªã©ã瀟ïŒã®FokïŒããŠãŒã€ã³ã°ã©ã³ã
ãã€ãªã©ã瀟ïŒããæãååéæšæºã§ãããã¬ãŒ
ã³ïŒã¯ã20ãµã€ã¯ã«åŸåå¿æ··åç©ïŒ©ã¯é©åãªåå
éãæããç¹å®ã®é åã倧éã«å«ã¿ãä»ã®æ€åºã§
ããçæç©ããªãããšã瀺ããŠãããïŒãµã€ã¯ã«
åŸã®åå¿æ··åç©ãã¬ãŒã³ïŒã«ç€ºãéãåºçºç©è³ª
ã§ããæ žé žãšä»ã®çæç©ã®ä»ã«ãã®çæç©ãå«ã
ã§ããã ïŒãµã€ã¯ã«åŸã®åå¿ããã®æ¶²5.0ÎŒã«äžè¿°
ã®åãã©ã€ããŒïŒãã³ã¢ã«ãå ããã溶液ãïŒå
é100âã«å ç±ã宀枩ãžæ»ãããããããïŒãã³
ã¢ã«ã®Î±â32Pâããªãã·ATPãαâ32Pâããª
ãã·CTPãαâ32Pããªãã·GTPåã³Î±â32Pâ
TTPã䞊ã³ã«ïŒåäœã®ã¯ã¬ãâæçãå ããã
æçµçãªå®¹ç©ã10ÎŒã§ããå¡©æ¿åºŠãäžèšããé
ãã§ããåå¿ã10åéè¡ããããããªã¡ã©ãŒãŒæŽ»
æ§ã¯60âã§20åéå ç±ãããšå€±ããããåå¿â
ã®åå¿æ¶²4ÎŒãã0.089Mããªã¹ç¡Œé žå¡©ç·©è¡æ¶²ã
2.5mMEDTAäžã§12ïŒ ããªã¢ã¯ãªã«ã¢ããã²ã«
ã«å ããããã®ã²ã«ã25ãã«ãïŒcmãïŒæéé»æ°
æ³³åããããã®åŸãªãŒãã©ãžãªã°ã©ãåŠçããã 第ïŒå³ã¯ãé»æ°æ³³åã®ãªãŒãã©ãžãªã°ã©ãã§ã
ããã¬ãŒã³ïŒã¯ååéæšæºãã¬ãŒã³ïŒã¯åå¿ã
ã¬ãŒã³ïŒã¯åå¿ãã¬ãŒã³ïŒã¯åå¿åã³ã¬ãŒã³
ïŒã¯åå¿ã§ãããå¯Ÿç §ãšããŠã®DNAã䌎ãªã
ãªãåå¿ã®ã¬ãŒã³ã¯ã¬ãŒã³ã®ã©ãã«ãã€ã¡ãŒãž
ãæããªããå³ãããæšçDNAããäºæ³ããã
94å¡©åºå¯Ÿæçã¯ãç¡å·ã®Î²âã°ãããªã³DNAé
åãå¢å¹ çšã«äœ¿çšã§ãããšãã®ã¿ååšã§ããããš
ãåããïŒã€ãŸãã¬ãŒã³ïŒã®pBR328ïŒHbAãã¬
ãŒã³ïŒã®pBR328ïŒHbSåã³ã¬ãŒã³ïŒã®
pBR328ïŒHbSïŒMstIIïŒãMstIIã«ããæ¶åã¯
pBR328ïŒHbAã94å¡©åºå¯Ÿé åäžã§åæãããã
ãå¢å¹ ã§ããªãããã«ãã94å¡©åºå¯Ÿã®ãã³ãã¯ã¬
ãŒã³ïŒã«çŸããªããããã«å¯ŸããpBR328ïŒHbS
ã®94å¡©åºå¯Ÿé åã¯ãã©ã¹ãããMstIIã§æ¶åãã
ãŠãåæãããåŸã€ãŠç¬¬ïŒå³ã«ç€ºãããã«å¢å¹ ã«
å©çšã§ããã 第ïŒå³ã¯94å¡©åºå¯Ÿé åãå¢å¹ ããïŒãµã€ã¯ã«ã®
é£éåå¿ã瀺ããã®ã§ãããPCO1ãšPCO2ã¯ã
ã©ã€ããŒïŒ¡åã³ïŒ¢ã§ãããå³ã®æ°ã¯ãµã€ã¯ã«ã瀺
ããå·Šã®æ°ã¯ç¹å®ã®ååãçç£ããããµã€ã¯ã«æ°
ã瀺ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ããããã¢ã°ããã³éºäŒåäžã®å¯Ÿç«
éºäŒåMstIIéšäœãå«ã110å¡©åºå¯Ÿé åã®å¢å¹ ã
瀺ãã®ã§ããã ãã©ã€ããŒã¯å®æœäŸïŒã®æè¡ã§èª¿è£œããããã®
ã§ããã1.0ãã€ã¯ãã°ã©ã ã®å šããDNAã100
ãã³ã¢ã«ã®ïœ
ïŒACACAACTGTGTTCACTAGCïŒåã³100ã
ã³ã¢ã«ã®ïœïŒCAACTTCATCCACGTTCACCïŒ
ã以äžã®ãããª100ÎŒlã®æº¶æ¶²ã«æº¶è§£ãããã 1.5mMåïŒã€ã®ããªãã·ãªããã¯ã¬ãªã·ãäž
ãªã³é ž 30mMPH7.9ã®ããªã¹ã¢ã»ããŒãç·©è¡æ¶² 60mMé ¢é žãããªãŠã 10mMé ¢é žãã°ãã·ãŠã 25mMãžããªã¹ã¬ã€ããŒã« ãã®æº¶æ¶²ã100âã§ïŒåéå ç±ããè¿ éã«25â
ã«äžããŠïŒåéå ç±ãããã®åŸDNAããªã¡ã©ãŒ
ãŒã®ã¯ã¬ããŒæç2.5åäœãå ãããããªã¡ã©ãŒ
ãŒã®åå¿ã25âã§ïŒåéè¡ãããã®åŸå ç±ãå·
åŽãã¯ã¬ããŒæçã®æ·»å åã³åå¿ãæãã ãç¹°ã
è¿ããã åãµã€ã¯ã«ã®å¹çã70âã§ã15ãµã€ã¯ã«è¡ã€
ãŠãβâã°ããã³éºäŒåã®ææã®110å¡©åºå¯Ÿæç
1.4ããšãã¢ã«ãåæããã å®æœäŸ ïŒ æ¬å®æœäŸã¯ããããã¢ã°ããã³éºäŒåã®å¯Ÿç«éº
äŒåäžã®MstIIéšäœãå«ã240å¡©åºå¯Ÿé åã®å¢å¹
ã瀺ããã®ã§ããããã®é åã¯ãMcoãHinf
åã³MstIIå¶ééšäœãå«ãã§ããã PHã8.0ã§ã60mMé ¢é žãããªãŠã ã30mMã
ãªã¹ã¢ã»ããŒãåã³10mMé ¢é žãã°ãã·ãŠã ã®æ··
åç©ïŒ0.1ãã³ã¢ã«ã®pBR328ïŒHbAãå«ãïŒã«ã 100ãã³ã¢ã«ã®ïœ
ïŒGGTTGGCCAATCTACTCCCAGGïŒãã©ã€
ããŒã 100ãã³ã¢ã«ã®ïœ
ïŒTAACCTTGATACCAACCTGCCCïŒãã©ã€
ããŒã å1000ãã³ã¢ã«ã®ããªãã·ATPãããªãã· CTPãããªãã·GTPåã³TTP ãå«ã2ÎŒã®æº¶æ¶²ïŒ¡ãå ããã ïŒã€ã®ãã©ã€ããŒã¯å®æœäŸïŒã«èšèŒããæè¡ã§
調補ããã溶液ã100âã§ïŒåéå ç±ãã空æ°äž
ã§ïŒåéå·åŽãããã®åŸE.ã³ãŒãªãŒDNAããªã¡
ã©ãŒãŒã®ã¯ã¬ããŒæçïŒåäœãå«ã液1ÎŒãå
ãããåå¿ã10åéé²è¡ããããã®åŸæº¶æ¶²ïŒ¡ã®æ·»
å ãå ç±ãå·åŽãããªã¡ã©ãŒãŒã®æ·»å åã³åå¿ã
ããªããµã€ã¯ã«ãïŒåç¹°ãè¿ãããåå¿æ¶²5.0ÎŒ
ã«ãäžèšã®åãªãªãŽãã¯ã¬ãªãããã©ã€ããŒïŒã
ã³ã¢ã«ãå ããã溶液ã10âã§ïŒåéå ç±ãã宀
æž©ãŸã§äžãããã®åŸããããïŒãã³ã¢ã«ã®Î±â
32Pâã©ãã«ãããããªãã·ãªããã¯ã¬ãªã·ãäž
ãªã³é žåã³ïŒåäœã®ã¯ã¬ããŒæçãå ãããæçµ
çãªå®¹éã10ÎŒã§å¡©æ¿åºŠãäžèšã®éãã§ããå
å¿ã10åéé²è¡ããããããªã¡ã©ãŒãŒæŽ»æ§ã¯60â
ã§20åéå ç±ãããšå€±æŽ»ããã2ÎŒã®ã¢ãªã³ãŒ
ããNcoãHinfåã³MstIIã§æ¶åããPH8.3ã®
0.089Mããªã¹ã¢ã»ããŒãç·©è¡æ¶²ã0.25mMEDTA
äžã§12ïŒ ããªã¢ã¯ãªã«ã¢ããã²ã«ã«å ãããã²ã«
ã25ãã«ãïŒcmã§ïŒæéé»æ°æ³³åããããªãŒãã©
ãžãªã°ã©ãåŠçããã第ïŒå³ã¯é»æ°æ³³åã®ãªãŒã
ã©ãžãªã°ã©ãã瀺ããããã§ã¬ãŒã³ïŒã¯ååéæš
æºãã¬ãŒã³ïŒã¯é µçŽ ã®æ¶åã䌎ããªããã®ïŒç¡å·
ã®240å¡©åºå¯ŸïŒãã¬ãŒã³ïŒã¯Ncoã«ããæ¶å
ïŒ131åã³109å¡©åºå¯ŸïŒãã¬ãŒã³ïŒã¯MstIIã«ããæ¶
åïŒ149åã³91å¡©åºå¯ŸïŒããããŠã¬ãŒã³ïŒã¯Hinf
ã«ããæ¶åïŒ144åã³96å¡©åºå¯ŸïŒã§ããããªãŒ
ãã©ãžãªã°ã©ãã¯240å¡©åºå¯Ÿåå¿ã®å¢å¹ ãããã®
ãšäžèŽããã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãé次çæ¶åã«ããéç¶èµ€è¡ç貧è¡
ãæ€åºããããã®æ¬çºæã®æ¹æ³ã®äœ¿çšã瀺ããã®
ã§ããã ãªãªãŽããªãã·ãªããã¯ã¬ãªããã®åæåã³
ãªã³é žå 5â²*
CTGACTCCTGAGGAGAAGTCTGCCGTTA
ïŒâ²ã®é åã®ã©ãã«ããã
DNAãããŒãïŒ*ãã©ãã«ãæå³ããïŒRS06ã
åã³RS06ãšïŒã€ã®å¡©åºå¯Ÿããã¹ãããããŠããã
3â²GACAGAGGTCACCTCTTCAGACGGCAA
ïŒâ²ã®é åã®ã©ãã«ãããŠ
ã
ãªããããã¯ãªãªãŽããŒRS10ããå®æœäŸïŒïŒïŒ
ã®æ¹æ³ã«åŸã€ãŠåæããããããŒãRS06ã¯ãã
ã®ïŒãã³ã¢ã«ãã70mMããªã¹ç·©è¡æ¶²ïŒPH7.6ïŒã
10mM MgCl2ã1.5mMã¹ãã«ãã³åã³2.5mMãž
ããªã¹ã¬ã€ããŒã«ãå«ãåå¿å®¹é40ÎŒäžã®ïŒå
äœã®T4ããªãã¯ã¬ãªãããããŒãŒïŒããŠãŒã€ã³
ã°ã©ããã€ãªã©ãïŒåã³50ãã³ã¢ã«ã®Î³â32Pâ
ATPïŒããŠãŒã€ã³ã°ã©ã³ãããŠãŒã¯ã¬ã¢ãçŽ
7200CiïŒmMïŒãšæ¥è§Šãããããšã«ããã©ãã«ã
ããå šå®¹éã25mMEDTAã§100ÎŒã«èª¿ç¯ãã
ããªã¹âEDTAïŒTEïŒç·©è¡æ¶²ïŒ10mMããªã¹ç·©è¡
液ã0.1mMEDTAãPH8.0ïŒã«ãã平衡åããã
ãã€ãªã©ãã補ã®1mlã®Bio Gel âïŒã¹ãã³é
æã«ã©ã äžã§ããã¢ãã€ã¹ããMolecular
Cloning464â465é ïŒ1982幎ïŒã«èšèŒããŠããæ¹
æ³ã«åŸã€ãŠç²Ÿè£œãããã©ãã«ããããããŒãã¯ã
ããªã¹âç¡Œé žâEDTAïŒTBEïŒç·©è¡æ¶²ïŒ89mMã
ãªã¹ã89mMç¡Œé žã2.5mMEDTAãPH8.3ïŒäž18
ïŒ ã®ããªã¢ã¯ãªã«ã¢ããã²ã«ïŒ19ïŒïŒã®ã¢ã¯ãªã«
ã¢ããïŒBISãšãã€ãªã©ããïŒäžã§500vhrã«ãŠé»
æ°æ³³åããŠããã«ç²Ÿè£œããããªãŒãã©ãžãªã°ã©ã
ã«ããäœçœ®ããã®åŸãã©ãã«ããããããŒããå«
ãéšåãåãåããç²ç ãã0.2mlã®TEç·©è¡æ¶²äž
ãžäžæ©ãããŠïŒâã§æº¶åºããããåå¿çæç©ã®
TCAæ²æŸ±ã¯æ¯æŽ»æ§ã4.9CiïŒããªã¢ã«ã§ãããæ
çµçæ¿åºŠã20ãã³ã¢ã«ïŒmlã§ããããšã瀺ããŠ
ããã ã©ãã«ãããªãRS10ããããã³ã°ãªãªãŽããŒ
ã¯ã200ãã³ã¢ã«ïŒmlã®æ¿åºŠã§äœ¿çšããã 现èç³»ããã®ããã²ãã DNAã®åé¢ å®è³ªçã«ã¹ãããã©ãŒãã®PNAS79å·»5966â
5970é ïŒ1982幎ãMolt4ã«ã€ããŠïŒã«èšèŒã®æ¹æ³
åã³ããã¢ãã€ã¹ãã®Molecular Cloning280â
281é ïŒ1982幎ïŒã«èšèŒã®æ¹æ³ã䜿çšããŠã
Molt4ãSCâïŒåã³GM2064ã®ãªã³ãçç³»ããé«
ååã®ã²ãã DNAãåé¢ããã Molt4ïŒããŠãŒãã³ã»ããŠãŒã¿ã³ãã»ã»ã«ã»ã
ããžããªãŒïŒGM2219CïŒã¯æ£åžžã®Î²âã°ããã³
ã«ã€ããŠãã¢æ¥åäœã®ïŒŽçŽ°èç³»ã§ããããããŠ
ATCC1985幎ïŒæ19æ¥ã«å¯èšãããSCâïŒã¯é
ç¶èµ€è¡ç貧è¡å¯Ÿç«éºäŒåã«ã€ããŠãã¢æ¥åäœã®
EBVã§åœ¢è³ªå€æããã现èç³»ã§ããã
GM2064ïŒããŠãŒãã³ã»ããŠãŒã¿ã³ãã»ã»ã«ã»ã
ããžããªãŒïŒGM2064ïŒã¯èå ãã¢ã°ããã³ã®éº
äŒçãªæ°žç¶æ§ïŒHPFHïŒã«ã€ããŠãã¢æ¥åäœã§
ããåäœåœååé¢ãããβâåã¯ÎŽâã°ããã³éº
äŒåé åãå«ãã§ããªããå šãŠçŽ°èç³»ã¯10ïŒ ã®ç
èå è¡æž ãå«ãRPMIâ1640äžã«ç¶æãããã èšåºè¡æ¶²è©Šæããã®ããã²ãã DNAã®åé¢ æ¢ç¥ã®éç¶çŽ°èãã€ãªã€ãŒïŒASïŒããã®CH12
ãšåä»ããããèšåºè¡æ¶²è©Šæãã«ã«ããªã«ãã¢å·
ãªãŒã¯ã©ã³ãã®å°å ç é¢ã®ãã«ãã©ã ã»ã«ãã³å
士ããåŸãããã³ãã«ã°ãã®Prc.Nat.Acad.Sci.
75å·»5553â5556é ïŒ1978幎ïŒã«èšèŒãããŠããæ¹
æ³ã®å€æ³ã䜿çšããŠãäž»ã«æ«æ¢¢ã®è¡æ¶²ãªã³ãçã
ãæãããã€ãŒã³ãŒãéšåããã²ãã DNAã調
補ããã 现èãã5mlã®ããªã¹âEDTAâNaCl
ïŒTENNïŒç·©è¡æ¶²ïŒPHïŒã®10mMããªã¹ãPHïŒã
1mMMEDTAã10mMNaClïŒäžã«åæžæ¿ãã
0.2mgïŒmlã®ãããã€ããŒãŒã0.5ïŒ ã®SDSã«èª¿ç¯
ãããããŠ37âã§äžæ©ã€ã³ããŠããŒããããéå¡©
çŽ é žãããªãŠã ã0.7Mã«å ãããããŠçŽ°è溶解
ç©ã宀枩ã§ïŒâïŒæéç©ããã«æ¯ãšãããã现è
溶解ç©ãããšããŒã«ãšã¯ããããªã«ã ã®ïŒïŒïŒæ··
åç©30mlã§æœåºããç¶ããŠã¯ããããªã«ã 30ml
ã§æœåºãã次ã«ãšã¿ããŒã«ã§æ žé žãæ²æŸ±ãããã
ãã¬ããã2mlã®TEç·©è¡æ¶²ã«åæžæ¿ããã
RNaseã0.005mgïŒmlã«å ããã37âã§ïŒæéæ¶
åãããåŸãDNAãåéã®ããšããŒã«ãããšã
ãŒã«ïŒã¯ããããªã«ã ãåã³ã¯ããããªã«ã ã§ã
ãããäžåºŠãã€æœåºãããšã¿ããŒã«ã§æ²æŸ±ãã
ããDNAã0.5mlã®TEç·©è¡æ¶²ã«åæžæ¿ããã
260nmã®åžåã«ããæ¿åºŠã決å®ããã βâã°ããã³é åãéžæçã«å¢å¹ ããããã®
ããªã¡ã©ãŒãŒé£éåå¿ ïŒãã€ã¯ãã°ã©ã ã®ã²ãã DNAãã10mMã
ãªã¹ç·©è¡å€ïŒPH7.5ïŒã50mMNaClã
10mMMgCl2ã150ãã³ã¢ã«ã®é å ïœïŒCACAGGGCACTAACGïŒã®ãã©ã€ããŒïŒ¡ã
åã³é å ïœïŒCTTTGCTTCTGCACAïŒã®ãã©ã€ããŒïŒ¢ã
å«ãåå¿å®¹é100ÎŒã®åœå溶液äžã§å¢å¹ ããã
ã€èžçºãé²ãããçŽ100ÎŒåã®é±æ²¹ã§è¢«èŠããã åDNAè©Šæã«ã€ããïŒãµã€ã¯ã«ã次ã®ïŒã¹ã
ããããæãå¢å¹ ã®ããã®15ãµã€ã¯ã«ãè¡ã€ãã (1) ïŒåé95âã§ç±ãããã¯ã»ããäžã§å€æ§ã
ãã (2) ç±ãããã¯ã»ãããçŽã¡ã«30âã«ç§»ãïŒåé
ãã©ã€ããŒãšã²ãã DNAãã¢ããŒãªã³ã°ãã
ããã«ããã (3) E.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©ã®ã¯ã¬ããŒ
æçïŒããŠãŒã€ã³ã°ã©ã³ããã€ãªã©ãïŒïŒåäœ
ãšããªãã·ATPãããªãã·CTPãããªãã·
GTPåã³TTPããããïŒããã¢ã«ãå«ãÎŒ
ã®æº¶æ¶²ïŒ10mMããªã¹ïŒPH7.5ïŒã50mMNaClã
10mMMgCl2ãåã³4mMãžããªã¹ã¬ã€ããŒã«
ããæãç·©è¡æ¶²äžïŒãå ããããã®äŒžé·åå¿ã
30âã«ãŠ10åéè¡ã€ãã æåŸã®ãµã€ã¯ã«ã®åŸã95âã«ïŒåéç¶æããŠ
åå¿ãåæ¢ããããé±æ²¹ã¯0.2mlã®ã¯ããããª
ã«ã ã§æœåºããŠå»æ£ãããæåŸã®åå¿æ¶²ã®å®¹é
ã¯130ÎŒã§ãã€ãã ãããŒãåã³DdeLïŒHinfIã«ããå¢å¹ ãã
ã²ãã DNAã®ãã€ããªãã€ãŒãŒã·ãšã³ïŒæ¶å 25ãã€ã¯ããªããã«ã®å¢å¹ ãããã²ãã DNA
ããšã¿ããŒã«ã§æ²æŸ±ãããåéã®TEç·©è¡æ¶²äžã«
åæžæ¿ããã10ãã€ã¯ããªããã«ïŒ154ngã®ã²ã
ã DNAãšåçã®åå¢å¹ äœãå«ãïŒã1.5mlã®ãã€
ã¯ãããŠãŒãžç®¡ã«å ¥ãããããŠ20ÎŒã®TEç·©è¡
液ã«ããæåŸã®å®¹éã30ÎŒãšãããè©Šæãé±æ²¹
ã§è¢«èŠããŠ95âã§10åéå€æ§ãããã©ãã«ããã
RS06ãããŒã0.02ãã³ã¢ã«ãå«ã0.6MMaCI10
ãã€ã¯ããªããã«ã管ã«å ããç©ããã«æ··åãã
çŽã¡ã«56âã®ç±ãããã¯ã«ç§»ããŠïŒæéãããã
ã©ãã«ããŠããªãRS10ããããã³ã°ãªãªãŽããŒ
ïŒãã€ã¯ããªããã«ïŒ0.8ãã³ã¢ã«ïŒãå ããæŽ
ã«10åéåã枩床ã§ãã€ããªãã€ãŒãŒã·ãšã³ãç¶
ãããïŒãã€ã¯ããªããã«ã®60mMMgCl2ïŒ0.1
ïŒ BSAåã³1ÎŒã®DelïŒ10åäœãããŠãŒã€ã³ã°
ã©ã³ããã€ãªã©ãïŒãå ããåã¢ããŒãªã³ã°ãã
ãDNAã56âã§30åéæ¶åãããïŒãã€ã¯ããª
ããã«ã®HinfïŒ10åäœãããŠãŒã€ã³ã°ã©ã³ãã
ã€ãªã©ãïŒãå ããæŽã«30åã€ã³ããŠããŒãã
ãã4ÎŒã®75mMEDTAãš6ÎŒã®ãã©ããã³ã°
ææãæçµå®¹ç©ã61ÎŒã«ãªãããã«åå¿æ··åç©
ã«å ããŠåå¿ãçµäºããã é±æ²¹ãïŒ2mlã®ã¯ããããªã«ã ã§æœåºãã18ÎŒ
ã®åå¿æ··åç©ïŒ45nmã®ã²ãã DNAïŒãããŒã
ã¢ãŒSE200è£ çœ®äžã®30ïŒ ããªã¢ã¯ãªã«ã¢ããã®ã
ãã²ã«ïŒ19ïŒïŒããã€ãªã©ãïŒã«è² è·ããããã®
ã²ã«ãããã¢ããšããŒã«ãã«ãŒææã®å端ãåœå
ã®äœçœ®ãã3.0cmåããŸã§çŽ300ãã«ãã§ïŒæéé»
æ°æ³³åãããã該ã²ã«ã®å端ã®1.5cmã¯åãé€ã
ããæ®ãã®ã²ã«ã¯ïŒæ¥éâ70âã§åŒ·åã¹ã¯ãªãŒã³
ã¯æãããã åçã®æ€èšïŒç¬¬ïŒå³ïŒ åã¬ãŒã³ã¯45ngã®å¢å¹ ãããã²ãã DNAãå«
ãã§ãããã¬ãŒã³ïŒ¡ã¯Mol4DNAããã¬ãŒã³ïŒ¢ã¯
CH12ããã¬ãŒã³ïŒ£ã¯SCâïŒããåã¬ãŒã³ïŒ€ã¯
GM2064ãå«ãã§ãããMolt4ã¯ã现èåœããïŒ
ã³ããŒã®Î²AéºäŒåãæããæ£åžžã®åäœã®éºäŒåå
CAAã§ãããCH12ã¯ã现èåœããïŒåã®Î²AãšïŒ
åã®Î²SéºäŒåãæããéç¶çŽ°èãã€ãªã¢ããã®èš
åºçšè©ŠæïŒASïŒã§ããããããŠSCâïŒã¯çŽ°èåœ
ããã³ããŒã®Î²Sãæããéç¶è¡çè¡è²§è¡åäœã®éº
äŒååãæå³ãããGM2064ã¯Î²âåã¯ÎŽâã°ã
ãã³é åãå«æããããã¬ãã€ãå¯Ÿç §ãšããŠååš
ããã åçããåããããã«Ddeã§éè£ããããβA
ç¹ç°çã§ãããªã¯ã¿ããŒã¯Î²AéºäŒåãå«ãDNA
ã«ã®ã¿ååšãïŒã¬ãŒã³ïŒ¡åã³ïŒ¢ïŒãHinfLã§éè£
ããããβSç¹ç°æ§ãæããããªããŒã¯ãβSéºäŒå
ãå«ãDNAã«ã®ã¿ååšããïŒã¬ãŒã³ïŒ¢åã³ïŒ£ïŒã
ããªããŒåã³ãªã¯ã¿ããŒã®äž¡è ã®ååšïŒã¬ãŒã³
ïŒã¯éç¶èµ€è¡ç貧è¡ãã€ãªã¢ã瀺ããã®ã§ã
ãããªã¯ã¿ããŒã®ã¿ãçããæ£åžžã®åäœïŒã¬ãŒã³
ïŒåã³ããªããŒã®ã¿ã瀺ãéç¶èµ€è¡ç貧è¡ã«ã
ãã€ãŠããåäœïŒã¬ãŒã³ïŒ£ïŒããåºå¥ãããã æ¯èŒã®ãããäžèšå®éšãå¢å¹ ãããŠããªãã²ã
ã DNAãçšããŠç¹°ãè¿ãè¡ããå¢å¹ ãè¡ããšæ€
åºæ床ãå°ãªããšã1000åå¢å ããããšãåãã€
ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãã©ãã«ããããããŒãã䜿çšãã
ããšãªãå šããDNAäžã®å šã粟補ãããŠãªãå
äžã³ããŒéºäŒåãã²ã«äžã§çŽæ¥æ€åºããæ¹æ³ã瀺
ããã®ã§ããã å®æœäŸïŒã«èšèŒããæè¡ãçšããβâã°ãããª
ã³éºäŒåã®ç¬¬ïŒãšã¯ãœã³äžã®é åããã®110å¡©åº
察æçããå šããDNA10ãã€ã¯ãã°ã©ã ãã20
ãµã€ã¯ã«ã§å¢å¹ ããããã®20ãµã€ã¯ã«åŸã«çç£ã
ãã110å¡©åºå¯Ÿæçã¯ãèåãšããžãŠã ã«ãã容
æã«æè²ãããŠã²ã«äžã§èŠãããšãã§ããã é åã¯ãæåã«å¶éé µçŽ Ddeã«ããåæãã
ããšãé åãβâã°ããã³ã®ïŒ³å¯Ÿç«éºäŒåäžã«ã
ããå Žåã®ããã«é µçŽ ã«ããèªèãããå¶ééšäœ
ãå«ãŸãªããã®ã§ãªãéããå¢å¹ ãããªãã€ãã å®æœäŸ ïŒ A.ããβâã°ããã³ïŒ¡å¯Ÿç«éºäŒåããã®1.9kb
æ¿å ¥éšãå«æããåèš100ããšã ãã¢ã«ã®
pBR328ã500CiïŒã¢ã«ã§ããåαâ32Pâããªã
ã·NTPã50ããã¢ã«ãã€ãåã³å®æœäŸïŒã§äœ¿çš
ããåãã©ã€ããŒïŒããã¢ã«ãã100ÎŒã®30mM
ããªã¹âã¢ã»ããŒãïŒPH7.9ïŒã60mMé ¢é žãããª
ãŠã ã100mMãžããªã¹ã¬ã€ããŒã«åã³10mMé ¢
é žãã°ãã·ãŠã ãå«ã溶液äžã«æº¶ãããããã®æº¶
液ã100âã«ããŠïŒåå ç±ãã25âã«ãŠïŒåå·åŽ
ããã4.5åäœã®E.ã³ãŒãªãŒDNAããªã¡ã©ãŒãŒïŒ©
åã³0.09åäœã®ç¡æ©ããããªã¹ãã¢ã¿ãŒãŒãå ã
ãŠåå¿æ··åç©äžã§ãããªã³é žãçããã®ãé²æ¢
ãããã®åŸåå¿ã25âã§ïŒåéé²è¡ãããæŽã«å
ç±ãå·åŽãé µçŽ ã®æ·»å åã³åå¿ã®ãµã€ã¯ã«ãïŒå
ç¹°ãè¿ãããååæãµã€ã¯ã«ã®åŸã10ÎŒã®ã¢ãª
ã³ãŒããåãåºã1ÎŒã®600mMEDTAã«å ã
ãããããããã90mMã®ããªã¹ãã¬ãŒãåã³
2.5mMã®EDTAäžãPH8.3ã§14ïŒ ã®ããªã¢ã¯ãªã«
ã¢ããã²ã«äžã§24ãã«ãïŒcmã2.5æéã§åæã
ããæäœã®çµäºããã²ã«ã¯ã0.5ÎŒgïŒmlã®èåãš
ããžãŠã ãå ããåãç·©è¡æ¶²ã«20å浞ããåœåã®
ç·©è¡æ¶²ã§æŽæµããèµ€ãã€ã«ã¿ãŒãçšããŠçŽ«å€ç·äž
ã§åçãæ®åœ±ããã çç£ããã110å¡©åºå¯Ÿæçã¯çŽ«å€ç·ãã²ã«ãã
åãåºãããããŠã¯ã¬ã³ã³ãæŸå°ã«ããä¿æ°ã
ããããµã€ã¯ã«æ°ãæå³ããïœããµã€ã¯ã«æ¯ã®
éšåçåçã§ããåŒ pmolesïŒ10ÎŒïŒ0.01ïŒïŒïŒïœïŒNâyNâïŒïŒã ã«ããŒã¿ãäžèŽãããããšããè©Šã¿ã¯ãïœã
0.619ã§ãããšãã«æ¥œèŠ³çãªãã®ãšãªããããã¯ã
ååãªå¢å¹ ãèµ·ãã€ãŠããããšãæ瀺ããŠããã B.åããªãã·NTPã100ããã¢ã«ãã€100ÎŒã®
åå¿æº¶æ¶²ã«å ããæŸå°æ§ã©ãã«ãè¡ãããåãµã€
ã¯ã«æ¯ã«æ¶²ãåãåºããªãã€ã以å€ã¯ãäžèšãšå
ãå®éšãç¹°ãè¿ããã10ãµã€ã¯ã«åŸã«åå¿ç©ãïŒ
åé沞隰ãããŠåå¿ãåæ¢ããã57âãïŒæéã§
åãã€ããªãã€ãŒãŒã·ãšã³ãè¡ã€ãã 110å¡©åºå¯Ÿçæç©ã®é åãããã®8ÎŒlã®ã¢ãªã³ãŒã
ãã1ÎŒã®ãŠã·è¡æž ã¢ã«ããã³ïŒïŒmgïŒmlïŒãš
1ÎŒã®å¥œé©ãªå¶éé µçŽ ïŒHinfIãMnlãMstIIã
NcoïŒãå ããŠå¶éåæãã37âã§15æéåå¿
ãããŠç¢ºèªãããPAGEã¯ãäžè¿°ã®éãè¡ã€ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãpBR328ãšpBR322ã®çš®ã ã®æç
ãå¢å¹ ããããã«ç°ãªã€ããã©ã€ããŒã䜿çšãã
äŸã瀺ãã  次ã®ãã©ã€ããŒã䜿ãpBR328ã®130å¡©åºå¯Ÿ
æçã調補ããããšä»¥å€ã¯å®æœäŸ7Aãšåãã
ãã«å®éšãç¹°ãè¿ããã ïœïŒTTTGCTTCTGACACAACTGTGTTCACTAGCïŒåã³ ïœïŒGCCTCACCACCAACTTCATCCACGTTCACCïŒ ïŒ¢ 次ã®ãã©ã€ããŒãçšããããšä»¥å€ã¯å®æœäŸ
7Aãšåãããã«å®éšãç¹°ãè¿ãpBR328ã®262
å¡©åºå¯Ÿæçã調補ãããåå¿æéã¯ãµã€ã¯ã«åœ
ãã20åã§ãã€ãã ïœïŒGGTTGGCCAATCTACTCCCAGGïŒ
åã³ ïœïŒTGGTCTCCTTAAACCTGTCTTGïŒ ïŒ£ ããβâã°ããã³ïŒ³å¯Ÿç«éºäŒåããã®1.9kb
ã®æ¿å ¥éšãå«ãã100ããšã ãã¢ã«ã®pBR328
ã®MstIIæ¶åç©ãåœåã®é³åãšããŠçšãã以å€
ã¯ãå®æœäŸ8Bãšåæ§ã«å®éšãè¡ã€ãã該ãã©
ã¹ããã¯MstIIã«ããæ°ååæãããããå¢å¹
ãã¹ãé åã®å åŽã§ã¯åæãèµ·ãããªãã€ãã
æŽã«ã䜿çšãããã©ã€ããŒã¯æ¬¡ã®éãã§ã240
å¡©åºå¯Ÿæçãçç£ããã ïœïŒGGTTGGCCAATCTACTCCCAGGïŒ
åã³ ïœïŒTAACCTTGATACCAACCTGCCCïŒ ïŒ€ 100ããšã ãã¢ã«ã®pBR322ã®Nruæ¶åç©ã
é³åãšããŠçšãã100ÎŒã®åå¿æ¶²äžã§åããª
ãã·NTPã200ããã¢ã«äœ¿çšãã次ã®ãã©ã€ã
ãŒã䜿çšããŠpBR322ãã500å¡©åºå¯Ÿæçãç
ç£ãã以å€ã¯å®æœäŸ7Bãšåæ§ã«å®éšãè¡ã€ãã ïœïŒTAGGCGTATCACGAGGCCCTïŒåã³ ïœïŒCTTCCCCATCGGTGATGTCGïŒ åå¿æéã¯37âã§ãµã€ã¯ã«åœãã20åã§ãã€
ããæåŸã®åãã€ããªãã€ãŒãŒã·ãšã³ã¯57âã§15
æéè¡ã€ããé»æ°æ³³åã¯ïŒïŒ ã¢ã¬ããŒã¹ã²ã«äžã§
è¡ã€ãã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãã€ã³ãããå€ç°ãå¢å¹ ãããã»ã°
ã¡ã³ãã«å°å ¥ããããããªæ¬çºææ¹æ³ãäŸç€ºãã
ãã®ã§ããã  Nruã§çŽç·åããpBR322åèš100ããšã ã
ã¢ã«ãïŒããã¢ã«ã®75å¡©åºå¯Ÿæçãçæããã
ãã«èšèšãããããããæ¬¡åŒ ïœïŒCGCATTAAAGCTTATCGATGïŒåã³ ïœïŒTAGGCGTATCACGAGGCCCTïŒ ã®ãã©ã€ããŒããããã100ããã¢ã«ã®åããª
ãã·NTPããPHïŒã®40mMã®ããªã¹ã
20mMMgCl2ã5mMã®ãžããªã¹ã¬ã€ããŒã«å
ã³ïŒmgïŒmlã®ãŠã·è¡æž ã¢ã«ããã³ã®æº¶æ¶²100ÎŒ
äžã§æ··åããããã®æ··åç©ã100âã«ããŠïŒ
åéå ç±ãã氎济äž23âã0.5åéå·åŽãã次
ã«4.5åäœã®ã¯ã¬ããŒæçãš0.09åäœã®ç¡æ©ã
ãããªã¹ãã¢ã¿ãŒãŒãå ããåå¿ãïŒåéè¡ã€
ããå ç±ãå·åŽãé µçŽ æ·»å åã³åå¿ãµã€ã¯ã«ã
ïŒåç¹°ãè¿ããã10åç®ã®åå¿ãµã€ã¯ã«ã¯åçµ
ã«ããçµäºãããåå¿æ··åç©ã®ã¢ãªã³ãŒã8ÎŒ
ãïŒïŒ ã¢ã¬ããŒã¹ã²ã«ã«é©çšããèåãšããž
ãŠã ã«ããèŠèŠåããã  ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãšããŠæ¬¡åŒã®
ãã®ã䜿çšãã以å€ã¯å®æœäŸ9Aãšåæ§ã®å®éš
ãç¹°ãè¿ããã ïœïŒCGCATTAAAGCTTATCGATGïŒåã³ ïœïŒAATTAATACGACTCACTATAGGGAGATAGGCGTATCACGA
GGCCCTïŒ ãããã®ãã©ã€ããŒã¯101å¡©åºå¯Ÿãçç£ããã
ãã«èšèšããããã®ïŒïŒçªç®ã®ãã©ã€ããŒäž
ã®ïŒ26ãã¯ã¬ãªããã¯pBR322ã«ã¯ååšããª
ãããããã®ãã¯ã¬ãªããã¯T7ããã¢ãŒã¿ãŒ
ã®é åãè¡šããã®ã§ãããããpBR322ããã®
75å¡©åºå¯Ÿé åã«ã20ã®çžè£çå¡©åºãš26å¡©åºã®
5â²åŽäŒžé·éšãšãæãããã©ã€ããŒã䜿çšããŠé£
çµããããã®æ¹æ³ã¯ïŒæéããå°ãªãæéã§å®
æœããããšãã§ãã100ããšã ãã¢ã«ã®
pBR322ããæ¯èŒççŽç²ãª101å¡©åºå¯ŸæçïŒã
ã³ã¢ã«ãçç£ããããšãã§ããã T7ããã¢ãŒã¿ãŒã¯RNA転åãéå§ãããã
ãã«äœ¿çšã§ãããT7ããªã¡ã©ãŒãŒã101å¡©åºå¯Ÿ
æçã«å ããŠåéRNAãçæããããããšã
ã§ããã  ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãšããŠäžèšã®
ãã®ã䜿çšããŠãpBR322ãã1000å¡©åºå¯Ÿæç
ã調補ãã以å€ã¯å®æœäŸ8Dãšåæ§ã«å®éšãç¹°
ãè¿ããã ïœïŒTAGGCGTATCACGAGGCCCTïŒåã³ ïœïŒCCAGCAAGACGTAGCCCAGCïŒ ïŒ€ äžèš9Cãšåæ§ã®å®éšãç¹°ãè¿ãããäœãã
ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãšããŠäžèšã®ã
ã®ã ïœïŒTAGGCGTATCACGAGGCCCTïŒåã³ ïœïŒAATTAATACGACTCACTATAGGGAGATAGGCGTATCACGA
GGCCCTïŒ äœ¿çšããŠ1026察æçã調補ãããïŒçªç®ã®ãã©
ã€ããŒ26ãã¯ã¬ãªããã¯pBR322ã«ã¯ååšããã
äžèšã®T7ããã¢ãŒã¿ãŒã瀺ããã®ã§ããããã®
ããã¢ãŒã¿ãŒã¯ãpBR322ããã®1000å¡©åºå¯Ÿæç
ã«é£æ¥ããŠæ¿å ¥ãããã ãããã®çµæã¯ãé³åéãšå®å šã«ãããããŠã
ãªããããã«ããããããååã«ãã€ããªãã€ãº
ããŠé µçŽ çã«äŒžé·ãããã©ã€ããŒã¯ãåœåã®é³å
ã«å¯Ÿå¿ããéããããããã©ã€ããŒã®éãå«ãé·
éçæç©ãçæãããããšããããšãæ瀺ããã
é·éçæç©ã¯ã€ã³ãããå€ç°ãçãããã第ïŒã®
ãã©ã€ããŒçšã®é³åãšããŠã®åœ¹å²ãæããããã®
åŸã®ãµã€ã¯ã«ã§ã¯ãæŽã«å€ãã®ãã¹ãã¢ãããã©
ã€ãã³ã°ãèŠæ±ãããªãã®ã§ãå¹çãæžå°ããã
ãšãªããã®å€ç°ã¯å¢å¹ ãããããã®å Žåãã®5â²æ«
端ã«çžè£çã§ãªã䌞é·éšåããããã©ã€ããŒãã
è€è£œãããã¹ãé³åã«é£æ¥ããŠçæç©ã«æ°ããé
åãæ¿å ¥ããããã«äœ¿çšãããã å®æœäŸ 10 æ¬å®æœäŸã¯åã³ããŒéºäŒåãå¢å¹ ãããéã«ã
ãã¯ã°ã©ãŠã³ããæžå°ãããããã«ãã¹ãç¶ã«
ïŒnestedïŒã»ãããããã©ã€ããŒã䜿çšããããš
ãäŸç€ºãããã®ã§ããã éæ§åβâã°ããã³å¯Ÿç«éºäŒåã«ã€ããŠãã¢æ¥
åäœã§ããå šããDNAã«å¯ŸããŠã20ãµã€ã¯ã«ã®
å¢å¹ ã次ã®ããã«è¡ã€ãã10ÎŒgã®DNAãããã
ã200ãã³ã¢ã«ã®æ¬¡åŒã®ãã©ã€ããŒã ïœïŒACACAACTGTGTTCACTAGCïŒåã³ ïœïŒCAACTTCATCCACGTTCACCïŒ äžŠã³ã«100ããã¢ã«ãã€ã®dNTPãã100ÎŒã®
30mMããªã¹âã¢ã»ããŒãã60mMã®é ¢é žãããª
ãŠã ã10mMã®ãžããªã¹ã¬ã€ããŒã«ãåã³10mM
ã®é ¢é žãã°ãã·ãŠã äžã§100âã«ãŠïŒåéå ç±ãã
25âã«ïŒåéäžããŠããããŠïŒåäœã®ã¯ã¬ããŒæ
çãšãšãã«ïŒåéåŠçãããå ç±ãå·åŽãã¯ã¬ã
ãŒè©Šè¬ã®æ·»å ã®ãµã€ã¯ã«ã19åç¹°ãè¿ããã10ÎŒ
ã®æ¶²äœãåå¿æ··åç©ããåãåºããæŽã«10åã®
å¢å¹ ã®ããã®ãµã€ã¯ã«ã次ã®åãã©ã€ããŒãçšã
ãŠè¡ã€ãã ïœ
ïŒCAGACACCATGGTGCACCTGACTCCTGïŒ
åã³ ïœïŒCCCCACAGGGCAGTAACGGCAGACTTCTCCïŒ ãããã¯ãäžèšã§çç£ããã110å¡©åºå¯Ÿæçäžã«
å«ãŸãã58å¡©åºå¯Ÿæçãå¢å¹ ãããå¢å¹ ãã¹ãæ
åŸã®10åã®ãµã€ã¯ã«ã¯ã10ÎŒã®ã¢ãªã³ãŒããã
äžèšããåããªãã·NTP100ããã¢ã«ãšåãã©ã€
ããŒ200ãã³ã¢ã«ãå«ã90ÎŒã®æ°ããããªã¹â
ã¢ã»ããŒãç·©è¡æ¶²ã«åžéããããšã«ããéæãã
ããšãã§ãããåå¿æ¡ä»¶ã¯äžèšã®éããšããã10
ãµã€ã¯ã«ã®åŸ10ÎŒã®ã¢ãªã³ãŒãïŒåœåã®DNA
ã®100ããã°ã©ã ã«å¯Ÿå¿ïŒãïŒïŒ ã®Nuã·ãŒã
ïŒFMC瀟ïŒã¢ã¬ããŒã¹ã²ã«ã«å ããèåãšããžãŠ
ã ã䜿ã€ãŠèŠèŠåããã 第ïŒïŒå³ã¯ã玫å€ç·ã§çºå ãããåŸæ¥æ³ã®éã
èµ€ããã€ã«ã¿ãŒãéããŠåçæ®åœ±ããäžèšã²ã«ã
瀺ããã®ã§ãããã¬ãŒã³ïŒã¯ååéã®ããŒã«ãŒã§
ãããã¬ãŒã³ïŒã¯äžèšåå¿ã®ã¢ãªã³ãŒãã§ããã
ã¬ãŒã³ïŒã¯åœåã®éæ§åDNAãå¢å¹ ã®åã«Dde
ã«ããéè£ãããããšä»¥å€ã¯äžèšãããã®ãšå
ãåå¿ã®ã¢ãªã³ãŒãã§ãããã¬ãŒã³ïŒã¯éç¶èµ€è¡
ç貧è¡Î²âã°ããã³å¯Ÿç«éºäŒåã«ã€ããŠãã¢æ¥å
äœã§ããããDNAãå¢å¹ ã®åã«Ddeã§åŠçã
ãããšä»¥å€ã¯äžèšãšåæ§ãªåå¿ã®ã¢ãªã³ãŒãã§ã
ãïŒéç¶èµ€è¡ç貧è¡å¯Ÿç«éºäŒåã¯å¢å¹ ãããæç
å ã«Ddeéšäœãå«ãŸãªãïŒãã¬ãŒã³ïŒã¯é®ã®ç²Ÿ
åDNAã§ããDNAã眮ãæãã以å€ã¯äžèšãšå
æ§ã®åå¿ã®ã¢ãªã³ãŒãã§ãããã¬ãŒã³ïŒã¯å¢å¹ åŸ
åå¿æ¶²ãDdeã§åŠçããããšä»¥å€ã¯äžèšãšåæ§
ãªåå¿ã®ã¢ãªã³ãŒãã§ããïŒDdeã¯58å¡©åºå¯Ÿã®
éæ§åçæç©ã27å¡©åºäœåã³34å¡©åºäœã®æçã«å€
æããïŒãã¬ãŒã³ïŒã¯å¢å¹ åŸDdeã§åŠçããã¬
ãŒã³ïŒã®ææã®ã¢ãªã³ãŒãã§ããïŒ58å¡©åºå¯Ÿã®é
ç¶èµ€è¡ç貧è¡çæç©ã¯Ddeãå«ãŸãªãïŒã ã¢ã¬ããŒã¹ã²ã«ã®èåãšããžãŠã æè²ã®ã¿ã䜿
çšããŠããDNAã®ïŒãã€ã¯ãã°ã©ã ããã®åã³
ããŒéºäŒåã代衚ãã58å¡©åºå¯Ÿæçãæ€åºããã
ãã«ã¯ãçŽ500000åã«å¢å¹ ããããšãå¿ èŠã§ã
ããããã¯ãããã§ïŒã€ã®ãªãªãŽãã¯ã¬ãªããã®
ãã¹ãç¶ã»ããã䜿çšããŠéæããããšãã§ã
ãã第ïŒã®ã»ããã¯110å¡©åºå¯Ÿæçãå¢å¹ ããå
éšã®ãã¹ãç¶ã»ããã¯ã第ïŒïŒå³ã«ç€ºãããã«äŸ¿
å©ã«æ€åºã§ããã¬ãã«ã«ãªããŸã§ãã®çæç©ã®ãµ
ããŒæçãå¢å¹ ãããå è¡ããå¢å¹ å·¥çšã§å¢å¹ ã
ããé åäžã«å«ãŸããåä»ã®ãã©ã€ããŒã®äŒžé·ç
æç©äžã«ãå«ãŸããããå°ããªé åããã©ã€ããŒ
ã䜿ã€ãŠå¢å¹ ããæ¬æ³ã¯ãäŸãã°ã³ããŒãã®
PNAS80å·»278é ïŒ1983幎ïŒåã³ã¬ã¢ãªãŒãã®
PNAS80å·»4045é ïŒ1983幎ïŒã«èšèŒãããŠããã
ãã«æŸå°æ§åäœäœåã¯éæŸå°æ§åäœäœãããŒãã®
ãã€ããªãã€ãŒãŒã·ãšã³ã®æ¹æ³è«ã«é Œãããšãª
ããβâã°ããã³ã®åº§ã«ãããéæ§åãéç¶èµ€è¡
ç貧è¡å¯Ÿç«éºäŒåããåºå¥ããããšãå¯èœã«ã
ãã å®æœäŸ 11 æ¬æ³ã¯æ£è ã®DNAè©Šæäžã®äŸãã°ã¯ã©ããžã¢
ã®ãããªäŒææ§çŸæ£ãšé¢é£ããç¹å®ã®é åããæ
æã®å¢å¹ ãããé åãå«ãããªãã³åããããã€
ããªãã€ãŒãŒã·ãšã³ãããŒãã䜿çšããã€åè¿°ã®
ç±³åœç¹èš±ç¬¬4358535å·ã«èšèŒãããæ¹æ³ã䜿çšã
ãŠæ€åºããéã«æçšã§ããããšãæåŸ ããããã
ãªãã³åããããã€ããªãã€ãŒãŒã·ãšã³ãããŒã
ã¯ãäžéšãäºééãšãªã€ãDNAã«ã次åŒã®ã¹ã
ãŒãµãŒã¢ãŒã ãä»ããŠããªãã³ã«çµåãã4â²âã¡
ãã¬ã³çœ®æâïŒïŒïŒïŒâïŒâããªã¡ãã«ããœã©ã¬
ã³ãæ¿å ¥ããã€å ãç §å°ããããšã«ãã調補ãã
ããšãã§ããã åŒäžïŒ²ã¯âåã¯CHOåºã§ãããRâ³ã¯âã§
ãããïœã¯ïŒãïŒã®æ°ã§ããããããŠïœã¯ïŒãïŒ
ã®æ°ã§ããããããŒãäžã®ããªããã«åºã®æ€åº
ã¯ããšã³ãŸãã€ãªã±ã 瀟ã«ããåžè²©ãããŠããã¹
ãã¬ãã¿ããžã³âé žæ§ããªã¹ãã¢ã¿ãŒãŒè€åäœã
çšããŠããã³ãã¬ããã«è£œé è ã瀺ããŠããæ€åº
æ¹æ³ã«ããéæããããšãã§ããããã€ããªãã€
ãŒãŒã·ãšã³ãããŒãã¯ãæ€åºçšè€åäœãšã®çµåã
åã³ããã«ç¶ãé žæ§ãã¹ãã¢ã¿ãŒãŒã«ãã觊åªã
ããåå¿ïŒãã®åå¿ãæ²æŸ±æ§è²çŽ ãçæããïŒã«
åºãæ²æŸ±ããæè²ã¹ããããšããŠèŠãããšãã§ã
ãã ææã®å¯èš 现èç³»SCâïŒïŒCTCCïŒ0082ïŒã¯ã1985幎ïŒæ
19æ¥ãç±³åœã20852ãã¡ãªãŒã©ã³ãå·ããã¯ãã«
ããŒã¯ããŒã³ãã©ã€ã12301ã«æåšããã¢ã¡ãªã«
ã³ã»ã¿ã€ãã»ã«ã«ãã€ãŒã»ã³ã¬ã¯ã·ãšã³
ïŒATCCïŒã«ATTTåççªå·ç¬¬CRL8756å·ãšããŠ
å¯èšããããSCâïŒã®å¯èšã¯ãATCCãšæ¬ç¹èš±
åºé¡äººã®ã·ãŒã¿ã¹ã»ã³ãŒãã¬ãŒã·ãšã³ãšã®éã®å¥
çŽã«åŸã€ãŠè¡ããããATCCãšã®å¥çŽã¯ãæ¬å¯èš
ãèšèŒããã€ç¹å®ããç±³åœç¹èš±ãçºè¡ãããå Žå
åã¯ç±³åœåã¯å€åœç¹èš±åºé¡ãå ¬è¡ã«å ¬åãããå Ž
ååã¯å ¬éãããå Žåã®ããããæ©ãæ¹ãæ¥ããš
ãã«ãã®çŽ°èç³»ã®åå«ãå ¬è¡ããããæ°žç¶çã«å©
çšã§ããããã«ããããã«æäŸããæŽã«æ¬çŽ°èç³»
ãå©çšãããããšã«ã€ããŠã¯ãç±³åœç¹èš±åæšå±é·
å®ãç±³åœç¹èš±æ³ç¬¬122æ¡åã³ããã«é¢ããé·å®ã®
ã«ãŒã«ïŒ37CFR1ã14æ¡ãç¹ã«886OG638ã«é¢é£
ããŠå«ãïŒã«åŸã€ãŠæš©éãæã€ãŠæ±ºå®ãã人éã«
察ããŠãè¡ããæ¬åºé¡ã®è·å人ã¯ããå¯èšãã现
èç³»ã奜é©ãªæ¡ä»¶äžã§å¹é€ããã«ããããããã
æ»æ» ãã倱ãããæå·ãããšãã¯éç¥ãåããŠã
ãè¿ éã«åã现èç³»ã®è²æå¹é€åºãšçœ®ãæããã
ãšã«åæããã çºãããšãæ¬çºæã¯ãŸãïŒã€åã¯ãã以äžã®ç¹
å®ã®æ žé žãããã©ã€ããŒã®äŒžé·ã«ããçç£ããã
çæç©ãåŒãç¶ã次ã®ãã©ã€ããŒã®äŒžé·åå¿ã®é³
åãšããŠã®åœ¹å²ãæãããããªé£éåå¿ãçšããŠ
å¢å¹ ãããããšã«ããæ žé žäžã®é åãæ€åºããã
ãã«ããæ¹æ³ãæäŸãããæ¬æ³ã¯åœåã«ã»ãã®å
ãã®éããå«ãŸããŠããªãæ žé žé åãæ€åºããã
ãã«ç¹ã«æçšã§ãããæŽã«å¢å¹ æ³ã¯ååã¯ããŒã
ã³ã°ã«ã䜿çšããããšãã§ããã
第ïŒå³ã¯ãå¢å¹
ãããããšãæãŸããããβâ
ã°ããã³ã®94å¡©åºå¯Ÿé·ã®é åã瀺ããã®ã§ããã
éç¶èµ€è¡ç貧è¡ã«äŒŽãåäžå¡©åºå¯Ÿå€åã94merã®
äžæ¹ã«æããŠããã第ïŒå³ã¯ãããã®éæ§å
DNAäžãåã³æ£åžžã®Î²âã°ããã³éºäŒåã®1.9kb
ã®AamHIæçãå«ããã©ã¹ããïŒpBR328ïŒ
HbAãšç€ºãããïŒäžã«å«ãŸããäžèš94merã®å¢
å¹ ã瀺ãèåãšããžãŠã ã§æè²ãããããªã¢ã¯ãª
ã«ã¢ããã®ã²ã«ã®åçã§ããã第ïŒå³ã¯ã
pBR328ïŒBbAãåã³Î²âã°ããã³ã®éç¶èµ€è¡ç
貧è¡å¯Ÿç«éºäŒåã®1.9kbã®BamHIæçãå«æãã
ãã©ã¹ããïŒpBR328ïŒHbSãšç§°ããïŒäžã«ååš
ããç¹å®ã®æšç94meré åã®ããããã®å¢å¹ ã瀺
ãããªã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åã®ãªãŒãã©ãž
ãªã°ã©ãã瀺ããpBR328ïŒHbAã§ã¯å¢å¹ ããã
ã¹ãé åãMstã«ããéè£ããããããŠ
pBR328ïŒHbSã§ã¯å¢å¹ ãããã¹ãé åãåŠçã
ããMstã«ããéè£ãããªãã€ãã第ïŒå³ã¯ã
ïŒã€ã®ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãçšããïŒ
ãµã€ã¯ã«ã«ã€ããŠãããβâã°ããã³ã®ææã®
94merãé åã®å¢å¹ ã®ããã®ããªã¡ã©ãŒãŒé£éå
å¿ã®ã¹ããããšçæç©ã®è©³çŽ°ã瀺ããã®ã§ããã
第ïŒå³ã¯ãpBR328ïŒHbAäžã®240meré åã®ïŒ
ãµã€ã¯ã«åŸã®å¢å¹ ã瀺ãèåãšããžãŠã ã§æè²ã
ããããªã¢ã¯ãªã«ã¢ããã®ã²ã«ã瀺ãåçã§ã
ããããã¯ã¢ãªã³ãŒããNCoïŒã¬ãŒã³ïŒïŒãMst
IIïŒã¬ãŒã³ïŒïŒåã¯HinfIïŒã¬ãŒã³ïŒïŒã«ããæ¶å
ããããã¬ãŒã³ïŒã¯ååéã®åºæºã§ãã¬ãŒã³ïŒã¯
ç¡å·ã®240bpã®çæç©ãå«ãã§ããã第ïŒå³ã¯ã
Pdeåã³HinfIå¶ééšäœéã«ããæ£åžžãªïŒÎ²AïŒ
βâã°ããã³éºäŒååã³éç¶èµ€è¡çïŒÎ²SïŒÎ²âã°
ããã³éºäŒåã®é åã瀺ããã®ã§ãβAã«ã€ããŠã®
ïŒæ¬ç·ã¯DdeéšäœïŒCTGAGïŒã®äœçœ®ã瀺ãã
βAåã³Î²Sã«ã€ããŠã®ïŒéç·ã¯HinfIéšäœ
ïŒGACTCïŒã®äœçœ®ã瀺ããŠããã第ïŒå³ã¯ã
40merãããŒãã䞊ã³Ddeåã³ããã«ç¶ãHin
fIå¶éé µçŽ ãçšããæ£åžžÎ²âã°ããã³ã®é次çãª
æ¶åã®çµæã瀺ããã®ã§ããã第ïŒå³ã¯ã第ïŒå³
ãšåã40merãããŒã䞊ã³ã«Ddeåã³ããã«ç¶
ãHinfIå¶éé µçŽ ã䜿çšããéç¶Î²âã°ããã³ã®
é次çãªæ¶åã®çµæã瀺ããã®ã§ããã第ïŒå³
ã¯ããã®çºæã®å¢å¹ ã«ãããããå šããDNAã®
è©Šæäžã«ååšããβâã°ããã³å¯Ÿç«éºäŒåãç¹ç°
çã«ç¹åŸŽä»ããããã®ã第ïŒå³ãšåã40merãã
ãŒãã®äœ¿çšã瀺ããèåãšããžãŠã ã§æè²ããã
ããªã¢ã¯ãªã«ã¢ããã®ã²ã«ã瀺ãåçã§ããã第
ïŒïŒå³ã¯ãèåãšããžãŠã ã玫å€ç·ãçšããŠèŠèŠ
åããïŒïŒ ã®Nuã·ãŒãã¢ã¬ããŒã¹ã²ã«ã®åçã
瀺ããã®ã§ããããã®åçã¯ã110âbpå¢å¹ çæ
ç©ã®ãµãâãã©ã°ã¡ã³ãã®å¢å¹ ã瀺ãããã®ãµã
âãã©ã°ã¡ã³ãã¯110bpæçå ã®å éšãã¹ãã§ã
ãã
ã°ããã³ã®94å¡©åºå¯Ÿé·ã®é åã瀺ããã®ã§ããã
éç¶èµ€è¡ç貧è¡ã«äŒŽãåäžå¡©åºå¯Ÿå€åã94merã®
äžæ¹ã«æããŠããã第ïŒå³ã¯ãããã®éæ§å
DNAäžãåã³æ£åžžã®Î²âã°ããã³éºäŒåã®1.9kb
ã®AamHIæçãå«ããã©ã¹ããïŒpBR328ïŒ
HbAãšç€ºãããïŒäžã«å«ãŸããäžèš94merã®å¢
å¹ ã瀺ãèåãšããžãŠã ã§æè²ãããããªã¢ã¯ãª
ã«ã¢ããã®ã²ã«ã®åçã§ããã第ïŒå³ã¯ã
pBR328ïŒBbAãåã³Î²âã°ããã³ã®éç¶èµ€è¡ç
貧è¡å¯Ÿç«éºäŒåã®1.9kbã®BamHIæçãå«æãã
ãã©ã¹ããïŒpBR328ïŒHbSãšç§°ããïŒäžã«ååš
ããç¹å®ã®æšç94meré åã®ããããã®å¢å¹ ã瀺
ãããªã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åã®ãªãŒãã©ãž
ãªã°ã©ãã瀺ããpBR328ïŒHbAã§ã¯å¢å¹ ããã
ã¹ãé åãMstã«ããéè£ããããããŠ
pBR328ïŒHbSã§ã¯å¢å¹ ãããã¹ãé åãåŠçã
ããMstã«ããéè£ãããªãã€ãã第ïŒå³ã¯ã
ïŒã€ã®ãªãªãŽãã¯ã¬ãªãããã©ã€ããŒãçšããïŒ
ãµã€ã¯ã«ã«ã€ããŠãããβâã°ããã³ã®ææã®
94merãé åã®å¢å¹ ã®ããã®ããªã¡ã©ãŒãŒé£éå
å¿ã®ã¹ããããšçæç©ã®è©³çŽ°ã瀺ããã®ã§ããã
第ïŒå³ã¯ãpBR328ïŒHbAäžã®240meré åã®ïŒ
ãµã€ã¯ã«åŸã®å¢å¹ ã瀺ãèåãšããžãŠã ã§æè²ã
ããããªã¢ã¯ãªã«ã¢ããã®ã²ã«ã瀺ãåçã§ã
ããããã¯ã¢ãªã³ãŒããNCoïŒã¬ãŒã³ïŒïŒãMst
IIïŒã¬ãŒã³ïŒïŒåã¯HinfIïŒã¬ãŒã³ïŒïŒã«ããæ¶å
ããããã¬ãŒã³ïŒã¯ååéã®åºæºã§ãã¬ãŒã³ïŒã¯
ç¡å·ã®240bpã®çæç©ãå«ãã§ããã第ïŒå³ã¯ã
Pdeåã³HinfIå¶ééšäœéã«ããæ£åžžãªïŒÎ²AïŒ
βâã°ããã³éºäŒååã³éç¶èµ€è¡çïŒÎ²SïŒÎ²âã°
ããã³éºäŒåã®é åã瀺ããã®ã§ãβAã«ã€ããŠã®
ïŒæ¬ç·ã¯DdeéšäœïŒCTGAGïŒã®äœçœ®ã瀺ãã
βAåã³Î²Sã«ã€ããŠã®ïŒéç·ã¯HinfIéšäœ
ïŒGACTCïŒã®äœçœ®ã瀺ããŠããã第ïŒå³ã¯ã
40merãããŒãã䞊ã³Ddeåã³ããã«ç¶ãHin
fIå¶éé µçŽ ãçšããæ£åžžÎ²âã°ããã³ã®é次çãª
æ¶åã®çµæã瀺ããã®ã§ããã第ïŒå³ã¯ã第ïŒå³
ãšåã40merãããŒã䞊ã³ã«Ddeåã³ããã«ç¶
ãHinfIå¶éé µçŽ ã䜿çšããéç¶Î²âã°ããã³ã®
é次çãªæ¶åã®çµæã瀺ããã®ã§ããã第ïŒå³
ã¯ããã®çºæã®å¢å¹ ã«ãããããå šããDNAã®
è©Šæäžã«ååšããβâã°ããã³å¯Ÿç«éºäŒåãç¹ç°
çã«ç¹åŸŽä»ããããã®ã第ïŒå³ãšåã40merãã
ãŒãã®äœ¿çšã瀺ããèåãšããžãŠã ã§æè²ããã
ããªã¢ã¯ãªã«ã¢ããã®ã²ã«ã瀺ãåçã§ããã第
ïŒïŒå³ã¯ãèåãšããžãŠã ã玫å€ç·ãçšããŠèŠèŠ
åããïŒïŒ ã®Nuã·ãŒãã¢ã¬ããŒã¹ã²ã«ã®åçã
瀺ããã®ã§ããããã®åçã¯ã110âbpå¢å¹ çæ
ç©ã®ãµãâãã©ã°ã¡ã³ãã®å¢å¹ ã瀺ãããã®ãµã
âãã©ã°ã¡ã³ãã¯110bpæçå ã®å éšãã¹ãã§ã
ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åäžã®é·ãåã¯ç°ãé·ãã®ïŒã€ã®å¥åã®çžè£
çéããæãæ žé žåã¯ãã®æ··åç©äžã«å«ãŸããå°
ãªããšãïŒçš®é¡ã®ç¹å®ã®æ žé žé åã®å¢å¹ æ¹æ³ã§ã
ã€ãŠã (a) åèšéããïŒä»¥äžã®ãªãªãŽãã¯ã¬ãªãããã©
ã€ããŒã«ããåŠçããŠãå¢å¹ ãããã¹ãæ žé žé
åã«ã€ããŠè©²æ žé žé åã®éã«çžè£çãªãã©ã€ã
ãŒã®äŒžé·çæç©ãåæããããã§ãåèšãã©ã€
ããŒã¯ãç¹å®ã®æ žé žé åã®éãšå®è³ªçã«çžè£ç
ã§ãããäžã€å¢å¹ ãããã¹ãæ žé žé åã®äž¡ç«¯ã
èŠå®ããåãã©ã€ããŒããåæããã䌞é·çæ
ç©ããã®çžè£äœããåé¢ãããå Žåã«æŽãªãå
æã®ããã®é³åãšããŠæ©èœããããšãã§ããã
ãã«éžæããïŒ (b) åèšãã©ã€ããŒäŒžé·çæç©ãããããåæã
ããé³åããåé¢ããŠåéååãçæãããïŒ
ãã㊠(c) 段é(b)ããçããåéååã段é(a)ã®ãã©ã€
ããŒã«ããåŠçããŠã段é(b)ã«ãããŠçæãã
ååéååãé³åãšããŠçšããŠãã©ã€ããŒäŒžé·
çæç©ãåæããïŒ ããšãå«ãã§æãæ¹æ³ã ïŒ æ®µé(b)åã³(c)ãå°ãªããšãïŒåå埩ããããš
ãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹
æ³ã ïŒ æ®µé(b)ãå€æ§ã«ãããåã¯é µçŽ ããªã«ãŒãŒã
䜿çšããŠè¡ãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé åã¯ç¬¬ïŒé ã«èšèŒã®æ¹æ³ã ïŒ æ®µé(b)åã³(c)ãéåèªå°å€ã䜿çšããŠè¡ãªã
ããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé
ã®ããããã«èšèŒã®æ¹æ³ã ïŒ æ®µé(a)åã³ïŒåã¯(c)ããE.ã³ãªïŒE.coliïŒ
DNAããªã¡ã©ãŒãŒïŒ©ãE.ã³ãªDNAããªã¡ã©ãŒãŒ
ã®KlenowæçãT4DNAããªã¡ã©ãŒãŒãç±å®
å®é µçŽ åã¯é転åé µçŽ ããéžæãããéåèªå°å€
ã䜿çšããŠè¡ãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã第ïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒ æ®µé(a)åã³(c)ãïŒçš®é¡ã®ç°ãªããã¯ã¬ãªã·ã
ããªãã¹ããšãŒããçšããŠè¡ãããšãç¹åŸŽãšãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒã第ïŒé ã®ããããïŒé ã«èš
èŒã®æ¹æ³ã ïŒ åèšæ žé žãDNAã§ããããšãç¹åŸŽãšããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé ã®ããããïŒé ã«èš
èŒã®æ¹æ³ã ïŒ åèšæ žé žãDNAã§ããããããŠåèšãã©ã€
ããŒããªãªãŽããªãã·ãªããã¯ã¬ãªããé¡ã§ãã
ããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé
ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒ ãã©ã€ããŒã®éåãåçžè£çéã®ããã«äœ¿çš
ããããããã©ã€ããŒã®ïŒã€ã¯åèšéãšå®è³ªçã«
çžè£çã§ããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã第ïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒïŒ 段é(a)ã«ãããŠäœ¿çšãããæ žé žã®æ··åç©ã
段é(c)ã«ãããŠå®çŸ©ãããããã«çæãããå è¡
ããå¢å¹ å·¥çšã®çæç©ã§ããããšãç¹åŸŽãšããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé ã®ããããïŒé ã«èš
èŒã®æ¹æ³ã ïŒïŒ 䜿çšããããã©ã€ããŒãå è¡ããå¢å¹ å·¥çš
ã§äœ¿çšããããã©ã€ããŒãšç°ãããšãç¹åŸŽãšãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããïŒé
ã«èšèŒã®æ¹æ³ã ïŒïŒ ïŒã®ãã©ã€ããŒããå¢å¹ ãããã¹ãç¹å®ã®
é åãšçžè£çã§ãªãå°ãªããšãïŒåã®ãã¯ã¬ãªã
ããå«æããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã第ïŒïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒïŒ 段é(a)åã³(c)ã«ããããã©ã€ããŒãããã
ãå°ãªããšã1000ïŒïŒã®ãã©ã€ããŒïŒçžè£çéã®
ã¢ã«æ¯ã§ååšããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããïŒé ã«èšèŒã®æ¹
æ³ã ïŒïŒ åèšæ žé žãåéRNAãŸãã¯åéDNAãã
åæãããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã第ïŒïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒïŒ åèšRNAãã¡ãã»ã³ãžã€ãŒRNAã§ããã
ãšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé ã«èšèŒã®
æ¹æ³ã ïŒïŒ åèšå¢å¹ ãããã¹ãç¹å®ã®æ žé žé åãè€æ°
ã®æ žé žã®æ··åç©äžã«å«ãŸããããšãç¹åŸŽãšããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããïŒé ã«
èšèŒã®æ¹æ³ã ïŒïŒ åèšå¢å¹ ãããã¹ãæ žé žé åããæåã«ã
ã倧ããªæ žé žäžã«å«æãããŠããããšãç¹åŸŽãšã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããïŒ
é ã«èšèŒã®æ¹æ³ã ïŒïŒ åèšãã©ã€ããŒã®ïŒâ²âæ«ç«¯ãçžè£çã§ãª
ãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒ
ïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒïŒ åèšæ®µé(a)åã³(b)ãç±å®å®æ§DNAããªã¡
ã©ãŒãŒé µçŽ ãçšããŠè¡ãããšãç¹åŸŽãšããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããïŒé ã«èšèŒ
ã®æ¹æ³ã ïŒïŒ åèšæ®µé(a)åã³(c)ã«ããããã©ã€ããŒãã
ãããå°ãªããšã106ïŒïŒã®ãã©ã€ããŒïŒçžè£é
ã®ã¢ã«æ¯ã§ååšããããšãç¹åŸŽãšããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããïŒé ã«èšèŒã®æ¹
æ³ã ïŒïŒ åèšæ®µé(b)åã³(c)ãå°ãªããšã10åå埩ã
ãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒ
ïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã ïŒïŒ åèšç¹å®ã®æ žé žé åãïŒæ¬ã®RNAéãšïŒ
æ¬ã®cDNAéããæãããšãç¹åŸŽãšããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé ã第ïŒé åã³ç¬¬ïŒé ã第ïŒïŒé ã®ã
ãããïŒé ã«èšèŒã®æ¹æ³ã ïŒïŒ åèšãã©ã€ããŒã®äžæ¹ãããã¢ãŒã¿ãŒãã³
ãŒãããŠããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã第ïŒïŒé ã®ããããïŒé ã«èšèŒã®æ¹æ³ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71697585A | 1985-03-28 | 1985-03-28 | |
| US716975 | 1985-03-28 | ||
| US791308 | 1997-01-30 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4177779A Division JP2622327B2 (ja) | 1985-03-28 | 1992-06-12 | æ žé žé åã®å¢å¹ æ段 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62281A JPS62281A (ja) | 1987-01-06 |
| JPH0467957B2 true JPH0467957B2 (ja) | 1992-10-29 |
Family
ID=24880205
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61068857A Granted JPS62281A (ja) | 1985-03-28 | 1986-03-28 | æ žé žé åã®å¢å¹ æ¹æ³ |
| JP6885886A Granted JPS61274697A (ja) | 1985-03-28 | 1986-03-28 | æ žé žé åã®å¢å¹ åã³æ€åºæ¹æ³ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6885886A Granted JPS61274697A (ja) | 1985-03-28 | 1986-03-28 | æ žé žé åã®å¢å¹ åã³æ€åºæ¹æ³ |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS62281A (ja) |
| ZA (2) | ZA862335B (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1932924A1 (en) | 2006-11-22 | 2008-06-18 | FUJIFILM Corporation | Nucleic acid amplification method using microchip and microchip, and nucleic acid amplification system using the same |
| EP3018215A1 (en) | 2006-02-13 | 2016-05-11 | Fluidigm Canada Inc. | Gene expression assays conducted by elemental analysis |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU606043B2 (en) * | 1985-03-28 | 1991-01-31 | F. Hoffmann-La Roche Ag | Detection of viruses by amplification and hybridization |
| JP2634208B2 (ja) * | 1987-11-13 | 1997-07-23 | ãã€ãªãã¢ã»ãã€âãã¬ããã»ã€ã³ã¿ãŒãã·ãšãã«ã»ã€ã³ã³ãŒãã¬ã€ããã | å¶éæçé·å€åæ§åææ¹æ³åã³ãã®è£ 眮 |
| CA1341584C (en) * | 1988-04-06 | 2008-11-18 | Bruce Wallace | Method of amplifying and detecting nucleic acid sequences |
| AU634969B2 (en) * | 1988-06-24 | 1993-03-11 | Amgen, Inc. | Method and reagents for detecting nucleic acid sequences |
| CA2013317A1 (en) * | 1989-04-17 | 1990-10-17 | Fred T. Oakes | Diagnostic kit, primer composition and their use for replication or detection of nucleic acids |
| DK0494955T3 (da) * | 1989-10-05 | 1998-10-26 | Optein Inc | Cellefri syntese og isolering af hidtil ukendte gener og polypeptider |
| JP3167138B2 (ja) * | 1991-02-25 | 2001-05-21 | æ ªåŒäŒç€Ÿã€ããã³ | åçŽãã«ãã¹ãŠã€ã«ã¹ã®åç¹ç°çæ€åºæ¹æ³ |
| DE69219726T2 (de) * | 1991-06-10 | 1997-11-27 | Baxter Int | Intravenöse dosierungen Ìberwachende vorrichtung |
| WO1993000428A1 (fr) * | 1991-06-27 | 1993-01-07 | Sumitomo Denki Kogyo | Nouveau procede d'elaboration d'adn et amorce utilisee a cette fin |
| EP1251182A3 (en) * | 1993-12-01 | 2002-11-27 | Toyo Boseki Kabushiki Kaisha | Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes |
| DK1614475T3 (da) | 1998-05-01 | 2007-09-17 | Gen Probe Inc | Indretning til omröring af vÊskeindholdet i en beholder |
| JP4013671B2 (ja) | 2002-07-05 | 2007-11-28 | æŸäžé»åšç£æ¥æ ªåŒäŒç€Ÿ | ããªã¡ã©ãŒãŒé£éåå¿å®¹åšåã³ãã®è£œé æ¹æ³ |
| JP4581380B2 (ja) | 2003-11-17 | 2010-11-17 | ãããœããã¯æ ªåŒäŒç€Ÿ | æ žé žå¢å¹ åå¿å®¹åšããã³ãã®è£œé æ¹æ³ |
| AU2006223223B2 (en) | 2005-03-10 | 2012-04-12 | Gen-Probe Incorporated | Systems and methods to perform assays for detecting or quantifying analytes within samples |
| JP4735645B2 (ja) | 2005-11-02 | 2011-07-27 | æ ªåŒäŒç€Ÿå³¶æŽ¥è£œäœæ | ïœïœã®æ€åºæ³ |
| WO2009034842A1 (ja) | 2007-09-11 | 2009-03-19 | Kaneka Corporation | æ žé žæ€åºæ¹æ³ãããã³æ žé žæ€åºããã |
| US9046507B2 (en) | 2010-07-29 | 2015-06-02 | Gen-Probe Incorporated | Method, system and apparatus for incorporating capacitive proximity sensing in an automated fluid transfer procedure |
| EP2678664B1 (en) | 2011-02-24 | 2019-08-07 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
| CA2857308C (en) | 2011-10-31 | 2019-10-01 | Eiken Kagaku Kabushiki Kaisha | Method for detecting target nucleic acid |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US675386A (en) * | 1896-08-25 | 1901-06-04 | Fried Krupp Grusonwerk | Hydraulic controller for carriages having axial recoil. |
| JPS6070086A (ja) * | 1983-09-07 | 1985-04-20 | ããŠãã¢ã«ã»ã€ã³ãã«ãããªãã«ã»ã¬ã»ãŒã«ãã»ããŒã»ãŽãšãŒ | ã³ãããŠã€ã«ã¹çšã¯ã¯ãã³ã®èª¿è£œæ¹æ³ |
| JPS61227785A (ja) * | 1984-11-27 | 1986-10-09 | ã¢ã¬ããŠã©âã»ãã€ã¢ã°ãã¹ãã€ãã¯ã¹ã»ã€ã³ã³âãã¬âããã | ïœïœããâãã®å€§èŠæš¡çç£ |
| JPH0467960A (ja) * | 1990-07-09 | 1992-03-03 | Brother Ind Ltd | ãããŒãžã§ããèšé²è£ 眮 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52143297A (en) * | 1976-05-21 | 1977-11-29 | Kaneko Agricult Machinery | Tobacco leaves grasping device |
| JPH0467957A (ja) * | 1990-07-09 | 1992-03-03 | Fujitsu Ltd | ããªã³ã¿ã®ã€ã³ãã¯ããããå°åããã |
-
1986
- 1986-03-27 ZA ZA862335A patent/ZA862335B/xx unknown
- 1986-03-27 ZA ZA862334A patent/ZA862334B/xx unknown
- 1986-03-28 JP JP61068857A patent/JPS62281A/ja active Granted
- 1986-03-28 JP JP6885886A patent/JPS61274697A/ja active Granted
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US675386A (en) * | 1896-08-25 | 1901-06-04 | Fried Krupp Grusonwerk | Hydraulic controller for carriages having axial recoil. |
| JPS6070086A (ja) * | 1983-09-07 | 1985-04-20 | ããŠãã¢ã«ã»ã€ã³ãã«ãããªãã«ã»ã¬ã»ãŒã«ãã»ããŒã»ãŽãšãŒ | ã³ãããŠã€ã«ã¹çšã¯ã¯ãã³ã®èª¿è£œæ¹æ³ |
| JPS61227785A (ja) * | 1984-11-27 | 1986-10-09 | ã¢ã¬ããŠã©âã»ãã€ã¢ã°ãã¹ãã€ãã¯ã¹ã»ã€ã³ã³âãã¬âããã | ïœïœããâãã®å€§èŠæš¡çç£ |
| JPH0467960A (ja) * | 1990-07-09 | 1992-03-03 | Brother Ind Ltd | ãããŒãžã§ããèšé²è£ 眮 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3018215A1 (en) | 2006-02-13 | 2016-05-11 | Fluidigm Canada Inc. | Gene expression assays conducted by elemental analysis |
| EP3561071A1 (en) | 2006-02-13 | 2019-10-30 | Fluidigm Canada Inc. | Gene expression assays conducted by elemental analysis |
| EP1932924A1 (en) | 2006-11-22 | 2008-06-18 | FUJIFILM Corporation | Nucleic acid amplification method using microchip and microchip, and nucleic acid amplification system using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA862335B (en) | 1987-11-25 |
| JPH0467960B2 (ja) | 1992-10-29 |
| JPS62281A (ja) | 1987-01-06 |
| ZA862334B (en) | 1987-11-25 |
| JPS61274697A (ja) | 1986-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2622327B2 (ja) | æ žé žé åã®å¢å¹ æ段 | |
| JP2546576B2 (ja) | æ žé žé åã®ã¯ããŒãã³ã°æ¹æ³ | |
| US4683195A (en) | Process for amplifying, detecting, and/or-cloning nucleic acid sequences | |
| US4800159A (en) | Process for amplifying, detecting, and/or cloning nucleic acid sequences | |
| JPH0467957B2 (ja) | ||
| US6040166A (en) | Kits for amplifying and detecting nucleic acid sequences, including a probe | |
| US6197563B1 (en) | Kits for amplifying and detecting nucleic acid sequences | |
| EP0333465B1 (en) | Mutation detection by competitive oligonucleotide priming | |
| US5629178A (en) | Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA) | |
| JP3421664B2 (ja) | ãã¯ã¬ãªããå¡©åºã®åå®æ¹æ³ | |
| WO1996013611A9 (en) | A method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (pna) | |
| DK175778B1 (da) | Kit til multiplicering og påvisning af nukleinsyresekvenser | |
| DK175248B1 (da) | Et förste og andet oligonukleotid og anvendelse deraf til eksponentiel multiplicering ved polymerase-kÊdereaktion af en specifik nukleinsyresekvens indeholdt i en enkelt- eller dobbeltstrenget nukleinsyre eller i en blanding af sådanne nukleinsyrer | |
| IE83456B1 (en) | Kit for use in amplifying and detecting nucleic acid sequences | |
| IE83464B1 (en) | Process for amplifying and detecting nucleic acid sequences | |
| IE19930227A1 (en) | Kit for use in amplifying and detecting nucleic acid sequences |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |